# EDGAR Filing Document

**Accession Number:** 0001734342
**File Stem:** 0001734342-25-000067
**Filing Date:** 2025-10
**Character Count:** 432277
**Document Hash:** b0e966399ef891559d3e56b665b49f4a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001734342-25-000067.hdr.sgml**: 20251031

**ACCESSION NUMBER**: 0001734342-25-000067

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 107

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251031

**DATE AS OF CHANGE**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Amerant Bancorp Inc.
- **CENTRAL INDEX KEY:** 0001734342
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 650032379
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38534
- **FILM NUMBER:** 251441261

**BUSINESS ADDRESS:**
- **STREET 1:** 220 ALHAMBRA CIRCLE
- **CITY:** CORAL GABLES
- **STATE:** FL
- **ZIP:** 33134
- **BUSINESS PHONE:** (305)460-4038

**MAIL ADDRESS:**
- **STREET 1:** 220 ALHAMBRA CIRCLE
- **CITY:** CORAL GABLES
- **STATE:** FL
- **ZIP:** 33134

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Mercantil Bank Holding Corp
- **DATE OF NAME CHANGE:** 20180312

?xml version='1.0' encoding='ASCII'? amtb-20250930

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended September 30, 2025

or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from __________ to __________

Commission File Number: 001-38534

![amerantimagea03.jpg](amtb-20250930_g1.jpg)

**Amerant Bancorp Inc.** 

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Florida** | **Florida** | **65-0032379** |
| (State or other jurisdiction of<br>incorporation or organization) | (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |
| **220 Alhambra Circle** | **220 Alhambra Circle** |  |
| **Coral Gables,** | **Florida** | **33134** |
| (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |
| **(305)** | **(305)** | **460-4728** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |
| **N/A** | **N/A** | **N/A** |
| (Former name, former address and former fiscal year, if changed since last report) | (Former name, former address and former fiscal year, if changed since last report) | (Former name, former address and former fiscal year, if changed since last report) |

---

Securities registered pursuant to Section 12(b) of the Act:

<u>Title of each class</u> <u>Trading Symbol(s)</u> <u>Name of exchange on which registered</u> <br> Class A Common Stock AMTB New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer  | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer  | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ &nbsp;&nbsp;&nbsp;&nbsp;No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

---

| | |
|:---|:---|
| Class | Outstanding as of October 29, 2025 |
| Class A Common Stock, $0.10 par value per share | 41,265,603 shares of Class A Common Stock |

---

------

**AMERANT BANCORP INC. AND SUBSIDIARIES**

**FORM 10-Q**

**September 30, 2025** 

**INDEX** 

---

| | | |
|:---|:---|:---|
| | | Page |
| <u>[PART I.](#ic566456e146f4e4cbdaaa9926d521e26_10)</u> | <u>[FINANCIAL INFORMATION](#ic566456e146f4e4cbdaaa9926d521e26_10)</u> |  |
| <u>[Item 1](#ic566456e146f4e4cbdaaa9926d521e26_13)</u> | <u>[Financial Statements](#ic566456e146f4e4cbdaaa9926d521e26_13)</u> | <u>[3](#ic566456e146f4e4cbdaaa9926d521e26_10)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Balance Sheets as of](#ic566456e146f4e4cbdaaa9926d521e26_16)[September](#ic566456e146f4e4cbdaaa9926d521e26_16)[30, 2025 (Unaudited) and December 31, 2024](#ic566456e146f4e4cbdaaa9926d521e26_16)</u> | <u>[3](#ic566456e146f4e4cbdaaa9926d521e26_16)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Operations and Comprehensive Income for the three and](#ic566456e146f4e4cbdaaa9926d521e26_19)[nine](#ic566456e146f4e4cbdaaa9926d521e26_19)[month periods ended](#ic566456e146f4e4cbdaaa9926d521e26_19)[September](#ic566456e146f4e4cbdaaa9926d521e26_19)[30, 2025 and 2024 (Unaudited)](#ic566456e146f4e4cbdaaa9926d521e26_19)</u> | <u>[4](#ic566456e146f4e4cbdaaa9926d521e26_19)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Changes in Stockholders' Equity for the three and](#ic566456e146f4e4cbdaaa9926d521e26_22)[nine](#ic566456e146f4e4cbdaaa9926d521e26_22)[month periods ended](#ic566456e146f4e4cbdaaa9926d521e26_22)[September 30, 2025](#ic566456e146f4e4cbdaaa9926d521e26_19)[and 2024 (Unaudited)](#ic566456e146f4e4cbdaaa9926d521e26_22)</u> | <u>[6](#ic566456e146f4e4cbdaaa9926d521e26_22)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Cash Flows for the](#ic566456e146f4e4cbdaaa9926d521e26_25)[nine](#ic566456e146f4e4cbdaaa9926d521e26_25)[months ended](#ic566456e146f4e4cbdaaa9926d521e26_25)[September](#ic566456e146f4e4cbdaaa9926d521e26_25)[30, 2025 and 2024 (Unaudited)](#ic566456e146f4e4cbdaaa9926d521e26_25)</u> | <u>[8](#ic566456e146f4e4cbdaaa9926d521e26_25)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Interim Consolidated Financial Statements (Unaudited)](#ic566456e146f4e4cbdaaa9926d521e26_28)</u> | <u>[10](#ic566456e146f4e4cbdaaa9926d521e26_28)</u> |
| <u>[Item 2](#ic566456e146f4e4cbdaaa9926d521e26_97)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#ic566456e146f4e4cbdaaa9926d521e26_97)</u> | <u>[54](#ic566456e146f4e4cbdaaa9926d521e26_97)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Cautionary Notice Regarding Forward-Looking Statements](#ic566456e146f4e4cbdaaa9926d521e26_100)</u> | <u>[54](#ic566456e146f4e4cbdaaa9926d521e26_100)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Overview](#ic566456e146f4e4cbdaaa9926d521e26_103)</u> | <u>[58](#ic566456e146f4e4cbdaaa9926d521e26_103)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Results of Operations](#ic566456e146f4e4cbdaaa9926d521e26_115)</u> | <u>[66](#ic566456e146f4e4cbdaaa9926d521e26_115)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Financial Condition](#ic566456e146f4e4cbdaaa9926d521e26_145)</u> | <u>[92](#ic566456e146f4e4cbdaaa9926d521e26_145)</u> |
| <u>[Item 3](#ic566456e146f4e4cbdaaa9926d521e26_205)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#ic566456e146f4e4cbdaaa9926d521e26_205)</u> | <u>[115](#ic566456e146f4e4cbdaaa9926d521e26_205)</u> |
| <u>[Item 4](#ic566456e146f4e4cbdaaa9926d521e26_208)</u> | <u>[Controls and Procedures](#ic566456e146f4e4cbdaaa9926d521e26_208)</u> | <u>[119](#ic566456e146f4e4cbdaaa9926d521e26_208)</u> |
| <u>[PART II](#ic566456e146f4e4cbdaaa9926d521e26_211)</u> | <u>[OTHER INFORMATION](#ic566456e146f4e4cbdaaa9926d521e26_211)</u> |  |
| <u>[Item 1](#ic566456e146f4e4cbdaaa9926d521e26_214)</u> | <u>[Legal Proceedings](#ic566456e146f4e4cbdaaa9926d521e26_214)</u> | <u>[120](#ic566456e146f4e4cbdaaa9926d521e26_214)</u> |
| <u>[Item 1A](#ic566456e146f4e4cbdaaa9926d521e26_217)</u> | <u>[Risk Factors](#ic566456e146f4e4cbdaaa9926d521e26_217)</u> | <u>[120](#ic566456e146f4e4cbdaaa9926d521e26_217)</u> |
| <u>[Item 2](#ic566456e146f4e4cbdaaa9926d521e26_220)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#ic566456e146f4e4cbdaaa9926d521e26_220)</u> | <u>[120](#ic566456e146f4e4cbdaaa9926d521e26_220)</u> |
| <u>[Item 3](#ic566456e146f4e4cbdaaa9926d521e26_223)</u> | <u>[Defaults Upon Senior Securities](#ic566456e146f4e4cbdaaa9926d521e26_223)</u> | <u>[120](#ic566456e146f4e4cbdaaa9926d521e26_223)</u> |
| <u>[Item 4](#ic566456e146f4e4cbdaaa9926d521e26_226)</u> | <u>[Mine Safety Disclosures](#ic566456e146f4e4cbdaaa9926d521e26_226)</u> | <u>[121](#ic566456e146f4e4cbdaaa9926d521e26_226)</u> |
| <u>[Item 5](#ic566456e146f4e4cbdaaa9926d521e26_229)</u> | <u>[Other Information](#ic566456e146f4e4cbdaaa9926d521e26_229)</u> | <u>[121](#ic566456e146f4e4cbdaaa9926d521e26_229)</u> |
| <u>[Item 6](#ic566456e146f4e4cbdaaa9926d521e26_235)</u> | <u>[Exhibits](#ic566456e146f4e4cbdaaa9926d521e26_235)</u> | <u>[122](#ic566456e146f4e4cbdaaa9926d521e26_235)</u> |
|  | <u>[Signatures](#ic566456e146f4e4cbdaaa9926d521e26_238)</u> | <u>[123](#ic566456e146f4e4cbdaaa9926d521e26_238)</u> |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Part 1. FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**Amerant Bancorp Inc. and Subsidiaries**

**Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| *(in thousands, except share data)* | **(Unaudited)** <br>**September 30, 2025** | **December 31, 2024** |
| **Assets** |  |  |
| Cash and due from banks | $46190 | $39197 |
| Interest earning deposits with banks | 570612 | 519853 |
| Restricted cash | 6894 | 24365 |
| Other short-term investments | 7162 | 6944 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 630858 | 590359 |
| Securities |  |  |
| &nbsp;&nbsp;&nbsp;Debt securities available for sale | 2122416 | 1437170 |
| &nbsp;&nbsp;&nbsp;Trading securities | 119935 |  |
| &nbsp;&nbsp;&nbsp;Equity securities with readily determinable fair value not held for trading | 2542 | 2477 |
| &nbsp;&nbsp;&nbsp;Federal Reserve Bank and Federal Home Loan Bank stock | 62808 | 58278 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Securities | 2307701 | 1497925 |
| Mortgage loans held for sale, at fair value |  | 42911 |
| Loans held for investment, gross | 6941792 | 7228411 |
| Less: allowance for credit losses | 94918 | 84963 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loans held for investment, net | 6846874 | 7143448 |
| Bank owned life insurance | 258042 | 243547 |
| Premises and equipment, net | 30268 | 31814 |
| Deferred tax assets, net | 46881 | 53543 |
| Operating lease right-of-use assets | 102872 | 100028 |
| Goodwill | 19193 | 19193 |
| Accrued interest receivable and other assets | 167510 | 178966 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $10410199 | $9901734 |
| **Liabilities and Stockholders' Equity** |  |  |
| Deposits |  |  |
| &nbsp;&nbsp;&nbsp;Demand |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Noninterest bearing | $1768764 | $1504755 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest bearing | 2294310 | 2229467 |
| &nbsp;&nbsp;&nbsp;Savings and money market | 2139964 | 1885928 |
| &nbsp;&nbsp;&nbsp;Time | 2097931 | 2234445 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deposits | 8300969 | 7854595 |
| Advances from the Federal Home Loan Bank | 831699 | 745000 |
| Senior notes |  | 59843 |
| Subordinated notes | 29752 | 29624 |
| Junior subordinated debentures held by trust subsidiaries | 64178 | 64178 |
| Operating lease liabilities | 109726 | 106071 |
| Accounts payable, accrued liabilities and other liabilities | 128935 | 151956 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 9465259 | 9011267 |
| Commitments and Contingencies (Note 11) |  |  |
| Stockholders' equity |  |  |
| &nbsp;&nbsp;Class A common stock, $0.10 par value, 250 million shares authorized; 41,265,378 shares issued and outstanding at September 30, 2025 (42,127,316 shares issued and outstanding at December 31, 2024) | 4125 | 4214 |
| &nbsp;&nbsp;&nbsp;Additional paid in capital | 327205 | 343828 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 620542 | 582231 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (6932) | (39806) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 944940 | 890467 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $10410199 | $9901734 |

---

The accompanying notes are an integral part of these consolidated financial statements (unaudited).

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

**Consolidated Statements of Operations and Comprehensive Income (Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| *(in thousands)* | **2025** | **2024** | **2025** | **2024** |
| **Interest income** |  |  |  |  |
| Loans | $121414 | $129752 | $364601 | $376574 |
| Investment securities | 26737 | 17127 | 68868 | 50168 |
| Interest earning deposits with banks and other interest income | 4592 | 4758 | 16777 | 15929 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest income | 152743 | 151637 | 450246 | 442671 |
| **Interest expense** |  |  |  |  |
| Interest bearing demand deposits | 10892 | 15345 | 32913 | 49860 |
| Savings and money market deposits | 18008 | 16830 | 52713 | 46690 |
| Time deposits | 20950 | 27260 | 67093 | 79355 |
| Advances from the Federal Home Loan Bank | 7316 | 8833 | 21746 | 21357 |
| Senior notes |  | 942 | 1020 | 2826 |
| Subordinated notes | 362 | 361 | 1084 | 1083 |
| Junior subordinated debentures | 1063 | 1067 | 3141 | 3176 |
| Securities sold under agreements to repurchase |  |  | 1 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | 58591 | 70638 | 179711 | 204349 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income | 94152 | 80999 | 270535 | 238322 |
| Provision for credit losses | 14600 | 19000 | 39106 | 50550 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net interest income after provision for credit losses | 79552 | 61999 | 231429 | 187772 |
| **Noninterest income** |  |  |  |  |
| Deposits and service fees | 5056 | 5046 | 15161 | 14652 |
| Brokerage, advisory and fiduciary activities | 4995 | 4466 | 14717 | 13331 |
| Gain on early extinguishment of advances from the Federal Home Loan Bank, net |  |  |  | 189 |
| Loan-level derivative income | 2372 | 3515 | 7084 | 6338 |
| Change in cash surrender value of bank owned life insurance | 2554 | 2332 | 7494 | 6916 |
| Cards and trade finance servicing fees | 1321 | 1430 | 4517 | 3984 |
| Derivative losses, net | (1383) |  | (3235) | (196) |
| Securities gains (losses), net | 1203 | (68484) | 3046 | (68655) |
| Other noninterest income | 1173 | 4012 | 7810 | 9666 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noninterest income (loss) | 17291 | (47683) | 56594 | (13775) |
| **Noninterest expense** |  |  |  |  |
| Salaries and employee benefits | 35094 | 34979 | 104477 | 101794 |
| Professional and other services fees | 15997 | 13711 | 44228 | 36784 |
| Occupancy and equipment | 5211 | 5891 | 16838 | 21408 |
| Telecommunication and data processing | 3155 | 2991 | 9559 | 9256 |
| Advertising expenses | 3987 | 3468 | 12441 | 10789 |
| FDIC assessments and insurance | 2549 | 2863 | 8681 | 8643 |
| Depreciation and amortization | 1487 | 1737 | 4626 | 4866 |
| Loan level derivative expense | 1834 | 1802 | 3307 | 2386 |
| Other real estate owned and repossessed assets expense, net | 215 | 5535 | 980 | 5033 |
| Losses on loans held for sale carried at the lower of cost or fair value  | 881 |  | 881 | 1258 |
| Other operating expenses | 7425 | 3231 | 17771 | 13887 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total noninterest expenses | 77835 | 76208 | 223789 | 216104 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before income tax (expense) benefit | 19008 | (61892) | 64234 | (42107) |
| Income tax (expense) benefit | (4252) | 13728 | (14518) | 9474 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Amerant Bancorp Inc. | $14756 | $(48164) | $49716 | $(32633) |

---

The accompanying notes are an integral part of these consolidated financial statements (unaudited).

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

**Consolidated Statements of Operations and Comprehensive Income (Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| *(in thousands, except per share data)* | **2025** | **2024** | **2025** | **2024** |
| **Other comprehensive income, net of tax** |  |  |  |  |
| Net unrealized holding gains on debt securities available for sale arising during the period | $18553 | $15142 | $33029 | $7060 |
| Net unrealized holding gains (losses) on cash flow hedges arising during the period | 82 | (205) | 268 | 92 |
| Reclassification adjustment for items included in net income | (119) | 51017 | (423) | 50683 |
| Other comprehensive income | 18516 | 65954 | 32874 | 57835 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income | $33272 | $17790 | $82590 | $25202 |
| Earnings Per Share (Note 13): |  |  |  |  |
| Basic earnings (loss) per common share | $0.35 | $(1.43) | $1.19 | $(0.97) |
| Diluted earnings (loss) per common share | $0.35 | $(1.43) | $1.19 | $(0.97) |

---

The accompanying notes are an integral part of these consolidated financial statements (unaudited).

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

**Consolidated Statements of Changes in Stockholders' Equity (Unaudited)**

**Three and Nine Month Periods Ended September 30, 2025** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common Stock | Common Stock | Additional<br>Paid<br>in Capital | Treasury Stock | Retained<br>Earnings | Accumulated Other Comprehensive loss | Total<br>Stockholders'<br>Equity |
| (in thousands, except share data) | Shares Outstanding | Issued Shares - Par Value | Additional<br>Paid<br>in Capital | Treasury Stock | Retained<br>Earnings | Accumulated Other Comprehensive loss | Total<br>Stockholders'<br>Equity |
| (in thousands, except share data) | Class A | Class A | Additional<br>Paid<br>in Capital | Treasury Stock | Retained<br>Earnings | Accumulated Other Comprehensive loss | Total<br>Stockholders'<br>Equity |
| **Balance at December 31, 2024** | 42127316 | $4214 | $343828 | $— | $582231 | $(39806) | $890467 |
| Repurchase of Class A common stock | (215427) |  |  | (5000) |  |  | (5000) |
| Treasury stock retired |  | (22) | (4978) | 5000 |  |  |  |
| Issuance of common shares for restricted stock unit vesting | 71839 | 7 | (7) |  |  |  |  |
| Restricted stock and restricted stock units surrendered | (26320) | (3) | (596) |  |  |  | (599) |
| Restricted stock forfeited | (4818) | (1) | 1 |  |  |  |  |
| Stock-based compensation expense |  |  | 790 |  |  |  | 790 |
| Dividends paid |  |  |  |  | (3885) |  | (3885) |
| Net income attributable to Amerant Bancorp Inc. |  |  |  |  | 11958 |  | 11958 |
| Other comprehensive income |  |  |  |  |  | 12532 | 12532 |
| **Balance at March 31, 2025** | 41952590 | $4195 | $339038 | $— | $590304 | $(27274) | $906263 |
| Repurchase of Class A common stock | (275666) |  |  | (5000) |  |  | (5000) |
| Treasury stock retired |  | (28) | (4972) | 5000 |  |  |  |
| Restricted stock and restricted stock units surrendered | (6241) | (1) | (252) |  |  |  | (253) |
| Stock issued for employee stock purchase plan | 34347 | 3 | 586 |  |  |  | 589 |
| Issuance of common shares for restricted stock unit vesting | 43404 | 4 | (4) |  |  |  |  |
| Stock-based compensation expense |  |  | 1625 |  |  |  | 1625 |
| Net income attributable to Amerant Bancorp Inc. |  |  |  |  | 23002 |  | 23002 |
| Dividends paid |  |  |  |  | (3766) |  | (3766) |
| Other comprehensive income |  |  |  |  |  | 1826 | 1826 |
| **Balance at June 30, 2025** | 41748434 | $4173 | $336021 | $— | $609540 | $(25448) | $924286 |
| Repurchase of Class A common stock | (487657) |  |  | (10000) |  |  | (10000) |
| Treasury stock retired |  | (49) | (9951) | 10000 |  |  |  |
| Restricted stock and restricted stock units surrendered | (2077) |  | (16) |  |  |  | (16) |
| Restricted stock forfeited | (675) |  |  |  |  |  |  |
| Issuance of common shares for restricted stock unit vesting | 7353 | 1 | (1) |  |  |  |  |
| Stock-based compensation expense |  |  | 1152 |  |  |  | 1152 |
| Net income attributable to Amerant Bancorp Inc. |  |  |  |  | 14756 |  | 14756 |
| Dividends paid |  |  |  |  | (3754) |  | (3754) |
| Other comprehensive income |  |  |  |  |  | 18516 | 18516 |
| **Balance at September 30, 2025** | 41265378 | $4125 | $327205 | $— | $620542 | $(6932) | $944940 |

---

The accompanying notes are an integral part of these consolidated financial statements (unaudited).

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

**Consolidated Statements of Changes in Stockholders' Equity (Unaudited)**

**Three and Nine Month Periods Ended September 30, 2024**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common Stock | Common Stock | Additional<br>Paid<br>in Capital | Treasury Stock | Retained<br>Earnings | Accumulated Other Comprehensive loss | Total<br>Stockholders'<br>Equity |
| *(in thousands, except share data)* | Shares Outstanding | Issued Shares - Par Value | Additional<br>Paid<br>in Capital | Treasury Stock | Retained<br>Earnings | Accumulated Other Comprehensive loss | Total<br>Stockholders'<br>Equity |
| *(in thousands, except share data)* | Class A | Class A | Additional<br>Paid<br>in Capital | Treasury Stock | Retained<br>Earnings | Accumulated Other Comprehensive loss | Total<br>Stockholders'<br>Equity |
| **Balance at December 31, 2023** | 33603242 | $3361 | $192701 | $— | $610802 | $(70796) | $736068 |
| Issuance of common shares for restricted stock unit vesting | 77615 | 8 | (8) |  |  |  |  |
| Issuance of common shares for performance shares unit vesting | 125271 | 13 | (13) |  |  |  |  |
| Restricted stock, restricted stock units and performance stock units surrendered | (92830) | (9) | (2078) |  |  |  | (2087) |
| Restricted stock forfeited | (3903) |  |  |  |  |  |  |
| Stock-based compensation expense |  |  | 1635 |  |  |  | 1635 |
| Dividends paid |  |  |  |  | (3011) |  | (3011) |
| Net income attributable to Amerant Bancorp Inc. |  |  |  |  | 10568 |  | 10568 |
| Other comprehensive loss |  |  |  |  |  | (5088) | (5088) |
| **Balance at March 31, 2024** | 33709395 | $3373 | $192237 | $— | $618359 | $(75884) | $738085 |
| Repurchase of Class A common stock | (200652) |  |  | (4448) |  |  | (4448) |
| Treasury stock retired |  | (20) | (4428) | 4448 |  |  |  |
| Restricted stock and restricted stock units surrendered | (7957) | (1) | (93) |  |  |  | (94) |
| Stock issued for employee stock purchase plan | 28510 | 3 | 483 |  |  |  | 486 |
| Restricted stock forfeited | (15043) | (2) | 2 |  |  |  |  |
| Restricted stock units vested | 48503 | 4 | (4) |  |  |  |  |
| Stock-based compensation expense |  |  | 1404 |  |  |  | 1404 |
| Net income attributable to Amerant Bancorp Inc. |  |  |  |  | 4963 |  | 4963 |
| Dividends paid |  |  |  |  | (3023) |  | (3023) |
| Other comprehensive loss |  |  |  |  |  | (3031) | (3031) |
| **Balance at June 30, 2024** | 33562756 | $3357 | $189601 | $— | $620299 | $(78915) | $734342 |
| Repurchase of Class A common stock | (143674) |  |  | (3108) |  |  | (3108) |
| Common stock issuance | 8684210 | 868 | 154882 |  |  |  | 155750 |
| Treasury stock retired |  | (14) | (3094) | 3108 |  |  |  |
| Restricted stock and restricted stock units surrendered | (4334) |  | (87) |  |  |  | (87) |
| Restricted stock forfeited | (3814) | (1) |  |  |  |  | (1) |
| Restricted stock units vested | 8479 |  |  |  |  |  |  |
| Stock-based compensation expense |  |  | 1206 |  |  |  | 1206 |
| Net loss attributable to Amerant Bancorp Inc. |  |  |  |  | (48164) |  | (48164) |
| Dividends paid |  |  |  |  | (3004) |  | (3004) |
| Other comprehensive income |  |  |  |  |  | 65954 | 65954 |
| **Balance at September 30, 2024** | 42103623 | $4210 | $342508 |  | $569131 | $(12961) | $902888 |

---

The accompanying notes are an integral part of these consolidated financial statements (unaudited).

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

**Consolidated Statements of Cash Flows (Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| *(in thousands)* | **2025** | **2024** |
| **Cash flows from operating activities** |  |  |
| Net income (loss) | $49716 | $(32633) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for credit losses | 39106 | 50550 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net premium amortization on securities | 1757 | 4049 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 4626 | 4866 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 3567 | 4245 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in cash surrender value of bank owned life insurance | (7494) | (6916) |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities (gains) losses, net | (3046) | 68655 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative losses, net | 3235 | 196 |
| &nbsp;&nbsp;&nbsp;Gains on sale of loans, net | (5257) | (5819) |
| &nbsp;&nbsp;&nbsp;Losses on loans held for sale carried at the lower of cost or fair value | 881 | 1258 |
| &nbsp;&nbsp;&nbsp;Deferred taxes and others | (1103) | 2518 |
| &nbsp;&nbsp;&nbsp;Gain on early extinguishment of advances from the FHLB, net |  | (189) |
| Proceeds from sales and repayments of loans held for sale (at fair value) | 135365 | 251815 |
| Originations and purchases of loans held for sale (at fair value) | (100400) | (291139) |
| Net changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued interest receivable and other assets | 1085 | (34459) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, accrued liabilities and other liabilities | (21540) | (12343) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 100498 | 4654 |
| **Cash flows from investing activities** |  |  |
| Purchases of investment securities: |  |  |
| &nbsp;&nbsp;Available for sale | (794586) | (242229) |
| &nbsp;&nbsp;Trading securities | (118444) |  |
| &nbsp;&nbsp;Federal Home Loan Bank stock | (8330) | (45910) |
|  | (921360) | (288139) |
| Maturities, sales, calls and paydowns of investment securities: |  |  |
| &nbsp;&nbsp;&nbsp;Available for sale | 151860 | 228933 |
| &nbsp;&nbsp;&nbsp;Trading securities | 1555 | 9622 |
| &nbsp;&nbsp;&nbsp;Federal Home Loan Bank stock | 3800 | 32600 |
|  | 157215 | 271155 |
| Proceeds from surrender of bank owned life insurance |  | 62741 |
| Net decrease (increase) in loans | 211582 | (788643) |
| Proceeds from loan portfolio sales | 58340 | 469934 |
| Proceeds from sales of other real estate owned | 2661 |  |
| Net purchases of premises and equipment and others | (2534) | (6609) |
| Proceeds from bank owned life insurance death benefit |  | 1232 |
| Purchase of bank owned life insurance | (7000) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (501096) | (278329) |
| **Cash flows from financing activities** |  |  |
| Net increase in demand, savings and money market accounts | 582888 | 109600 |
| Net (decrease) increase in time deposits | (136514) | 106481 |
| Proceeds from advances from the Federal Home Loan Bank | 380000 | 1412500 |
| Repayments of advances from the Federal Home Loan Bank | (293387) | (1142311) |
| Redemption of senior notes | (60000) |  |
| Repurchase of common stock - Class A | (20000) | (7556) |
| Net proceeds from issuance of common stock |  | 155750 |
| Dividend paid | (11405) | (9038) |
| Disbursements arising from stock-based compensation, net | (485) | (1782) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 441097 | 623644 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase in cash and cash equivalents and restricted cash | 40499 | 349969 |
| **Cash, cash equivalents and restricted cash** |  |  |
| Beginning of period | 590359 | 321872 |
| End of period | $630858 | $671841 |

---

The accompanying notes are an integral part of these consolidated financial statements (unaudited).

------

**Amerant Bancorp Inc. and Subsidiaries**

**Consolidated Statements of Cash Flows (Unaudited) (continued)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| *(in thousands)* | **2025** | **2024** |
| **Supplemental disclosures of cash flow information** |  |  |
| Cash paid: |  |  |
| &nbsp;&nbsp;&nbsp;Interest | $184259 | $207389 |
| &nbsp;&nbsp;&nbsp;Income taxes | 6077 | 4821 |
| Right-of-use assets obtained in exchange for new lease obligations | 6999 |  |
| Noncash investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Transfer from debt securities held to maturity to debt securities available for sale |  | 216560 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans held for sale (at fair value) transferred to loans held for investment | 8868 | 28115 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans transferred to other assets | 1893 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans held for sale (at lower of cost or fair value) transferred to loans held for investment | 40597 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans held for investment (at lower of cost or fair value) transferred to loans held for sale | 40597 | 560161 |
| &nbsp;&nbsp;&nbsp;&nbsp;Premises and equipment transferred to other assets |  | 11405 |
| &nbsp;&nbsp;&nbsp;&nbsp;Right-of-use assets transferred to other assets |  | 15368 |

---

The accompanying notes are an integral part of these consolidated financial statements (unaudited).

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**1. Business, Basis of Presentation and Summary of Significant Accounting Policies**

**a) Business**

Amerant Bancorp Inc. (the "Company") is a Florida corporation incorporated in 1985, which has operated since January 1987. The Company is a bank holding company registered under the Bank Holding Company Act of 1956 ("BHC Act"), as a result of its 100% ownership of Amerant Bank, N.A. (the "Bank"). The Company's principal office is in the City of Coral Gables, Florida. The Bank is a member of the Federal Deposit Insurance Corporation ("FDIC"), the Federal Reserve Bank of Atlanta ("Federal Reserve") and the Federal Home Loan Bank of Atlanta ("FHLB"). The Bank is a national bank subject to regulation and regular examinations by the Office of the Comptroller of the Currency ("OCC"). Amerant Investments, Inc., a securities broker-dealer ("Amerant Investments") is an operating subsidiary of the Bank.

Elant Bank & Trust Ltd., a Grand-Cayman based trust company (the "Cayman Bank") is a subsidiary of the Bank. The Company is executing a plan for the dissolution of the Cayman Bank and, as of September 30, 2025 and December 31, 2024, the Cayman Bank no longer had any trust relationships, many of which were transferred to the Bank. The dissolution of the Cayman Bank is expected to be completed in 2025, once regulatory approval from the applicable regulatory agency is received.

Amerant Mortgage, LLC, a mortgage lending company domiciled in Florida ("Amerant Mortgage") is another subsidiary of the Bank. In April 2025, considering its strategic decision to focus on Florida, the Company announced it would transition its mortgage business from a national mortgage originator model to in-footprint focused approach, emphasizing mortgage lending that supports the Company's retail and private banking customers. Since April 2025 and throughout the early part of the fourth quarter of 2025, the Company has progressively reduced the mortgage-focused FTE count from 77 FTEs to 17. All but 5 of the 17 remaining FTEs have been transferred to the Bank. In addition, loans owned are expected to be transferred into the Bank's core platform, and existing vendor contracts are expected to be terminated or modified. The Company is also in the process of assessing strategic alternatives for an eventual wind-down or sale of Amerant Mortgage, which it currently expects to complete in the first half of 2026.

<u>Sale of Houston Banking Operations</u>

During the second quarter of 2024, the Bank entered into a Purchase and Assumption Agreement with MidFirst Bank ("MidFirst") pursuant to which MidFirst agreed to purchase certain assets and assume certain liabilities (the "Houston Sale Transaction") of the banking operations and six branches in the Houston, Texas metropolitan statistical area. In the first nine months of 2024, the Company recorded non-routine expenses in connection with the Houston Sale Transaction totaling approximately $5.5 million as follows: (i) $3.4 million in market value adjustments for two branches owned based on third party appraisals; (ii) $1.3 million in loan valuation allowance due to deferred loan costs; (iii) $0.5 million for legal and investment banking fees; and (iv) $0.3 million in intangible write-off. For complete details of the Houston Sale Transaction, see the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed on March 5, 2025 (the "2024 Form 10-K") for more information.

<u>Public Offering and Securities Repositioning</u>

During the third quarter of 2024, the Company completed a public offering of 8,684,210 shares of its Class A voting common stock, at a price to the public of $19.00 per share, which included 784,210 shares issued upon the exercise in full by the underwriters of their option to purchase additional shares of common stock (the "Public Offering"). The total gross proceeds from the offering were approximately $165 million, with net proceeds of approximately $155.8 million after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

Upon successfully completing the Public Offering, the Company initiated a repositioning of the Company's securities portfolio (the "Securities Repositioning"). The Securities Repositioning consisted of the following actions: (i) transfer at their fair value (which was below their amortized cost) of all of the Company's debt securities previously classified as held to maturity and carried at amortized cost to the available for sale category; (ii) sale of all corporate notes and subordinated debt; and (iii) sale of all other debt securities classified as available for sale (including those previously classified as held to maturity) with a book yield of less than 2.75%. As a result of the Securities Repositioning, the Company recorded a total pre-tax loss of approximately $68.5 million in the three and nine months ended September 30, 2024. For complete details of the Public Offering and Securities Repositioning, see the 2024 Form 10-K for more information.

<u>Senior Notes</u>

On April 1, 2025, the Company redeemed $60.0 million in aggregate principal amount of its 5.75% Senior Notes that were due June 30, 2025 (the "Senior Notes"). The Senior Notes were redeemed in full at a redemption price equal to 100% of the principal amount of the Senior Notes, plus accrued and unpaid interest. The aggregate redemption price, including accrued interest, totaled approximately $60.9 million.

<u>Segment Information</u>

*Determination of the CODM*

The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer (CEO). The CEO makes the overall decisions about the Company's resource allocation and assesses the performance of the Company.

*<u>Determination and Identification of operating segments</u>*

The CODM manages the Company as one operating segment: the consolidated Company as one entity. All decisions regarding the allocation of financial, operational, and other resources are managed under this one segment. As part of the determination for the allocation of resources, the CODM regularly reviews net income as the measure of profit or loss. In addition, as part of the CODM's assessment of the performance of the consolidated entity, the CODM also reviews the consolidated financial statements for significant expenses which include both cash and noncash items, such as amortization and depreciation and stock-based compensation. For more information on the significant components of net income or any significant cash or noncash items, refer to our accompanying consolidated financial statements or the Notes to Consolidated Financial Statements contained within. The measure of assets is reported on the consolidated balance sheet as total consolidated assets.

*Segment results*

As the Company's consolidated financial information as of September 30, 2025 and December 31, 2024 conform with generally accepted accounting principles in the United States (GAAP) and the Company is managed on a single operating business segment, we collectively refer to the accompanying consolidated financial statements for the Segment Results for the measures of consolidated profit or loss, as well as consolidated total assets.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

<u>Stock Repurchase Program</u>

On December 19, 2022, the Company announced that the Board of Directors authorized a new repurchase program pursuant to which the Company may purchase, from time to time, up to an aggregate amount of $25 million of its shares of Class A common stock (the "Stock Repurchase Program"). On December 6, 2023, the Board approved to extend the expiration date of the Stock Repurchase Program that was set to expire on December 31, 2023 to December 31, 2024. On December 11, 2024, the Company announced that the Board approved to extend the expiration date to December 31, 2025. As of December 11, 2024, there was approximately $12.4 million available for repurchases under the Stock Repurchase Program. On May 28, 2025, the Company announced that the Board of Directors approved an increase in the amount available for repurchases of the Company' shares of Class A common stock under the Stock Repurchase Program to $25 million.

In the three and nine month periods ended September 30, 2025, the Company repurchased an aggregate of 487,657 and 978,750 shares of Class A common stock, respectively, at a weighted average price of $20.51 and $20.43 per share, respectively, under the Stock Repurchase Program. The aggregate purchase price for these transactions was $10.0 million and $20.0 million in the three and nine months ended September 30, 2025, respectively, including transaction costs. In the three and nine month periods ended September 30, 2024, the Company repurchased an aggregate of 143,674 shares of Class A common stock at a weighted average price of $21.59 per share, and 344,326 shares of Class A common stock at a weighted average price of $21.94 per share. The aggregate purchase price for these transactions was $3.1 million and $7.6 million in the three and nine month periods ended September 30, 2024, respectively, including transaction costs.

In the three and nine months ended September 30, 2025 and 2024, the Company's Board of Directors authorized the cancellation of all shares of Class A common stock previously repurchased. As of September 30, 2025 and 2024, there were no shares of Class A common stock held as treasury stock.

<u>Dividends</u>

Set forth below are the details of dividends declared and paid by the Company in the three and nine month periods ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Declaration Date</u>** | **<u>Record Date</u>** | **<u>Payment Date</u>** | **<u>Dividend Per Share</u>** | **<u>Dividend Amount</u>** |
| 07/23/2025 | 08/15/2025 | 08/29/2025 | $0.09 | $3.8 million |
| 04/23/2025 | 05/15/2025 | 05/30/2025 | $0.09 | $3.8 million |
| 01/22/2025 | 02/14/2025 | 02/28/2025 | $0.09 | $3.8 million |
| 07/24/2024 | 08/15/2024 | 08/30/2024 | $0.09 | $3.0 million |
| 04/24/2024 | 05/15/2024 | 05/30/2024 | $0.09 | $3.0 million |
| 01/17/2024 | 02/14/2024 | 02/29/2024 | $0.09 | $3.0 million |

---

On October 22, 2025, the Company's Board of Directors declared a cash dividend of $0.09 per share of common stock. The dividend is payable on November 28, 2025, to shareholders of record on November 14, 2025.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**b) Basis of Presentation and Summary of Significant Accounting Policies**

<u>Significant Accounting Policies</u> 

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required for a fair statement of financial position, results of operations and cash flows in conformity with GAAP. These unaudited interim consolidated financial statements reflect all adjustments that are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. These adjustments are of a normal, recurring nature. Interim period operating results may not be indicative of the operating results for a full year or any other period. These unaudited interim consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements as of December 31, 2024 and 2023 and for each of the three years in the period ended December 31, 2024 and the accompanying footnote disclosures for the Company, which are included in the 2024 Form 10-K.

In the second quarter of 2025, the Company changed its policy for charging off unsecured consumer loans when balances are past-due 120 days or more. Previously, the Company charged-off these loan types when balances were 90 days past due. The Company believes this change is in line with regulatory guidance. There was no material impact to Company's consolidated financial statements as of and for the nine months ended September 30, 2025 as a result of this change in policy.

For a complete summary of our significant accounting policies, *see* Note 1 to the Company's audited consolidated financial statements in the 2024 Form 10-K.

<u>Estimates</u>

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include: (i) the determination of the allowance for credit losses; (ii) the fair values of loans, securities and derivative contracts; (iii) the cash surrender value of bank owned life insurance; and (iv) the determination of whether the amount of deferred tax assets will more likely than not be realized. Management believes that these estimates are appropriate. Actual results could differ from these estimates.

**c) Recently Issued Accounting Pronouncements**

<u>Issued and Not Yet Adopted</u>

The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03 and 2025-01 Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, and Clarifying the Effective Date. This new guidance is intended to improve the disclosures a public company makes with respect to its expenses and seeks to address requests from financial statement users for more detailed information about the types of expenses in common captions. This new guidance is effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is in the process of evaluating the impact of this guidance on its consolidated financial statements when adopted.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

*New Guidance on Income Taxes*

In December 2023, the FASB issued ASU 2023-09—Income Taxes (Topic 740): Improvements to Income Tax Disclosures which amended guidance that requires entities to provide additional income tax disclosures on an annual basis. This includes the disclosure of more detailed information on income tax reconciliations and income tax paid. In addition, the amendments remove certain existing disclosure requirements related to uncertain tax positions and unrecognized deferred tax liabilities. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2024. The Company intends to adopt this guidance prospectively and we expect to expand our disclosures around income taxes in our 2025 Form 10-K. We believe that the adoption of this ASU will not have any other significant impacts on the Company's financial statements.

For a description of other recently issued accounting pronouncements, *see* Note 1 to the Company's audited consolidated financial statements in the 2024 Form 10-K.

**d) Subsequent Events**

The effects of significant subsequent events, if any, have been recognized or disclosed in these unaudited interim consolidated financial statements.

On October 21, 2025, the Company entered into a Wind-down and Settlement Agreement (the "Wind-down Agreement") with a commercial borrower to resolve an existing loan participation agreement. Under the Wind-down Agreement, the Company assumes the risk of future credit losses under the participation agreement, up to a cumulative cap of $7.7 million through June 30, 2026 (the "Loss Cap"). If actual credit losses are below the Loss Cap as of that date, the Company will pay the difference to the borrower by June 30, 2026. The Company is currently unable to estimate the difference between the actual credit losses that may be incurred through June 30, 2026 and the Loss Cap. As of September 30, 2025, the amount remaining to be covered towards the "Loss Cap" was $5.9 million. As part of the Wind-down Agreement, the borrower has agreed to irrevocably and unconditionally guarantee the full and timely payment of all amounts due to the Company under the loan participation agreement that exceed the Loss Cap, up to a maximum of $13.9 million.

On October 24, 2025, the Company collected $11.8 million on a commercial loan that had been previously charged off. The collection of this loan resulted in a loan recovery of $8.7 million and interest income recovery of $0.3 million in the fourth quarter of 2025.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**2. Interest Earning Deposits with Banks, Other Short-Term Investments and Restricted Cash**

At September 30, 2025 and December 31, 2024, interest earning deposits with banks are mainly comprised of deposits with the Federal Reserve and other U.S. banks of approximately $571 million and $520 million, respectively. At September 30, 2025 and December 31, 2024, the average interest rate on these deposits was approximately 4.41% and 5.31%, respectively. These deposits have no stated maturity dates.

As of September 30, 2025 and December 31, 2024, the Company held US Treasury Bills classified as part of other short-term investments in the Company's consolidated balance sheets. At September 30, 2025 and December 31, 2024, the Company held $7.2 million and $6.9 million, respectively, with an average yield of 4.22% and 5.07%, respectively, related to these investments. These other short-term investments have a stated maturity of 90 days or less and as such are deemed cash and cash equivalents.

At September 30, 2025 and December 31, 2024, the Company had restricted cash balances of $6.9 million and $24.4 million, respectively. These balances include cash pledged as collateral, by other banks to us, to secure derivatives' margin calls. This cash pledged as collateral also represents an obligation, by the Bank, to repay according to margin requirements. At September 30, 2025 and December 31, 2024, this obligation was $5.9 million and $23.5 million, respectively, which is included as part of other liabilities in the Company's consolidated balance sheets. In addition, we have cash balances pledged as collateral to secure the issuance of letters of credit by other banks on behalf of our customers.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**3. Securities**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**a) Debt Securities**

*<u>Debt securities available for sale</u>*

The Company's investments in debt securities primarily consist of mortgage-backed securities ("MBS"). The following tables present granular information such as amortized cost, allowance for credit losses and approximate fair values of all debt securities available for sale:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Amortized<br>Cost** | **Gross Unrealized** | **Gross Unrealized** | **Allowance for Credit Losses** | **Estimated<br>Fair Value** |
| *(in thousands)* | **Amortized<br>Cost** | **Gains** | **Losses** | **Allowance for Credit Losses** | **Estimated<br>Fair Value** |
| U.S. Treasury Securities | $2492 | $— | $— | $— | $2492 |
| U.S. Government agency and sponsored enterprise residential MBS | 1951732 | 15551 | (23574) |  | 1943709 |
| U.S. Government agency and sponsored enterprise commercial MBS | 156846 | 941 | (2797) |  | 154990 |
| U.S. Government agency and sponsored enterprise obligations | 12760 | 3 | (292) |  | 12471 |
| Non-agency commercial MBS (1) | 7320 |  | (176) |  | 7144 |
| Municipal Bonds (2) | 1732 |  | (122) |  | 1610 |
| Total debt securities available for sale (3) | $2132882 | $16495 | $(26961) | $— | $2122416 |

---

__________________

(1)Issued by a financial institution.

(2)Includes MBS securities with a fair value of $1.6 million and amortized cost of $1.7 million.

(3)Excludes accrued interest receivable of $8.0 million as of September 30, 2025, which is included as part of accrued interest receivable and other assets in the Company's consolidated balance sheet. The Company did not record any write offs on accrued interest receivable related to these securities in the three and nine month periods ended September 30, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Amortized<br>Cost** | **Gross Unrealized** | **Gross Unrealized** | **Allowance for Credit Losses** | **Estimated<br>Fair Value** |
| *(in thousands)* | **Amortized<br>Cost** | **Gains** | **Losses** | **Allowance for Credit Losses** | **Estimated<br>Fair Value** |
| U.S. Treasury Securities | $1932 | $1 | $— | $— | $1933 |
| U.S. Government agency and sponsored enterprise residential MBS | 1310419 | 758 | (48537) |  | 1262640 |
| U.S. Government agency and sponsored enterprise commercial MBS | 148338 | 137 | (5937) |  | 142538 |
| U.S. Government agency and sponsored enterprise obligations | 17060 | 10 | (388) |  | 16682 |
| Non-agency commercial MBS (1) | 12517 |  | (725) |  | 11792 |
| Municipal Bonds (2) | 1732 |  | (147) |  | 1585 |
| Total debt securities available for sale (3) | $1491998 | $906 | $(55734) | $— | $1437170 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

__________________

(1)Issued by a financial institution.

(2)Includes MBS securities with a fair value of $1.6 million and amortized cost of $1.7 million.

(3)Excludes accrued interest receivable of $5.7 million as of December 31, 2024, which is included as part of accrued interest receivable and other assets in the Company's consolidated balance sheet. The Company did not record any write offs on accrued interest receivable related to these securities in 2024.

There were no investments in foreign corporate bonds available for sale at September 30, 2025 and December 31, 2024. At September 30, 2025 and December 31, 2024, the Company had no foreign sovereign or foreign government agency debt securities available for sale. Investments in foreign corporate debt securities available for sale, if any, are denominated in U.S. Dollars.

In the three and nine month periods ended September 30, 2025, there were no sales, calls or redemptions of debt securities available for sale.

In the three and nine month periods ended September 30, 2024, proceeds from sales, redemptions and calls, gross realized gains, and gross realized losses of debt securities available for sale were as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Nine Months Ended September 30,** |
| *(in thousands)* | **2024** | **2024** |
| Proceeds from sales, redemptions and calls of debt securities available for sale | $139886 | $142766 |
| Gross realized gains | $— | $— |
| Gross realized losses | (6753) | (6873) |
| &nbsp;&nbsp;&nbsp;&nbsp;Realized loss, net  | $(6753) | $(6873) |

---

The Company's investment in debt securities available for sale with unrealized losses aggregated by the length of time that individual securities have been in a continuous unrealized loss position, are summarized below:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Less Than 12 Months** | **Less Than 12 Months** | **Less Than 12 Months** | **12 Months or More** | **12 Months or More** | **12 Months or More** | **Total** | **Total** |
| *(in thousands, except securities count)* | **Number of Securities** | **Estimated<br>Fair Value** | **Unrealized<br>Loss** | **Number of Securities** | **Estimated<br>Fair Value** | **Unrealized<br>Loss** | **Estimated<br>Fair Value** | **Unrealized<br>Loss** |
| &nbsp;&nbsp;U.S. Government agency and sponsored enterprise residential MBS | 10 | $56483 | $(249) | 315 | $490929 | $(23325) | $547412 | $(23574) |
| &nbsp;&nbsp;Non-agency commercial MBS |  |  |  | 1 | 7144 | (176) | 7144 | (176) |
| &nbsp;&nbsp;U.S. Government agency and sponsored enterprise commercial MBS | 2 | 16971 | (51) | 31 | 72463 | (2746) | 89434 | (2797) |
| &nbsp;&nbsp;U.S. Government agency and sponsored enterprise obligations | 3 | 213 | (1) | 42 | 12071 | (291) | 12284 | (292) |
| &nbsp;&nbsp;Municipal bonds |  |  |  | 3 | 1610 | (122) | 1610 | (122) |
|  | 15 | $73667 | $(301) | 392 | $584217 | $(26660) | $657884 | $(26961) |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Less Than 12 Months** | **Less Than 12 Months** | **Less Than 12 Months** | **12 Months or More** | **12 Months or More** | **12 Months or More** | **Total** | **Total** |
| *(in thousands, except securities count)* | **Number of Securities** | **Estimated<br>Fair Value** | **Unrealized<br>Loss** | **Number of Securities** | **Estimated<br>Fair Value** | **Unrealized<br>Loss** | **Estimated<br>Fair Value** | **Unrealized<br>Loss** |
| &nbsp;&nbsp;U.S. Government agency and sponsored enterprise residential MBS | 133 | $717487 | $(13555) | 324 | $407841 | $(34982) | $1125328 | $(48537) |
| &nbsp;&nbsp;Non-agency commercial MBS |  |  |  | 1 | 11792 | (725) | 11792 | (725) |
| &nbsp;&nbsp;U.S. Government agency and sponsored enterprise commercial MBS | 13 | 63468 | (1261) | 30 | 64606 | (4676) | 128074 | (5937) |
| &nbsp;&nbsp;U.S. Government agency and sponsored enterprise obligation | 2 | 228 | (1) | 47 | 15982 | (387) | 16210 | (388) |
| &nbsp;&nbsp;Municipal Bonds |  |  |  | 3 | 1585 | (147) | 1585 | (147) |
|  | 148 | $781183 | $(14817) | 405 | $501806 | $(40917) | $1282989 | $(55734) |

---

<u>U.S. Government Sponsored Enterprise Debt Securities and U.S. Government Agency Debt Securities</u>

At September 30, 2025 and December 31, 2024, the Company held certain debt securities issued or guaranteed by the U.S. government and U.S. government-sponsored entities and agencies. The Company evaluates these securities for credit losses by reviewing current market conditions, the extent and nature of changes in fair value, credit ratings, default and delinquency rates and current analysts' evaluations. The Company believes the decline in fair value on these debt securities below their amortized cost basis is attributable to changes in interest rates and investment securities markets, generally, and not credit quality. As a result, the Company did not record an Allowance for Credit Losses, or ACL, on these securities as of September 30, 2025 and December 31, 2024. Additionally, the Company does not intend to sell these debt securities and it considers it is more likely than not that it will not be required to sell the securities before their anticipated recovery.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

*<u>Contractual maturities</u>*

Contractual maturities of debt securities at September 30, 2025 are as follows:

---

| | | |
|:---|:---|:---|
| | **Available for Sale** | **Available for Sale** |
| *(in thousands)* | **Amortized<br>Cost** | **Estimated<br>Fair Value** |
| Within 1 year | $1994 | $1993 |
| After 1 year through 5 years | 51763 | 51527 |
| After 5 years through 10 years | 49654 | 48456 |
| After 10 years | 2029471 | 2020440 |
|  | $2132882 | $2122416 |

---

*<u>Trading Securities</u>*

Trading securities are used to support the Company's liquidity management activities and reported on the Company's Consolidated Balance Sheet at fair value. Our trading portfolio is entirely composed of U.S. Government agency and sponsored enterprise residential MBS with a fair value of $119.9 million at September 30, 2025. Changes in the fair value of trading securities are recorded in securities gains/losses on the Company's consolidated statements of income. The Company did not have any debt securities classified as trading securities at December 31, 2024.

Changes in the fair value of trading securities for the three and nine month periods ended September 30, 2025 and 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30** | **Three Months Ended September 30** | **Nine Months Ended September 30** | **Nine Months Ended September 30** |
| *(in thousands)* | **2025** | **2024** | **2025** | **2024** |
| Net gains recognized during the period on trading securities | $1185 | $— | $2962 | $— |
| Less: Net gains and losses recognized during the period on trading securities sold during the period |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized gains recognized during the reporting period on trading securities still held at the reporting date | $1185 | $— | $2962 | $— |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**b) Equity securities with readily available fair value not held for trading**

As of September 30, 2025 and December 31, 2024, the Company had an equity security with readily available fair value not held for trading with an original cost of $2.5 million and a fair value of $2.5 million. These equity securities have no stated maturities. There were no significant unrealized gains and losses related to these equity securities in the three and nine month periods ended September 30, 2025 and 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**c) Securities Pledged**

As of September 30, 2025 and December 31, 2024, the Company had $60.3 million and $135.7 million, respectively, in securities pledged as collateral. These securities were pledged to secure public funds, advances from the Federal Home Loan Bank and for other purposes as permitted by law.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**4. Loans**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**a) Loans held for investment**

Loans held for investment consist of the following loan classes:

---

| | | |
|:---|:---|:---|
| *(in thousands)* | **September 30,<br>2025** | **December 31,<br>2024** |
| Real estate loans |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Nonowner occupied | $1656180 | $1678473 |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential | 361650 | 336229 |
| &nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans | 544727 | 483210 |
|  | 2562557 | 2497912 |
| &nbsp;&nbsp;&nbsp;Single-family residential | 1550724 | 1528080 |
| &nbsp;&nbsp;&nbsp;Owner occupied | 900596 | 1007074 |
|  | 5013877 | 5033066 |
| Commercial loans | 1519778 | 1751902 |
| Loans to financial institutions and acceptances | 164974 | 170435 |
| Consumer loans and overdrafts | 243163 | 273008 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total loans held for investment, gross (1) | $6941792 | $7228411 |

---

_________________

(1)Excludes accrued interest receivable.

At September 30, 2025 and December 31, 2024, loans with outstanding principal balances of $1.8 billion and $2.0 billion, respectively, were pledged as collateral to secure advances from the FHLB.

The amounts above include loans under syndication facilities of approximately $368.3 million and $393.7 million at September 30, 2025 and December 31, 2024, respectively, which include Shared National Credit facilities and agreements to enter into credit agreements with other lenders (club deals) and other agreements.

International loans included above were $34.9 million and $40.7 million at September 30, 2025 and December 31, 2024, respectively, mainly comprised of single-family residential loans. These loans are generally secured by real estate properties located in the U.S.

There were no significant purchases of loans held for investment in the three and nine month periods ended September 30, 2025. In the three and nine months ended September 30, 2024, the Company purchased single-family residential loans totaling $6.7 million and $17.9 million, respectively.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

The age analyses of the loan portfolio by class as of September 30, 2025 and December 31, 2024, are summarized in the following tables:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Total Loans,<br>Net of<br>Unearned<br>Income** | | **Past Due** | **Past Due** | **Past Due** | **Past Due** |
| *(in thousands)* | **Total Loans,<br>Net of<br>Unearned<br>Income** | **Current** | **30-59<br>Days** | **60-89<br>Days** | **Greater than<br>90 Days** | **Total Past<br>Due** |
| Real estate loans |  |  |  |  |  |  |
| &nbsp;&nbsp;Commercial real estate |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | $1656180 | $1654893 | $265 | $— | $1022 | $1287 |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential | 361650 | 354566 | 7084 |  |  | 7084 |
| &nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans | 544727 | 519727 | 25000 |  |  | 25000 |
|  | 2562557 | 2529186 | 32349 |  | 1022 | 33371 |
| &nbsp;&nbsp;Single-family residential | 1550724 | 1525544 | 18418 | 1817 | 4945 | 25180 |
| &nbsp;&nbsp;Owner occupied | 900596 | 886047 | 10350 | 325 | 3874 | 14549 |
|  | 5013877 | 4940777 | 61117 | 2142 | 9841 | 73100 |
| Commercial loans | 1519778 | 1474516 | 22021 | 7882 | 15359 | 45262 |
| Loans to financial institutions and acceptances | 164974 | 164974 |  |  |  |  |
| Consumer loans and overdrafts | 243163 | 233215 | 8596 | 627 | 725 | 9948 |
|  | $6941792 | $6813482 | $91734 | $10651 | $25925 | $128310 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Total Loans,<br>Net of<br>Unearned<br>Income** | | **Past Due** | **Past Due** | **Past Due** | **Past Due** |
| *(in thousands)* | **Total Loans,<br>Net of<br>Unearned<br>Income** | **Current** | **30-59<br>Days** | **60-89<br>Days** | **Greater than<br>90 Days** | **Total Past<br>Due** |
| Real estate loans |  |  |  |  |  |  |
| &nbsp;&nbsp;Commercial real estate |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Nonowner occupied | $1678473 | $1676816 | $361 | $1296 | $— | $1657 |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential | 336229 | 335984 | 245 |  |  | 245 |
| Land development and construction loans | 483210 | 479091 | 4119 |  |  | 4119 |
|  | 2497912 | 2491891 | 4725 | 1296 |  | 6021 |
| &nbsp;&nbsp;Single-family residential | 1528080 | 1512536 | 2816 | 4668 | 8060 | 15544 |
| &nbsp;&nbsp;Owner occupied | 1007074 | 995443 | 6196 | 336 | 5099 | 11631 |
|  | 5033066 | 4999870 | 13737 | 6300 | 13159 | 33196 |
| Commercial loans | 1751902 | 1732409 | 12608 | 1362 | 5523 | 19493 |
| Loans to financial institutions and acceptances | 170435 | 170435 |  |  |  |  |
| Consumer loans and overdrafts | 273008 | 269761 | 1984 | 1255 | 8 | 3247 |
|  | $7228411 | $7172475 | $28329 | $8917 | $18690 | $55936 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**Nonaccrual status**

The following tables present the amortized cost basis of loans on nonaccrual status and loans past due over 90 days and still accruing as of September 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
| *(in thousands)* | **Nonaccrual Loans With No Related Allowance** | **Nonaccrual Loans With Related Allowance** | **Total Nonaccrual Loans** | **Loans Past Due Over 90 Days and Still Accruing** |
| Real estate loans |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonowner occupied | $4109 | $265 | $4374 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential | 7018 |  | 7018 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans | 19577 |  | 19577 |  |
|  | 30704 | 265 | 30969 |  |
| &nbsp;&nbsp;&nbsp;Single-family residential | 3115 | 5723 | 8838 |  |
| &nbsp;&nbsp;&nbsp;Owner occupied | 12737 | 2550 | 15287 |  |
|  | 46556 | 8538 | 55094 |  |
| Commercial loans | 31667 | 35414 | 67081 | 1392 |
| Consumer loans and overdrafts | 725 |  | 725 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $78948 | $43952 | $122900 | $1392 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
| *(in thousands)* | **Nonaccrual Loans With No Related Allowance** | **Nonaccrual Loans With Related Allowance** | **Total Nonaccrual Loans** | **Loans Past Due Over 90 Days and Still Accruing** |
| Real estate loans |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans | $4119 | $— | $4119 | $— |
|  | 4119 |  | 4119 |  |
| &nbsp;&nbsp;&nbsp;Single-family residential | 73 | 8067 | 8140 | 1201 |
| &nbsp;&nbsp;&nbsp;Owner occupied | 21710 | 1481 | 23191 | 837 |
|  | 25902 | 9548 | 35450 | 2038 |
| Commercial loans | 46822 | 17750 | 64572 | 2033 |
| Consumer loans and overdrafts |  |  |  | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $72724 | $27298 | $100022 | $4079 |

---

The Company did not recognize any interest income on nonaccrual loans during the three and nine month periods ended September 30, 2025 and 2024.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**b) Loans held for sale**

Loans held for sale consist of the following loan classes:

---

| | | |
|:---|:---|:---|
| *(in thousands)* | **September 30,<br>2025** | **December 31, 2024** |
| **<u>Mortgage loans held for sale at fair value</u>** |  |  |
| &nbsp;&nbsp;Land development and construction loans |  | 10768 |
| &nbsp;&nbsp;Single-family residential |  | 32143 |
| Total mortgage loans held for sale at fair value (1)(2) |  | 42911 |

---

_______________

(1)Loans held for sale in connection with Amerant Mortgage's ongoing business.

(2)Excludes accrued interest receivable.

During the nine months ended September 30, 2025, the Company transferred a $40.6 million commercial loan from held for investment to held for sale and transferred it back to held for investment. The Company sold this loan in September 2025 and recognized a loss on sale of $0.9 million. Additionally, in the first nine months of 2025, the Company transferred approximately $6.9 million in construction mortgage loans and $2.0 million in single family residential mortgage loans from held for sale to held for investment.

**c) Concentration of risk** 

While seeking diversification of our loan portfolio, the Company is dependent mostly on the economic conditions that affect South Florida, the greater Tampa, Houston and the five New York City boroughs. At September 30, 2025, our commercial real estate loans held for investment based in Florida, Houston, New York and other regions were $2.0 billion, $152 million, $197 million and $232 million, respectively.

**d) Accrued interest receivable on loans**

Accrued interest receivable on total loans, including loans held for investment and held for sale, was $29.7 million and $40.4 million as of September 30, 2025 and December 31, 2024, respectively.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**5. Allowance for Credit Losses**

The analyses by loan segment of the changes in the Allowance for Credit Losses, or ACL, for loans for the three and nine month periods ended September 30, 2025 and 2024 is summarized in the following tables:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| *(in thousands)* | **Real Estate** | **Commercial** | **Financial<br>Institutions** | **Consumer<br>and Others** | **Total** |
| **Balance at beginning of the period** | $23056 | $40048 | $— | $23415 | $86519 |
| Provision for (reversal of) credit losses - loans | 2519 | 12778 |  | (47) | 15250 |
| Loans charged-off | (1268) | (6244) |  | (2024) | (9536) |
| Recoveries | 77 | 1876 |  | 732 | 2685 |
| **Balance at end of the period** | $24384 | $48458 | $— | $22076 | $94918 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| *(in thousands)* | **Real Estate** | **Commercial** | **Financial<br>Institutions** | **Consumer<br>and Others** | **Total** |
| **Balance at beginning of the period** | $16668 | $44732 | $— | $23563 | $84963 |
| Provision for credit losses - loans | 8889 | 22907 |  | 4210 | 36006 |
| Loans charged-off | (1268) | (24701) |  | (7526) | (33495) |
| Recoveries | 95 | 5520 |  | 1829 | 7444 |
| **Balance at end of the period** | $24384 | $48458 | $— | $22076 | $94918 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended September 30, 2024** | **Three months ended September 30, 2024** | **Three months ended September 30, 2024** | **Three months ended September 30, 2024** | **Three months ended September 30, 2024** |
| *(in thousands)* | **Real Estate** | **Commercial** | **Financial<br>Institutions** | **Consumer<br>and Others** | **Total** |
| **Balance at beginning of the period** | $19064 | $52143 | $— | $23193 | $94400 |
| (Reversal of) provision for credit losses - loans | (2126) | 16234 |  | 3762 | 17870 |
| Loans charged-off |  | (31416) |  | (4175) | (35591) |
| Recoveries | 15 | 1944 |  | 1252 | 3211 |
| **Balance at end of the period** | $16953 | $38905 | $— | $24032 | $79890 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| *(in thousands)* | **Real Estate** | **Commercial** | **Financial<br>Institutions** | **Consumer<br>and Others** | **Total** |
| **Balance at beginning of the period** | $25876 | $41809 | $— | $27819 | $95504 |
| (Reversal of) provision for credit losses - loans | (8383) | 41465 |  | 14838 | 47920 |
| Loans charged-off | (591) | (47294) |  | (21122) | (69007) |
| Recoveries | 51 | 2925 |  | 2497 | 5473 |
| **Balance at end of the period** | $16953 | $38905 | $— | $24032 | $79890 |

---

The ACL was determined utilizing a reasonable and supportable forecast period. The ACL was determined using a weighted-average of various economic scenarios provided by a third-party and incorporated qualitative components. There have not been material changes in our policies and methodology to estimate the ACL in the nine months ended September 30, 2025.

The ACL increased by $10.0 million, or 11.7% at September 30, 2025, compared to December 31, 2024. The ACL as a percentage of total loans held for investment was 1.37% at September 30, 2025 compared to 1.18% at December 31, 2024. The increase in the ACL during the period included a provision for credit losses on loans in the three and nine month periods ended September 30, 2025, which was partially offset by net charge-offs.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

In the third quarter of 2025, the provision for credit losses on loans was comprised of $7.8 million in additional specific reserves, $8.9 million to cover charge-offs, and $3.6 million due to credit quality and macro-economic factors. This was partially offset by a release of $2.3 million due to the reduction in loan balances and $2.7 million due to recoveries.

In the first nine months of 2025, the provision for credit losses on loans included $21.9 million for specific reserves, $18.8 million to cover net charge-offs, and $4.7 million due to model adjustments for macroeconomic factors, and $2.5 million due to credit quality and other macroeconomic updates. This was partially offset by releases of $4.6 million due to lower loan balances and $7.5 million due to recoveries.

The following is a summary of net proceeds from sales of loans held for investment by portfolio segment:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| *<br>(in thousands)* | **Real Estate** | **Commercial** | **Financial <br>Institutions** | **Consumer<br>and others** | **Total** |
| 2025 | $— | $30493 | $— | $3264 | $33757 |
| 2024 | $28656 | $6960 | $— | $— | $35616 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| *<br>(in thousands)* | **Real Estate** | **Commercial** | **Financial <br>Institutions** | **Consumer<br>and others** | **Total** |
| 2025 | $4025 | $43168 | $— | $11147 | $58340 |
| 2024 | $30424 | $72588 | $— | $— | $103012 |

---

In the third quarter of 2025, the Company sold one Substandard owner occupied loan with an outstanding balance of $30.4 million at the time of sale and recognized a loss of $0.9 million in connection with the transaction.

In the second quarter of 2025, the Company sold a participation in a Quick Service Restaurant ("QSR")-related loan with carrying value of $6.9 million and ACL of $4.8 million as of March 31, 2025. Proceeds from the sale were $2.2 million which resulted in a charge off against the ACL of $4.8 million in the second quarter 2025.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**<u>Loan Modifications to Borrowers Experiencing Financial Difficulty</u>**

The Company modifies loans related to borrowers experiencing financial difficulties by providing multiple types of concessions. Typically, one type of concession, such as a term extension, is granted initially. If the borrower continues to experience financial difficulty, another concession, such as principal forgiveness, may be granted.

The Company had no new loan modifications to borrowers experiencing financial difficulty during the three and nine month periods ended September 30, 2025 and 2024. There were no modified loans that defaulted in the three and nine months ended September 30, 2025 and 2024 and had been modified within the 12 months preceding the payment default.

As of September 30, 2025, there were no outstanding balances related to loan modifications to borrowers experiencing financial difficulties compared to $9.4 million as of December 31, 2024. The $9.4 million as of December 31, 2024 was related to one commercial nonaccrual loan that was paid off in the second quarter of 2025.

**Credit Risk Quality**

The sufficiency of the ACL is reviewed at least quarterly by the Deputy Chief Credit Officer and the Chief Financial Officer. The Board of Directors considers the ACL as part of its review of the Company's consolidated financial statements. As of September 30, 2025 and December 31, 2024, the Company believes the ACL to be sufficient to absorb expected credit losses in the loans portfolio in accordance with GAAP.

Loans may be classified but not considered collateral dependent due to one of the following reasons: (1) the Company has established minimum dollar amount thresholds for individual assessment of expected credit losses, which results in loans under those thresholds being excluded from individual assessment of expected credit losses; and (2) classified loans may be considered in the assessment because the Company expects to collect all amounts due.

As part of the on-going monitoring of the credit quality of the Company's loan portfolio, management tracks certain credit quality indicators including trends related primarily to (i) the risk rating of loans, (ii) the loan payment status, (iii) net charge-offs, (iv) nonperforming loans and (v) the general economic conditions in the main geographies where the Company's borrowers conduct their businesses. The Company considers the views of its regulators as to loan classification and in the process of estimating expected credit losses.

The Company utilizes an internal risk rating system to identify the risk characteristics of each of its loans, or group of homogeneous loans such as consumer loans. Internal risk ratings are updated on a continuous basis on a scale from 1 (worst credit quality) to 10 (best credit quality). Loans are then grouped in five master risk categories for purposes of monitoring rising levels of potential loss risks and to enable the activation of collection or recovery processes as defined in the Company's Credit Risk Policy. Internal risk ratings are considered the most meaningful indicator of credit quality for commercial loans. Generally, internal risk ratings for commercial real estate loans and commercial loans with balances over $3 million are updated at least annually and more frequently if circumstances indicate that a change in risk rating may be warranted. For consumer loans, single-family residential loans and smaller commercial loans under $3 million, risk ratings are updated based on the loans past due status. The following is a summary of the master risk categories and their associated loan risk ratings, as well as a description of the general characteristics of the master risk category:

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

---

| | |
|:---|:---|
| | **Loan Risk Rating** |
| **Master risk category** | |
| Nonclassified | 4 to 10 |
| Classified | 1 to 3 |
| Substandard | 3 |
| Doubtful | 2 |
| Loss | 1 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**Nonclassified** 

This category includes loans considered as Pass (5-10) and Special Mention (4). A loan classified as Pass is considered of sufficient quality to preclude a lower adverse rating. These loans are generally well protected by the current net worth and paying capacity of the borrower or by the value of any collateral received. Special Mention loans are defined as having potential weaknesses that deserve management's close attention which, if left uncorrected, could potentially result in further credit deterioration. Special Mention loans may include loans originated with certain credit weaknesses or that developed those weaknesses since their origination.

**Classified** 

This classification indicates the presence of credit weaknesses which could make loan repayment unlikely, such as partial or total late payments and other contractual defaults.

**Substandard** 

A loan classified substandard is inadequately protected by the sound worth and paying capacity of the borrower or the collateral pledged. They are characterized by the distinct possibility that the Company will sustain some loss if the credit weaknesses are not corrected. Loss potential, while existing in the aggregate amount of substandard loans, does not have to exist in individual assets.

**Doubtful** 

These loans have all the weaknesses inherent in a loan classified as substandard with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. These are poor quality loans in which neither the collateral, if any, nor the financial condition of the borrower presently ensure collection in full in a reasonable period of time. As a result, the possibility of loss is extremely high.

**Loss** 

Loans classified as loss are considered uncollectible and of such little value that the continuance as bankable assets is not warranted. This classification does not mean that the assets have absolutely no recovery or salvage value, but not to the point where a write-off should be deferred even though partial recoveries may occur in the future. This classification is based upon current facts, not probabilities. As a result, loans in this category should be promptly charged off in the period in which they are determined to be uncollectible.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**Loans held for investment by Credit Quality Indicators** 

The following tables present Loans held for investment by credit quality indicators and year of origination as of September 30, 2025 and December 31, 2024:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Term Loans** | **Term Loans** | **Term Loans** | **Term Loans** | **Term Loans** | **Term Loans** | | |
| | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | | |
| *(in thousands)* | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans<br>Amortized Cost<br>Basis** | **Total** |
| **Real estate loans** |  |  |  |  |  |  |  |  |
| Commercial real estate |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Nonowner occupied |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | $245368 | $317985 | $114196 | $116367 | $309234 | $345866 | $111474 | $1560490 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 19855 |  |  |  | 28033 | 5396 | 53284 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 3087 | 1022 | 27383 |  | 10914 |  | 42406 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total Nonowner occupied | 245368 | 340927 | 115218 | 143750 | 309234 | 384813 | 116870 | 1656180 |
| &nbsp;&nbsp;Multi-family residential |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 18902 | 15639 | 1492 | 66975 | 80023 | 116166 | 33023 | 332220 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 22413 |  |  |  | 7017 |  | 29430 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total Multi-family residential | 18902 | 38052 | 1492 | 66975 | 80023 | 123183 | 33023 | 361650 |
| &nbsp;&nbsp;Land development and construction loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 112573 | 199453 | 43362 |  | 3109 | 34474 | 128220 | 521191 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 3959 |  |  |  |  |  | 3959 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  |  | 19577 |  |  |  |  | 19577 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total land development and construction loans | 112573 | 203412 | 62939 |  | 3109 | 34474 | 128220 | 544727 |
| Single-family residential |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 110073 | 290857 | 204340 | 366716 | 120717 | 130114 | 318452 | 1541269 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  | 738 |  |  | 738 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 1101 | 1048 | 2245 | 404 | 2245 | 1674 | 8717 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total Single-family residential | 110073 | 291958 | 205388 | 368961 | 121859 | 132359 | 320126 | 1550724 |
| Owner occupied |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 78650 | 161425 | 93596 | 145408 | 183284 | 121659 | 36124 | 820146 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  | 27101 |  | 3616 | 3802 | 10846 |  | 45365 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 18046 | 760 | 12461 | 836 | 492 | 2490 | 35085 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total owner occupied | 78650 | 206572 | 94356 | 161485 | 187922 | 132997 | 38614 | 900596 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | | |
| *(in thousands)* | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans<br>Amortized Cost<br>Basis** | **Total** |
| **Non-real estate loans** |  |  |  |  |  |  |  |  |
| Commercial Loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | $162743 | $288602 | $132158 | $67035 | $8006 | $27144 | $607188 | $1292876 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention | 16503 | 59371 | 5854 | 6758 | 61 |  | 32450 | 120997 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard | 2276 | 4658 | 30495 | 16432 | 14877 | 4028 | 33139 | 105905 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| Total commercial Loans | 181522 | 352631 | 168507 | 90225 | 22944 | 31172 | 672777 | 1519778 |
| Loans to financial institutions and acceptances |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 4981 | 107789 |  |  |  |  | 52204 | 164974 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total loans to financial institutions and acceptances | 4981 | 107789 |  |  |  |  | 52204 | 164974 |
| Consumer loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 7796 | 18360 | 10031 | 48014 | 6536 | 766 | 150935 | 242438 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  |  | 75 | 589 | 61 |  |  | 725 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| Total consumer loans and overdrafts | 7796 | 18360 | 10106 | 48603 | 6597 | 766 | 150935 | 243163 |
| Total loans held for investment, gross | $759865 | $1559701 | $658006 | $879999 | $731688 | $839764 | $1512769 | $6941792 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Term Loans** | **Term Loans** | **Term Loans** | **Term Loans** | **Term Loans** | **Term Loans** | | |
| | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | **Amortized Cost Basis by Origination Year** | | |
| *(in thousands)* | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** | **Revolving Loans<br>Amortized Cost<br>Basis** | **Total** |
| **Real estate loans** |  |  |  |  |  |  |  |  |
| Commercial real estate |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Nonowner occupied |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | $372893 | $145462 | $183099 | $373673 | $31878 | $448365 | $101312 | $1656682 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  | 361 |  | 361 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  |  |  | 21430 |  |  |  | 21430 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total Nonowner occupied | 372893 | 145462 | 183099 | 395103 | 31878 | 448726 | 101312 | 1678473 |
| &nbsp;&nbsp;Multi-family residential |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 45528 | 1832 | 69729 | 83120 | 5804 | 129559 | 657 | 336229 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total Multi-family residential | 45528 | 1832 | 69729 | 83120 | 5804 | 129559 | 657 | 336229 |
| &nbsp;&nbsp;Land development and construction loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 177239 | 86527 | 4288 | 37596 | 9469 | 26974 | 136998 | 479091 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  |  |  |  |  |  | 4119 | 4119 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total land development and construction loans | 177239 | 86527 | 4288 | 37596 | 9469 | 26974 | 141117 | 483210 |
| Single-family residential |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 375340 | 268959 | 394786 | 126639 | 49853 | 74404 | 228661 | 1518642 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 742 | 4575 |  | 43 | 1287 | 2791 | 9438 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total Single-family residential | 375340 | 269701 | 399361 | 126639 | 49896 | 75691 | 231452 | 1528080 |
| Owner occupied |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 214385 | 123111 | 165681 | 228801 | 24751 | 165873 | 14549 | 937151 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  | 5047 |  | 5047 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 49449 | 9951 | 992 |  | 1874 | 2610 | 64876 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total owner occupied | 214385 | 172560 | 175632 | 229793 | 24751 | 172794 | 17159 | 1007074 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | **Term Loans Amortized Cost Basis by Origination Year** | | |
| *(in thousands)* | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** | **Revolving Loans<br>Amortized Cost<br>Basis** | **Total** |
| **Non-real estate loans** |  |  |  |  |  |  |  |  |
| Commercial Loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | $565879 | $322047 | $144910 | $43603 | $2117 | $34807 | $571934 | $1685297 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  | 7561 | 16566 | 91 | 94 | 9463 | 32830 | 66605 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| Total commercial Loans | 565879 | 329608 | 161476 | 43694 | 2211 | 44270 | 604764 | 1751902 |
| Loans to financial institutions and acceptances |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 156935 |  |  |  |  | 13500 |  | 170435 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Total loans to financial institutions and acceptances | 156935 |  |  |  |  | 13500 |  | 170435 |
| Consumer loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit Risk Rating: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonclassified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pass | 68289 | 16371 | 88501 | 17557 | 2604 |  | 79678 | 273000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special Mention |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Classified |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Substandard | 8 |  |  |  |  |  |  | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Doubtful |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss |  |  |  |  |  |  |  |  |
| Total consumer loans and overdrafts | 68297 | 16371 | 88501 | 17557 | 2604 |  | 79678 | 273008 |
| Total loans held for investment, gross | $1976496 | $1022061 | $1082086 | $933502 | $126613 | $911514 | $1176139 | $7228411 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

The following tables present gross charge-offs by year of origination for the periods presented:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | | |
| *(in thousands)* | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans<br>Charge-Offs** | **Total** |
| **Quarter-To-Date Gross Charge-offs** |  |  |  |  |  |  |  |  |
| Real estate loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonowner occupied | $— | $— | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential |  |  |  |  |  | 1268 |  | 1268 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  | 1268 |  | 1268 |
| &nbsp;&nbsp;&nbsp;Single-family residential |  |  |  | 33 |  |  |  | 33 |
| &nbsp;&nbsp;&nbsp;Owner occupied |  |  |  |  |  |  |  |  |
|  |  |  |  | 33 |  | 1268 |  | 1301 |
| Commercial loans |  | 1779 | 1611 | 62 | 123 | 2669 |  | 6244 |
| Loans to financial institutions and acceptances |  |  |  |  |  |  |  |  |
| Consumer loans and overdrafts | 188 |  | 96 | 1088 | 542 | 77 |  | 1991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Quarter-To-Date Gross Charge-Offs | $188 | $1779 | $1707 | $1183 | $665 | $4014 | $— | $9536 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | | |
| *(in thousands)* | **2025** | **2024** | **2023** | **2022** | **2021** | **Prior** | **Revolving Loans<br>Charge-Offs** | **Total** |
| **Year-To-Date Gross Charge-offs** |  |  |  |  |  |  |  |  |
| Real estate loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonowner occupied | $— | $— | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential |  |  |  |  |  | 1268 |  | 1268 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  | 1268 |  | 1268 |
| &nbsp;&nbsp;&nbsp;Single-family residential |  |  | 141 | 55 | 15 | 38 |  | 249 |
| &nbsp;&nbsp;&nbsp;Owner occupied |  |  |  |  |  | 130 |  | 130 |
|  |  |  | 141 | 55 | 15 | 1436 |  | 1647 |
| Commercial loans |  | 2058 | 6732 | 11960 | 386 | 3435 |  | 24571 |
| Loans to financial institutions and acceptances |  |  |  |  |  |  |  |  |
| Consumer loans and overdrafts | 476 | 8 | 693 | 4605 | 1284 | 211 |  | 7277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Year-To-Date Gross Charge-Offs | $476 | $2066 | $7566 | $16620 | $1685 | $5082 | $— | $33495 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** | **Three Months Ended September 30, 2024** |
| | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | | |
| *(in thousands)* | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** | **Revolving Loans<br>Charge-Offs** | **Total** |
| **Quarter-To-Date Gross Charge-offs** |  |  |  |  |  |  |  |  |
| Real estate loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonowner occupied | $— | $— | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Single-family residential |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Owner occupied |  |  |  |  |  |  |  |  |
| Commercial loans |  | 5345 | 15046 | 68 | 36 | 10921 |  | 31416 |
| Loans to financial institutions and acceptances |  |  |  |  |  |  |  |  |
| Consumer loans and overdrafts | 51 | 358 | 2876 | 741 | 121 | 28 |  | 4175 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Quarter-To-Date Gross Charge-Offs | $51 | $5703 | $17922 | $809 | $157 | $10949 | $— | $35591 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | **Term Loans Charge-offs by Origination Year** | | |
| *(in thousands)* | **2024** | **2023** | **2022** | **2021** | **2020** | **Prior** | **Revolving Loans<br>Charge-Offs** | **Total** |
| **Year-To-Date Gross Charge-offs** |  |  |  |  |  |  |  |  |
| Real estate loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonowner occupied | $— | $— | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential |  |  |  |  |  | 591 |  | 591 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  | 591 |  | 591 |
| &nbsp;&nbsp;&nbsp;Single-family residential |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Owner occupied |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  | 591 |  | 591 |
| Commercial loans | 173 | 6133 | 29327 | 305 | 157 | 11199 |  | 47294 |
| Loans to financial institutions and acceptances |  |  |  |  |  |  |  |  |
| Consumer loans and overdrafts | 185 | 943 | 14300 | 4669 | 680 | 345 |  | 21122 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Year-To-Date Gross Charge-Offs | $358 | $7076 | $43627 | $4974 | $837 | $12135 | $— | $69007 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

 **<u>Collateral -Dependent Loans</u>**

Loans are considered collateral-dependent when the repayment of the loan is expected to be provided by the sale or operation of the underlying collateral. The Company performs an individual evaluation as part of the process of calculating the allowance for credit losses related to these loans. The following tables present the amortized cost basis of collateral dependent loans related to borrowers experiencing financial difficulty by type of collateral as of September 30, 2025 and December 31, 2024:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
| | **Collateral Type** | **Collateral Type** | **Collateral Type** | **Collateral Type** | |
| *(in thousands)* | **Commercial Real Estate** | **Residential Real Estate** | **Other** | **Total** | **Specific Reserves** |
| Real estate loans |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonowner occupied (1) | $42141 | $— | $— | $42141 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential (2) | 29430 |  |  | 29430 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans (3) | 19590 |  |  | 19590 |  |
|  | 91161 |  |  | 91161 |  |
| &nbsp;&nbsp;Single-family residential |  |  |  |  |  |
| &nbsp;&nbsp;Owner occupied (4) | 29218 |  |  | 29218 |  |
|  | 120379 |  |  | 120379 |  |
| Commercial loans | 5386 |  | 29578 | 34964 | 4793 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $125765 | $— | $29578 | $155343 | $4793 |

---

_________________

(1)Weighted-average loan-to-value was approximately 85.5% at September 30, 2025.

(2)Weighted-average loan-to-value was approximately 49.1% at September 30, 2025.

(3)Weighted-average loan-to-value was approximately 32.1% at September 30, 2025.

(4)Weighted-average loan-to-value was approximately 52.8% at September 30, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
| | **Collateral Type** | **Collateral Type** | **Collateral Type** | **Collateral Type** | |
| *(in thousands)* | **Commercial Real Estate** | **Residential Real Estate** | **Other** | **Total** | **Specific Reserves** |
| Real estate loans |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonowner occupied (1) | $21430 | $— | $4992 | $26422 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans (2) | 4121 |  |  | 4121 |  |
|  | 25551 |  | 4992 | 30543 |  |
| &nbsp;&nbsp;&nbsp;Single-family residential (3) |  | 67 |  | 67 |  |
| &nbsp;&nbsp;&nbsp;Owner occupied (4) | 63111 |  |  | 63111 |  |
|  | 88662 | 67 | 4992 | 93721 |  |
| Commercial loans |  |  | 62572 | 62572 | 2105 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $88662 | $67 | $67564 | $156293 | $2105 |

---

_________________

(1)Weighted-average loan-to-value was approximately 64.8% at December 31, 2024.

(2)Weighted-average loan-to-value was approximately 67.0% at December 31, 2024.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

(3)Weighted-average loan-to-value was approximately 22.3% at December 31, 2024.

(4)Weighted-average loan-to-value was approximately 67.5% at December 31, 2024.

Collateral dependent loans are evaluated on an individual basis for purposes of determining expected credit losses. For collateral-dependent loans where the borrower is experiencing financial difficulty and the Company expects repayment of the financial asset to be provided substantially through the operation or sale of the collateral, the ACL is measured based on the difference between the fair value of the collateral and the amortized cost basis of the loan as of the measurement date. When repayment is expected to be from the operation of the collateral, expected credit losses are calculated as the amount by which the amortized cost basis of the loan exceeds the present value of expected cash flows from the operation of the collateral. When repayment is expected to be from the sale of the collateral, expected credit losses are calculated as the amount by which the amortized cost basis of the loan exceeds the fair value of the underlying collateral less estimated costs to sell. The ACL may be zero if the fair value of the collateral at the measurement date exceeds the amortized cost basis of the loan.

**<u>Other Individually Evaluated Loans</u>**

As of September 30, 2025, as part of the process of calculating the ACL, in addition to collateral dependent

loans, the Company evaluated individually $72.6 million and $2.5 million in commercial and owner occupied loans,

respectively, primarily in the restaurant, transportation, healthcare, real estate industries, in addition to collateral

dependent loans ($7.2 million in a commercial loan in the restaurant industry as of December 31, 2024). As of September 30, 2025, the ACL on these loans was $7.8 million. As of December 31, 2024, the ACL on the $7.2 million commercial loan was not significant.

**6. Time Deposits**

Time deposits in denominations of $100,000 or more amounted to approximately $1.3 billion at September 30, 2025 and December 31, 2024, respectively. Time deposits in denominations of more than $250,000 amounted to approximately $746 million and $731 million at September 30, 2025 and December 31, 2024, respectively. As of September 30, 2025 and December 31, 2024, brokered time deposits amounted to $550 million and $702 million, respectively.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

***Large Time Deposits by Maturity***

The following table sets forth the maturities of our time deposits with individual balances equal to or greater than $100,000 as of September 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| *(in thousands, except percentages)* |  |  |  |  |
| Less than 3 months | $513088 | 40.1% | $386857 | 30.4% |
| 3 to 6 months | 366766 | 28.7% | 349673 | 27.5% |
| 6 to 12 months | 336339 | 26.3% | 464812 | 36.6% |
| 1 to 3 years | 48426 | 3.8% | 53745 | 4.2% |
| Over 3 years | 14850 | 1.1% | 15386 | 1.3% |
| Total | $1279469 | 100.0% | $1270473 | 100.0% |

---

**7. Advances from the Federal Home Loan Bank**

At September 30, 2025 and December 31, 2024, the Company had outstanding advances from the FHLB as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | **Outstanding Balance** | **Outstanding Balance** |
|<br>**Year of Maturity** |<br>**Interest<br>Rate** |<br>**Interest<br>Rate Type** | **September 30, 2025** | **December 31, 2024** |
|  |  |  | *(in thousands)* | *(in thousands)* |
| 2025 | 4.33% | Variable | $20000 | $— |
| 2025 | 4.44% | Fixed |  | 30000 |
| 2026 | 3.78% to 4.90% | Fixed | 80000 | 10000 |
| 2027 | 3.77% to 4.89% | Fixed | 20000 | 200000 |
| 2028 | 4.05% to 4.40% | Fixed | 206699 |  |
| 2029 | 3.54% to 4.45% | Fixed | 505000 | 505000 |
| Total (1) |  |  | $831699 | $745000 |

---

_______________

(1)As of September 30, 2025 and December 31, 2024, includes advances from the FHLB with quarterly callable features totaling $435.0 million, with fixed interest rates ranging from 3.54% to 3.76%, and maturing in 2029.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the third quarter of 2025, the Company restructured $210.0 million of its fixed-rate FHLB advances. This restructuring consisted of changing the original maturity at lower interest rates. The new maturity for each contract was approximately 3 years, consistent with their original maturity. The Company incurred an early termination and modification penalty of $3.4 million which was deferred and is being amortized over the term of the new advances, as an adjustment to the yields. In each of the third quarter and first nine months of 2025, the Company recognized $0.1 million, included as part of interest expense, as a result of this amortization. The modifications were not considered a substantial modification in accordance with GAAP.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**8. Derivative Instruments**

At September 30, 2025 and December 31, 2024, the notional amounts and fair values of the Company's derivative instruments were as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| *(in thousands)* | **Number of contracts** | **Notional Amounts** | **Other Assets** | **Other Liabilities** | **Number of contracts** | **Notional Amounts** | **Other Assets** | **Other Liabilities** |
| Derivatives designated as hedging instruments |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Interest rate swaps designated as cash flow hedges | 6 | $114178 | $423 | $— | 6 | $114178 | $137 | $81 |
| Customer Derivatives not designated as hedging instruments |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Interest rate swaps: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Customers | 149 | 1463303 | 19669 | 19937 | 131 | 1309781 | 4300 | 42194 |
| &nbsp;&nbsp;&nbsp;&nbsp;Third party broker | 149 | 1463303 | 19937 | 19669 | 131 | 1309781 | 42194 | 4300 |
|  | 298 | 2926606 | 39606 | 39606 | 262 | 2619562 | 46494 | 46494 |
| &nbsp;&nbsp;&nbsp;&nbsp;Credit risk participation agreements | 13 | 157096 |  |  | 11 | 112010 |  |  |
| &nbsp;&nbsp;Interest rate caps: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Customers | 6 | 104109 |  | 291 | 7 | 131251 |  | 932 |
| &nbsp;&nbsp;&nbsp;&nbsp;Third party broker | 6 | 104109 | 291 |  | 7 | 131251 | 932 |  |
|  | 12 | 208218 | 291 | 291 | 14 | 262502 | 932 | 932 |
| Economic hedges: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward to be announced (MBS) | 2 | 118700 | 508 |  |  |  |  |  |
| &nbsp;&nbsp;Mortgage derivatives: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward to be announced (MBS) |  |  |  |  | 1 | 25000 |  | 59 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate lock commitments |  |  |  |  | 60 | 30081 | 301 | 46 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loan forward contracts |  |  |  |  | 16 | 29000 | 147 | 3 |
|  |  |  |  |  | 77 | 84081 | 448 | 108 |
| Total derivatives not designated as hedging instruments | 325 | $3410620 | $40405 | $39897 | 364 | $3078155 | $47874 | $47534 |
| Total derivative instruments | 331 | $3524798 | $40828 | $39897 | 370 | $3192333 | $48011 | $47615 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

<u>Derivatives Designated as Hedging Instruments</u> 

*Interest Rate Swaps On Debt Instruments*

The Company enters into interest rate swap contracts on debt instruments which the Company designates and qualifies as cash flow hedges. These interest rate swaps are designed as cash flow hedges to manage the exposure that arises from differences in the amount of the Company's known or expected cash receipts and the known or expected cash payments on designated debt instruments. These interest rate swap contracts involve the Company's payment of fixed-rate amounts in exchange for the Company receiving variable-rate payments over the life of the contracts without exchange of the underlying notional amount.

At September 30, 2025 and December 31, 2024, the Company had five interest rate swap contracts with notional amounts totaling $64.2 million. These contracts were designated as cash flow hedges to manage the exposure of variable rate interest payments on all of the Company's outstanding variable-rate junior subordinated debentures with principal amounts at September 30, 2025 and December 31, 2024 totaling $64.2 million. The Company expects these interest rate swaps to be highly effective in offsetting the effects of changes in interest rates on cash flows associated with the Company's variable-rate junior subordinated debentures. The Company recognized unrealized gains of $0.1 million and $0.2 million in the three months ended September 30, 2025 and 2024, respectively, and unrealized gains of $0.2 million and $0.7 million in the nine months ended September 30, 2025 and 2024, respectively, in connection with these interest rate swap contracts, which were included as part of interest expense on junior subordinated debentures in the Company's consolidated statement of operations and comprehensive income.

In the third quarter of 2025, two of the five interest rate swap contracts disclosed above, with a total notional amount of $41.3 million, matured and were renewed. Additionally, in October 2025, two contracts with a total notional amount of $14.7 million matured and were renewed. Furthermore, in October 2025, the remaining contract, with a notional amount of $8.2 million, matured and was redesignated. The new maturity of each contract is 4 years. The redesignation of the $8.2 million contract in October 2025 had no material impact on the Company's consolidated financial statements.

In 2019, the Company terminated 16 interest rate swaps that had been designated as cash flow hedges of variable rate interest payments on the outstanding and expected rollover of variable-rate advances from the FHLB. The Company is recognizing the contracts' cumulative net unrealized gains of $8.9 million in earnings over the remaining original life of the terminated interest rate swaps ranging between one month and seven years. The Company recognizes a reduction of interest expense on FHLB advances as a result of this amortization. As of September 30, 2025, the remaining cumulative net unrealized gains related to these interest rate swaps was $0.7 million.

*Interest Rate Swaps On Loans*

As of September 30, 2025 and December 31, 2024, the Company had one interest rate swap contract with a notional amount of $50.0 million. In the second quarter of 2025, this contract matured and was renewed for another 2 years. The Company designates this interest rate swap contract as a cash flow hedge to manage interest rate risk exposure on variable rate interest receipts on the first $50 million principal balance of a pool of loans. This interest rate swap contract involves the Company's payment of variable-rate amounts in exchange for the Company receiving fixed-rate payments over the life of the contract without exchange of the underlying notional amount. Unrealized losses on these instruments are included as part of interest income on loans in the Company's consolidated statement of operations and comprehensive income.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

<u>Derivatives Not Designated as Hedging Instruments</u>

&nbsp;&nbsp;&nbsp;&nbsp;***a) Customer related positions***

The Company offers certain derivatives products, including interest rate swaps and caps, directly to qualified commercial banking customers to facilitate their risk management strategies. The Company partially offsets its exposure to interest rate swaps and caps by entering similar derivative contracts with various third-party brokers.

 *Interest Rate Swaps*

Interest rate swap contracts involve the Company's payment of variable-rate amounts to customers in exchange for the Company receiving fixed-rate payments from customers over the life of the contracts without exchange of the underlying notional amount.

The Company enters into swap participation agreements with other financial institutions to manage the credit risk exposure on certain interest rate swaps with customers. Under these agreements, the Company, as the beneficiary or guarantor, will receive or make payments from/to the counterparty if the borrower defaults on the related interest rate swap contract. The notional amount of these agreements is based on the Company's pro-rata share of the related interest rate swap contracts.

*Interest Rate Caps*

Interest rate cap contracts involve the Company making payments if an interest rate exceeds the agreed strike price.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***b) Economic Hedges***

The Company enters into forward sale contracts to effectively offset changes in market valuation on the trading securities portfolio. These forward sale contracts are the commitment to sell To-Be-Announced ("TBA") mortgage-backed securities on a specific future date. At December 31, 2024, there were no derivatives classified as economic hedges. In each of the three and nine month periods ended September 30, 2025, the net unrealized loss on these instruments was $1.4 million and $3.2 million, respectively. This amount was included in derivative losses, net in the Company's consolidated statement of operations and comprehensive income.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***c) Mortgage Derivatives***

The Company enters into interest rate lock commitments and forward sale contracts to manage the risk exposure in the mortgage banking area. Interest rate lock commitments guarantee the funding of residential mortgage loans originated for sale, at specified interest rates and times in the future. Forward sale contracts consist of commitments to deliver mortgage loans, originated and/or purchased, in the secondary market at a future date. A separate type of forward sale contracts are the commitment to sell To-Be-Announced ("TBA") mortgage-backed securities on a specific future date. In the three months ended September 30, 2025, the change in fair value of these instruments was not significant. In the nine months ended September 30, 2025, the change in the fair value of these instruments was an unrealized loss of $0.3 million. In the three and nine months ended September 30, 2024, the change in the fair value of these instruments was unrealized gain of $0.3 million and $0.7 million, respectively. These amounts were recorded as part of other noninterest income in the consolidated statements of operations and comprehensive income.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

*Credit Risk-Related Contingent Features*

Some agreements may require the Company to pledge securities as collateral when the valuation of the interest rate swap derivative contracts fall below a certain amount. At September 30, 2025 and December 31, 2024, there were $9.2 million and $0.4 million, respectively, in securities pledged as collateral for interest rate swaps in a liability position. Additionally, most of our derivative arrangements with counterparties require the posting of collateral upon meeting certain net exposure thresholds. As of September 30, 2025 and December 31, 2024, the Company had cash held as collateral for derivatives margin calls of $5.9 million and $23.5 million, respectively. *See* Note 2 "Interest Earning Deposits with Banks, Other Short-Term Investments and Restricted Cash" for additional information about cash held as collateral.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**9. Income Taxes**

The Company uses an estimated annual effective tax rate method in computing its interim tax provision. This effective tax rate is based on forecasted annual consolidated pre-tax income, permanent tax differences and statutory tax rates. Under this method, the tax effect of certain items that do not meet the definition of ordinary income or expense are computed and recognized as discrete items when they occur.

The effective combined federal and state tax rates for the nine months ended September 30, 2025 and 2024 were 22.60% and 22.50%, respectively. Effective tax rates differ from the statutory rates mainly due to the impact of forecasted permanent non-taxable interest and other income, forecasted permanent non-deductible expenses, and the effect of corporate state taxes.

**Legislative Developments**

On July 4, 2025, federal legislation generally referred to as H.R. 1 - One Big Beautiful Bill Act (the "Act") was signed into law. The Act includes a variety of tax provisions including permanently extending and modifying certain key aspects of existing tax law. U.S. GAAP requires the effects of changes in tax laws and rates to be recognized in its financial statements in the period in which legislation is enacted. The Company evaluated the impact of the Act on its consolidated financial statements and determined there is not a material impact resulting from the Act.

**10.&nbsp;&nbsp;&nbsp;&nbsp; Accumulated Other Comprehensive Loss/Income ("AOCL/AOCI"):** 

The components of AOCL/AOCI are summarized as follows using applicable blended average federal and state tax rates for each period:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| *(in thousands)* | **Before Tax<br>Amount** | **Tax<br>Effect** | **Net of Tax<br>Amount** | **Before Tax<br>Amount** | **Tax<br>Effect** | **Net of Tax<br>Amount** |
| Net unrealized holding losses on debt securities available for sale | $(10466) | $2673 | $(7793) | $(54828) | $14006 | $(40822) |
| Net unrealized holding gains on interest rate swaps designated as cash flow hedges | 1155 | (294) | 861 | 1364 | (348) | 1016 |
| Total AOCL | $(9311) | $2379 | $(6932) | $(53464) | $13658 | $(39806) |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

The components of other comprehensive income for the periods presented are summarized as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *(in thousands)* | **Before Tax<br>Amount** | **Tax<br>Effect** | **Net of Tax<br>Amount** | **Before Tax<br>Amount** | **Tax<br>Effect** | **Net of Tax<br>Amount** |
| Net unrealized holding gains on debt securities available for sale: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value arising during the period | $24921 | $(6368) | $18553 | $20411 | $(5269) | $15142 |
| &nbsp;&nbsp;&nbsp;Reclassification adjustment for net losses included in net income |  |  |  | 68564 | (17332) | 51232 |
|  | $24921 | $(6368) | $18553 | $88975 | $(22601) | $66374 |
| Net unrealized holding gains (losses) on interest rate swaps designated as cash flow hedges: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value arising during the period | 109 | (27) | 82 | (278) | 73 | (205) |
| &nbsp;&nbsp;&nbsp;Reclassification adjustment for net interest income included in net income | (160) | 41 | (119) | (287) | 72 | (215) |
|  | (51) | 14 | (37) | (565) | 145 | (420) |
| Total other comprehensive income | $24870 | $(6354) | $18516 | $88410 | $(22456) | $65954 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *(in thousands)* | **Before Tax<br>Amount** | **Tax<br>Effect** | **Net of Tax<br>Amount** | **Before Tax<br>Amount** | **Tax<br>Effect** | **Net of Tax<br>Amount** |
| &nbsp;&nbsp;Net unrealized holding gains on debt securities available for sale: |  |  |  |  |  |  |
| &nbsp;&nbsp;Change in fair value arising during the period | $44362 | $(11333) | $33029 | $9554 | $(2494) | $7060 |
| &nbsp;&nbsp;Reclassification adjustment for net losses included in net income |  |  |  | 68684 | (17362) | 51322 |
|  | $44362 | $(11333) | $33029 | $78238 | $(19856) | $58382 |
| &nbsp;&nbsp;Net unrealized holding losses on interest rate swaps designated as cash flow hedges: |  |  |  |  |  |  |
| &nbsp;&nbsp;Change in fair value arising during the period | 359 | (91) | 268 | 120 | (28) | 92 |
| &nbsp;&nbsp;Reclassification adjustment for net interest income included in net income | (568) | 145 | (423) | (855) | 216 | (639) |
|  | (209) | 54 | (155) | (735) | 188 | (547) |
| Total other comprehensive income | $44153 | $(11279) | $32874 | $77503 | $(19668) | $57835 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**11.&nbsp;&nbsp;&nbsp;&nbsp;Commitments and Contingencies**

From time to time the Company and its subsidiaries may be exposed to loss contingencies. In the ordinary course of business, those contingencies may include, known but unasserted claims, and legal/regulatory inquiries or examinations. The Company records these loss contingencies as a liability when the likelihood of loss is probable and an amount or range of loss can be reasonably estimated. In the opinion of management, the Company maintains a liability that is in an estimated amount sufficient to cover said loss contingencies, if any, at the reporting dates.

Financial instruments whose contract amount represents off-balance sheet credit risk at September 30, 2025 are generally short-term and are as follows:

---

| | |
|:---|:---|
| *(thousands)* | **Approximate<br>Contract<br>Amount** |
| Commitments to extend credit | $1633799 |
| Standby letters of credit | 178428 |
| Commercial letters of credit |  |
|  | $1812227 |

---

The following table summarizes the changes in the allowance for credit losses for off-balance sheet credit risk exposures for the three and nine month periods ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(in thousands)* | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Balances at beginning of period** | $9692 | $4602 | $5942 | $3102 |
| (Reversal of) provision for credit losses - off balance sheet exposures | (650) | 1130 | 3100 | 2630 |
| **Balances at end of period** | $9042 | $5732 | $9042 | $5732 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**12.&nbsp;&nbsp;&nbsp;&nbsp;Fair Value Measurements** 

Assets and liabilities measured at fair value on a recurring basis are summarized below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| *(in thousands)* | **Quoted<br>Prices in<br>Active<br>Markets<br>for Identical<br>Assets<br>(Level 1)** | **Third-Party<br>Models with<br>Observable<br>Market<br>Inputs<br>(Level 2)** | **Internal<br>Models<br>with<br>Unobservable<br>Market<br>Inputs<br>(Level 3)** | **Total<br>Carrying<br>Value in the<br>Consolidated<br>Balance<br>Sheet** |
| **Assets** |  |  |  |  |
| Cash and Cash equivalents |  |  |  |  |
| &nbsp;&nbsp;Other short-term investments | $— | $7162 | $— | $7162 |
| Securities |  |  |  |  |
| &nbsp;&nbsp;Trading securities |  | 119935 |  | 119935 |
| &nbsp;&nbsp;Debt securities available for sale |  |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S Treasury Securities |  | 2492 |  | 2492 |
| &nbsp;&nbsp;&nbsp;U.S. Government agency and sponsored enterprise residential MBS |  | 1941018 |  | 1941018 |
| &nbsp;&nbsp;&nbsp;U.S. government agency and sponsored enterprise commercial MBS |  | 157681 |  | 157681 |
| &nbsp;&nbsp;&nbsp;U.S. Government agency and sponsored enterprise obligations |  | 12471 |  | 12471 |
| &nbsp;&nbsp;&nbsp;Non-agency commercial MBS |  | 7144 |  | 7144 |
| &nbsp;&nbsp;&nbsp;Municipal Bonds |  | 1610 |  | 1610 |
|  |  | 2122416 |  | 2122416 |
| &nbsp;&nbsp;Equity securities with readily determinable fair values not held for trading | 2542 |  |  | 2542 |
|  | 2542 | 2242351 |  | 2244893 |
| Mortgage loans held for sale (at fair value) |  |  |  |  |
| Bank owned life insurance |  | 258042 |  | 258042 |
| Other assets |  |  |  |  |
| &nbsp;&nbsp;Mortgage servicing rights (MSRs) |  |  | 1362 | 1362 |
| &nbsp;&nbsp;Derivative instruments |  | 40828 |  | 40828 |
|  | $2542 | $2548383 | $1362 | $2552287 |
| **Liabilities** |  |  |  |  |
| Other liabilities |  |  |  |  |
| Derivative instruments | $— | $39897 | $— | $39897 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| *(in thousands)* | **Quoted<br>Prices in<br>Active<br>Markets<br>for Identical<br>Assets<br>(Level 1)** | **Third-Party<br>Models with<br>Observable<br>Market<br>Inputs<br>(Level 2)** | **Internal<br>Models<br>with<br>Unobservable<br>Market<br>Inputs<br>(Level 3)** | **Total<br>Carrying<br>Value in the<br>Consolidated<br>Balance<br>Sheet** |
| **Assets** |  |  |  |  |
| Cash and Cash equivalents |  |  |  |  |
| &nbsp;&nbsp;Other short-term investments | $— | $6944 | $— | $6944 |
| Securities |  |  |  |  |
| &nbsp;&nbsp;Debt securities available for sale |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S Treasury Securities |  | 1933 |  | 1933 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government agency and sponsored enterprise residential MBS |  | 1262640 |  | 1262640 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. government agency and sponsored enterprise commercial MBS |  | 142538 |  | 142538 |
| &nbsp;&nbsp;&nbsp;&nbsp;U.S. Government agency and sponsored enterprise obligations |  | 16682 |  | 16682 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-agency commercial MBS |  | 11792 |  | 11792 |
| &nbsp;&nbsp;&nbsp;&nbsp;Municipal Bonds |  | 1585 |  | 1585 |
|  |  | 1437170 |  | 1437170 |
| &nbsp;&nbsp;Equity securities with readily determinable fair values not held for trading | 2477 |  |  | 2477 |
|  | 2477 | 1437170 |  | 1439647 |
| Mortgage loans held for sale (at fair value) |  | 42911 |  | 42911 |
| Bank owned life insurance |  | 243547 |  | 243547 |
| Other assets |  |  |  |  |
| &nbsp;&nbsp;Mortgage servicing rights (MSRs) |  |  | 1491 | 1491 |
| &nbsp;&nbsp;Derivative instruments |  | 48011 |  | 48011 |
|  | $2477 | $1778583 | $1491 | $1782551 |
| **Liabilities** |  |  |  |  |
| Other liabilities |  |  |  |  |
| Derivative instruments | $— | $47615 | $— | $47615 |

---

The Company had no trading securities as of December 31, 2024.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

<u>Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</u>

The following tables present the major categories of assets measured at fair value on a non-recurring basis at September 30, 2025 and December 31, 2024:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| *(in thousands)* | **Carrying Amount** | **Quoted<br>Prices in<br>Active<br>Markets<br>for Identical<br>Assets<br>(Level 1)** | **Significant<br>Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** | **Total Write Downs** |
| **Description** |  |  |  |  |  |
| Loans held for investment measured for credit deterioration using the fair value of the collateral (1) | 38833 |  |  | 38833 | 12650 |
| Other Real Estate Owned (2) | 15606 |  |  | 15606 | 1872 |
|  | $54439 | $— | $— | $54439 | $14522 |

---

_______________

(1)Includes loans with specific reserves of $4.8 million total write downs of $12.6 million at September 30, 2025.

(2)Includes $14.0 million and $1.6 million in commercial and residential real estate property, respectively.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| *(in thousands)* | **Carrying Amount** | **Quoted<br>Prices in<br>Active<br>Markets<br>for Identical<br>Assets<br>(Level 1)** | **Significant<br>Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** | **Total Write Downs** |
| **Description** |  |  |  |  |  |
| Loans held for investment measured for credit deterioration using the fair value of the collateral (1)(2) | 23265 |  |  | 23265 | 11889 |
| Other Real Estate Owned (3) | 18074 |  |  | 18074 | 5672 |
|  | $41339 | $— | $— | $41339 | $17561 |

---

_______________

(1)Includes commercial and owner-occupied loans with a carrying amount of $23.0 million and $0.1 million, respectively, at December 31, 2024.

(2)Includes loans with specific reserves of $2.5 million and total write downs of $5.1 million at December 31, 2024.

(3)Includes $17.7 million and $0.4 million in commercial and residential real estate property, respectively.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

The following table presents the significant unobservable inputs (Level 3) used in the valuation of assets measured at fair value on a nonrecurring basis.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Financial Instrument** | **Unobservable Inputs** | **Valuation Methods** | **Discount Range** | **Typical Discount** |
| Collateral dependent loans | Discount to fair value | Appraisal value, as adjusted | 0-30% | 6-7% |
|  |  | Inventory | 0-100% | 50-75% |
|  |  | Accounts receivables | 0-100% | 35-50% |
|  |  | Equipment | 0-100% | 20-30% |
| Other Real Estate Owned | Discount to fair value | Appraisal value, as adjusted | N/A | 6-7% |

---

There were no other significant assets or liabilities measured at fair value on a nonrecurring basis at September 30, 2025 and December 31, 2024.

**Loans Held for Sale, at Lower of Cost or Fair Value**

For loans held for sale that are carried at the lower of cost or fair value, the fair value is generally based on quoted market prices of similar loans less estimated cost to sell and is considered to be Level 3.

 **Collateral Dependent Loans Measured For Expected Credit Losses**

The carrying amount of collateral dependent loans is typically based on the fair value of the underlying collateral. The Company primarily uses third party appraisals to assist in measuring expected credit losses on collateral dependent loans. The Company also uses third party appraisal reviewers for loans with an outstanding balance of $1 million and above. These appraisals generally use the market or income approach valuation technique and use market observable data to formulate an opinion of the fair value of the loan's collateral. However, the appraiser uses professional judgment in determining the fair value of the collateral or properties and may also adjust these values for changes in market conditions subsequent to the appraisal date. When current appraisals are not available for certain loans, the Company uses judgment on market conditions to adjust the most current appraisal. The sales prices may reflect prices of sales contracts not closed and the amount of time required to sell out the real estate project may be derived from current appraisals of similar projects. As a consequence, the fair value of the collateral is considered a Level 3 valuation.

 **OREO** 

The Company values Other Real Estate Owned (OREO), at the lower of cost or fair value of the property, less cost to sell. The fair value of the property is generally based upon recent appraisal values of the property, less cost to sell. The Company primarily uses third party appraisals to assist in measuring the valuation of OREO. Period revaluations are classified as Level 3 as the assumptions used may not be observable. The Company had OREO balances of $15.6 million and $18.1 million as of September 30, 2025 and December 31, 2024, respectively. In the first nine months of 2025, the Company sold two OREO properties for an aggregate of $2.7 million and recognized a total net loss on sale $0.8 million in connection with these transactions.

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;**Fair Value of Financial Instruments**

The estimated fair value of financial instruments where fair value differs from carrying value are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| *(in thousands)* | **Carrying<br>Value** | **Estimated<br>Fair<br>Value** | **Carrying<br>Value** | **Estimated<br>Fair<br>Value** |
| **Financial assets:** |  |  |  |  |
| &nbsp;&nbsp;Loans | 2662372 | 2648917 | 3187223 | 3113807 |
| **Financial liabilities:** |  |  |  |  |
| &nbsp;&nbsp;Time deposits | 1547743 | 1546330 | 1532563 | 1532002 |
| &nbsp;&nbsp;Advances from the FHLB | 831699 | 850491 | 745000 | 743910 |
| &nbsp;&nbsp;Senior notes |  |  | 59843 | 59714 |
| &nbsp;&nbsp;Subordinated notes | 29752 | 27688 | 29624 | 28481 |
| &nbsp;&nbsp;Junior subordinated debentures | 64178 | 63818 | 64178 | 63255 |

---

------

**<u>[**Table of Contents**](#ic566456e146f4e4cbdaaa9926d521e26_7)</u>**

**Amerant Bancorp Inc. and Subsidiaries**

Notes to Interim Consolidated Financial Statements (Unaudited)

**13. Earnings Per Share**

The following table shows the calculation of basic and diluted earnings (loss) per share:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| *(in thousands, except share data and per share amounts)* | **2025** | **2024** | **2025** | **2024**  |
| Numerator: |  |  |  |  |
| Net income attributable to Amerant Bancorp Inc. | $14756 | $(48164) | $49716 | $(32633) |
| Net income available to common stockholders | $14756 | $(48164) | $49716 | $(32633) |
| Denominator: |  |  |  |  |
| Basic weighted average shares outstanding | 41590201 | 33784999 | 41802195 | 33635439 |
| Dilutive effect of share-based compensation awards | 183900 |  | 141051 |  |
| Diluted weighted average shares outstanding | 41774101 | 33784999 | 41943246 | 33635439 |
| Basic earnings (loss) per common share | $0.35 | $(1.43) | $1.19 | $(0.97) |
| Diluted earnings (loss) per common share | $0.35 | $(1.43) | $1.19 | $(0.97) |

---

As of September 30, 2025, potential dilutive instruments consisted of unvested shares of restricted stock, restricted stock units ("RSUs") and performance share units totaling 558,172 (restricted stock and RSUs totaling 399,920 as of September 30, 2024). In the three and nine month periods ended September 30, 2025 potential dilutive instruments were included in the diluted earnings per share computation because, when the unamortized deferred compensation cost related to these shares was divided by the average market price per share in those periods, fewer shares would have been purchased than restricted shares assumed issued. Therefore, in those periods, such awards resulted in higher diluted weighted average shares outstanding than basic weighted average shares outstanding, and had a dilutive effect on per share earnings. In the three and nine month periods ended September 30, 2024, potential dilutive instruments were excluded from the diluted earnings per share computation because the Company reported a net loss and their inclusion would have an anti-dilutive effect in per share earnings in those periods.

------

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

The following discussion and analysis is designed to provide a better understanding of various factors related to Amerant Bancorp Inc.'s (the "Company," "Amerant," "our" or "we") results of operations and financial condition and its subsidiaries, including its principal subsidiary, Amerant Bank, N.A. (the "Bank"). Amerant Investments, Inc., a securities broker-dealer ("Amerant Investments") is an operating subsidiary of the Bank. *For an update on the strategic focus of our mortgage business* and Amerant Mortgage, LLC, a mortgage lending company domiciled in Florida ("Amerant Mortgage"), *see "Amerant Mortgage Updates" below*.

This discussion is intended to supplement and highlight information contained in the accompanying unaudited interim consolidated financial statements and related footnotes included in this Quarterly Report on Form 10-Q (the "Form 10-Q"), as well as the information contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed on March 5, 2025 (the "2024 Form 10-K").

**Cautionary Note Regarding Forward-Looking Statements**

Various of the statements made in this Form 10-Q, including information incorporated herein by reference to other documents, are "forward-looking statements" within the meaning of, and subject to, the protections of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

All statements other than statements of historical fact are statements that could be forward-looking statements. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions and future performance and condition. Examples of forward-looking statements include but are not limited to: our future operating or financial performance, including revenues, expenses, expense savings, income or loss and earnings or loss per share, and other financial items; statements regarding expectations, plans or objectives for future operations, products or services, and our expectations on our securities repositioning and loan recoveries or reaching positive resolutions on problem loans. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause the actual results, performance, achievements, or financial condition of the Company to be materially different from future results, performance, achievements, or financial condition expressed or implied by such forward-looking statements. You should not expect us to update any forward-looking statements, except as required by law. These forward-looking statements should be read together with the "Risk Factors" included in the 2024 Form 10-K , and in our other filings with the U.S. Securities and Exchange Commission (the "SEC"), which are available at the SEC's website www.sec.gov.

All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as "may," "will," "anticipate," "assume," "seek," "should," "indicate," "would," "believe," "contemplate," "consider", "expect," "estimate," "continue," "plan," "point to," "project," "could," "intend," "target" and other similar words and expressions of the future. These forward-looking statements may not be realized due to a variety of factors, including, without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Liquidity risks could affect our operations and jeopardize our financial condition and certain funding sources could increase our interest rate expense;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not be able to develop and maintain a strong core deposit base or other low-cost funding sources;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may elect or be compelled to seek additional capital in the future, but that capital may not be available when it is needed or on acceptable terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to receive dividends from our subsidiaries could affect our liquidity and our ability to pay dividends;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our profitability is subject to interest rate risk;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our allowance for credit losses may prove inadequate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our concentration of CRE loans could result in increased loan losses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Many of our loans are to commercial borrowers, which have unique risks compared to other types of loans;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our valuation of securities and the determination of a credit loss allowance in our investment securities portfolio are subjective and, if changed, could materially adversely affect our results of operations or financial condition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nonperforming and similar assets take significant time to resolve and may adversely affect our business, financial condition, results of operations, or cash flows;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to environmental liability risk associated with lending activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Weakness in the demand for mortgage loans or in the secondary market for residential mortgage loans can adversely affect us.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Many of our major systems depend on and are operated by third-party vendors, and any systems failures or interruptions could adversely affect our operations and the services we provide to our customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our information systems are exposed to cybersecurity threats and may experience interruptions and security breaches that could adversely affect our business and reputation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our strategic plan and growth strategy may not be achieved as quickly or as fully as we seek;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Defaults by or deteriorating asset quality of other financial institutions could adversely affect us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• New lines of business, new products and services, or strategic project initiatives may subject us to additional risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are susceptible to operational risks in general and fraudulent risk in particular;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not have the ability or resources to keep pace with rapid technological changes in the financial services industry or implement new technology effectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Conditions in Venezuela could adversely affect our operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to environmental, social and governance, or ESG, risks, many of which are outside of our control, that could harm our reputation, our business, operations, financial condition, and/or the price of our common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be unable to attract and retain key people to support our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Severe weather, natural disasters, global pandemics, acts of war or terrorism, theft, civil unrest, government expropriation or other external events could have significant effects on our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Any failure to protect the confidentiality of customer information could adversely affect our reputation and subject us to financial sanctions and other costs that could adversely affect our business, financial condition, results of operations, or cash flows;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We could be required to write down our goodwill or other intangible assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We have a net deferred tax asset that may or may not be fully realized;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may incur losses due to minority investments in fintech and specialty finance companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to risks associated with sub-leasing portions of our corporate headquarters building;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our success depends on our ability to compete effectively in highly competitive markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Potential gaps in our risk management policies and internal audit procedures may leave us exposed to unidentified or unanticipated risk, which could negatively affect our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Any failure to maintain effective internal control over financial reporting could impair the reliability of our financial statements, which in turn could harm our business, impair investor confidence in the accuracy and completeness of our financial reports and our access to the capital markets and cause the price of our common stock to decline and subject us to regulatory penalties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in accounting standards could materially impact our financial statements;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Material and negative developments adversely impacting the financial services industry at large and causing volatility in financial markets and the economy may have materially adverse effects on our liquidity, business, financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our business may be adversely affected by economic conditions in general and by conditions in the financial markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to extensive regulation that could limit or restrict our activities and adversely affect our earnings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• There is uncertainty surrounding the potential legal, regulatory and policy changes by the presidential administration in the United States that may directly affect financial institutions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in federal, state or local tax laws, or audits from tax authorities, could negatively affect our business, financial condition, results of operations or cash flows;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Litigation and regulatory investigations are increasingly common in our businesses and may result in significant financial losses and/or harm to our reputation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are subject to capital adequacy and liquidity standards, and if we fail to meet these standards, whether due to losses, growth opportunities or an inability to raise additional capital or otherwise, our business, financial condition, results of operations, or cash flows would be adversely affected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Increases in FDIC deposit insurance premiums and assessments could adversely affect our financial condition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Federal banking agencies periodically conduct examinations of our business, including our compliance with laws and regulations, and our failure to comply with any regulatory actions, if any, could adversely impact us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Federal Reserve may require us to commit capital resources to support the Bank;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may face higher risks of noncompliance with the Bank Secrecy Act and other anti-money laundering statutes and regulations than other financial institutions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failures to comply with the fair lending laws, CFPB regulations or the Community Reinvestment Act, or CRA, could adversely affect us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our principal shareholders and management own a significant percentage of our shares of voting common stock and will be able to exert significant control over matters subject to shareholder approval;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The rights of our common shareholders are subordinate to the holders of any debt securities that we have issued or may issue from time to time;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The stock price of financial institutions, like Amerant, may fluctuate significantly;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We can issue additional equity securities, which would lead to dilution of our issued and outstanding Class A common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Certain provisions of our amended and restated articles of incorporation and amended and restated bylaws, Florida law, and U.S. banking laws could have anti-takeover effects;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not be able to generate sufficient cash to service all of our debt, including the Subordinated Notes and the Debentures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We are a holding company with limited operations and depend on our subsidiaries for the funds required to make payments of principal and interest on the Subordinated Notes and the Debentures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may incur a substantial level of debt that could materially adversely affect our ability to generate sufficient cash to fulfill our obligations under the Subordinated Notes and the Debentures; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The other factors and information included in the 2024 Form 10-K and other filings that we make with the SEC under the Exchange Act and Securities Act. *See* "Risk Factors" in the 2024 Form 10-K.

------

The foregoing factors should not be construed as exhaustive and should be read together with the other cautionary statements included in the 2024 Form 10-K. Because of these risks and other uncertainties, our actual future financial condition, results, performance or achievements, or industry results, may be materially different from the results indicated by the forward-looking statements in this Form 10-Q. In addition, our past results of operations are not necessarily indicative of our future results of operations. You should not rely on any forward-looking statements as predictions of future events.

Any forward-looking statement speaks only as of the date on which it is made, and we do not undertake any obligation to update, revise or correct any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. All written or oral forward-looking statements that are made by us or are attributable to us are expressly qualified in their entirety by this cautionary notice, together with those risks and uncertainties described in "Risk Factors" in the 2024 Form 10-K, and in our other filings with the SEC, which are available at the SEC's website www.sec.gov.

------

**OVERVIEW**

**Our Company**

We are a bank holding company headquartered in Coral Gables, Florida. We provide individuals and businesses a comprehensive array of deposit, credit, investment, wealth management, retail banking, mortgage services, and fiduciary services. We serve customers in our United States markets and select international customers. These services are offered through its main subsidiary, Amerant Bank, which is also headquartered in Coral Gables, Florida, as well as its other subsidiary, Amerant Investments. Fiduciary, investment, wealth management and mortgage lending services are provided by the Bank and the Bank's securities broker-dealer, Amerant Investments. The Bank's primary markets are South Florida, where we are headquartered and operate 20 banking centers in Miami-Dade, Broward and Palm Beach counties; and Tampa, Florida where we have a regional headquarters office and currently operate two banking centers.

The Cayman Bank is a subsidiary of the Bank. The Company is executing a plan for the dissolution of the Cayman Bank and, as of the end of the third quarter of 2024, the Cayman Bank no longer had any trust relationships, many of which were transferred to the Bank. The dissolution of the Cayman Bank, is expected to be completed in 2025, once regulatory approval from the applicable regulatory agency is received.

**Business Developments**

For more information on the progress of our business strategy and strategic initiatives in 2024, *see* Item 1. Business section included in the 2024 Form 10-K.

<u>People and Channels</u>

In July 2025, we hired our new Head of Credit of C&I. Additionally, in the third quarter of 2025, we hired a new Head of Loan Syndications and Sales, who we expect will also contribute with our loan growth agenda across the business. Subsequent to quarter-end, we also hired a managing executive director for our Miami-Dade market and promoted our Tampa Market president to interim Head of Commercial Banking.

In April 2025, we opened our new regional headquarters office and our new banking center in West Palm Beach. In July 2025, the Company received regulatory approval for the opening of a new banking center in St Petersburg, Florida which we currently expect to open in mid-2026. In September 2025, we opened a new banking center in Miami Beach, as previously announced, with plans to open a second one later this year. Lastly, in October 2025, we opened a second banking center in downtown Tampa, FL.

------

<u>Amerant Mortgage Updates</u>

In April 2025, considering its strategic decision to focus on Florida, the Company announced it would transition its mortgage business from national mortgage originator model to in-footprint mortgage focused approach, emphasizing mortgage lending that supports the Company's retail and private banking customers. Since April 2025 and throughout the early part of the fourth quarter of 2025, the Company has progressively reduced the mortgage-focused FTE count from 77 FTEs to 17. All but 5 of the 17 remaining FTEs have been transferred to the Bank. In addition, loans owned are expected to be transferred into the Bank's core platform, and existing vendor contracts are expected to be terminated or modified. The Company is also in the process of assessing strategic alternatives for an eventual wind-down or sale of Amerant Mortgage, which it currently expects to complete in the first half of 2026.

We believe these strategic actions will support our ongoing efforts in becoming the bank of choice in the markets we serve.

**Macroeconomic Outlook**

The economy is currently experiencing heightened uncertainty, primarily due to market reactions to changes in tariff policies. Tariffs have the potential to exacerbate inflationary pressures, although the duration of their impact—whether temporary or prolonged—remains uncertain.

Throughout the third quarter of 2025, the Federal Reserve cut rates by 25 basis points marking its first cut since December 2024. Additionally, on October 29, 2025, the Federal Reserve announced an additional rate cut of 25 basis points.

In terms of employment, data shows a sharp deceleration in job growth, as job reports showed negative job growth in the third quarter of 2025. Federal Reserve officials, including Chairman Powell, have indicated a willingness to exercise patience at current levels of inflation and unemployment to better understand how policy changes affect economic indicators.

Overall, the economic data presents a mixed picture. While the manufacturing sector continues to contract, the services sector is expanding, albeit at a slower pace compared to the previous two quarters. Additionally, consumer spending in the United States appears to be decelerating. Historical data suggests signs of an economic slowdown are emerging. While recession odds have decreased from earlier highs in 2025, they remain somewhat elevated compared to the long-term average.

This macroeconomic environment has contributed to volatility across the banking industry and other sectors. Consequently, we continuously face challenges in executing our business strategy. These include expanding our balance sheet (especially loans and deposits) amid fierce competition, adapting to fluctuating interest rates, and complying with evolving regulatory requirements.

While these are widespread challenges for the banking industry, the Company has not experienced a material impact to its business, financial condition, results of operations, or cash flows.

On July 4, 2025, federal legislation generally referred to as H.R. 1 - One Big Beautiful Bill Act (the "Act") was signed into law. The Act includes a variety of tax provisions including permanently extending and modifying certain key aspects of existing tax law. U.S. GAAP requires the effects of changes in tax laws and rates to be recognized in its financial statements in the period in which legislation is enacted. The Company evaluated the impact of the Act on its consolidated financial statements and determined there is not a material impact resulting from the Act.

------

**Primary Factors Used to Evaluate Our Business**

***Results of Operations.*** In addition to net income or loss, the primary factors we use to evaluate and manage our results of operations include net interest income, noninterest income and expenses, and indicators of financial performance including return on assets ("ROA") and return on equity ("ROE"). We also use certain non-GAAP financial measures in the internal evaluation and management of our businesses.

***Net Interest Income.*** Net interest income represents interest income less interest expense. We generate interest income from interest, dividends and fees received on interest-earning assets, including loans and investment securities we own. We incur interest expense from interest paid on interest-bearing liabilities, including interest-bearing deposits, and borrowings such as advances from the Federal Home Loan Bank of Atlanta ("FHLB") and other borrowings such as repurchase agreements, notes, debentures and other funding sources we may have from time to time. Net interest income typically is the most significant contributor to our revenues and net income. To evaluate net interest income, we measure and monitor: (i) yields on our loans and other interest-earning assets; (ii) the costs of our deposits and other funding sources; (iii) our net interest spread; (iv) our net interest margin, or NIM; and (v) our provisions for credit losses. Net interest spread is the difference between rates earned on interest-earning assets and rates paid on interest-bearing liabilities. NIM is calculated by dividing net interest income for the period by average interest-earning assets during that same period. Because noninterest-bearing sources of funds, such as noninterest-bearing deposits and stockholders' equity, also fund interest-earning assets, NIM includes the benefit of these noninterest-bearing sources of funds. Non-refundable loan origination fees, net of direct costs of originating loans, as well as premiums or discounts paid on loan purchases, are deferred and recognized over the life of the related loan as an adjustment to interest income in accordance with generally accepted accounting principles ("GAAP").

Changes in market interest rates and the interest we earn on interest-earning assets, or which we pay on interest-bearing liabilities, as well as the volumes and the types of interest-earning assets, interest-bearing and noninterest-bearing liabilities and stockholders' equity, usually have the largest impact on periodic changes in our net interest spread, NIM and net interest income. We measure net interest income before and after the provision for credit losses.

***Noninterest Income.*** Noninterest income consists of, among other revenue streams: (i) service fees on deposit accounts; (ii) income from brokerage, advisory and fiduciary activities; (iii) benefits from and changes in cash surrender value of bank-owned life insurance, or BOLI, policies; (iv) card and trade finance servicing fees; (v) securities gains or losses; (vi) net gains and losses on early extinguishment of FHLB advances which we may execute from time to time as part of asset/liability management activities; (vii) income from derivative transactions with customers; (viii) derivative gains or losses; and (ix) other noninterest income which includes mortgage banking revenue and gains or losses on the sale of loans originated for investment.

Our income from service fees on deposit accounts is affected primarily by the volume, growth and mix of deposits we hold and volume of transactions initiated by customers (i.e. wire transfers). These are affected by prevailing market pricing of deposit services, interest rates, our marketing efforts and other factors.

Our income from brokerage, advisory and fiduciary activities consists of brokerage commissions related to our customers' trading volume, fiduciary and investment advisory fees generally based on a percentage of the average value of assets under management and custody ("AUM"), and account administrative services and ancillary fees during the contractual period.

Income from changes in the cash surrender value of our BOLI policies represents the amounts that may be realized under the contracts with the insurance carriers, which are nontaxable.

------

Interchange fees, other fees and revenue sharing are recognized when earned. Trade finance servicing fees, which primarily include commissions on letters of credit, are generally recognized over the service period on a straight line basis. Card servicing fees include credit and debit card interchange fees and other fees. We have also entered into referral arrangements with recognized U.S.-based card issuers, which permit us to serve our customers and earn referral fees and share interchange revenue without exposure to credit risk.

Our gains and losses on sales of securities are derived from sales from our securities portfolio and are primarily dependent on changes in U.S. Treasury interest rates and asset liability management activities. Generally, as U.S. Treasury rates increase, our securities portfolio decreases in market value, and as U.S. Treasury rates decrease, our securities portfolio increases in value. We also recognize unrealized gains or losses on changes in the valuation of our trading securities portfolio and our marketable equity securities not held for trading.

Our fee income generated on customer interest rate swaps and other loan level derivatives is primarily dependent on the volume of transactions completed with customers and are included in noninterest income.

Derivatives unrealized net gains and derivatives unrealized net losses are primarily derived from fair market value changes in the derivative position of our economic hedges on trading.

Other noninterest income includes mortgage banking income/loss generated through our subsidiary, Amerant Mortgage, and consists of gain on sale of loans, gain on loans market valuation, other fees and smaller sources of income. Mortgage banking loss was $0.4 million in the three months ended September 30, 2025 compared to mortgage banking income of $2.8 million in the same period last year. In the first nine months of 2025 and 2024, mortgage banking income was $0.8 million and $5.8 million, respectively. Other income in the three and nine months ended September 30, 2025, includes approximately $0.1 million and $3.6 million, respectively, of net gain on sale of loans originated for investment.

Non-routine noninterest income items include other non-routine noninterest income which include the effect of items such as derivative losses, securities gains and losses, gains on sale of loans, amongst other items non-recurrent in nature. See "Non-GAAP Financial Measures" for more information on non-routine noninterest income items.

***Noninterest Expense.*** Noninterest expenses generally increase as our business grows and whenever necessary to implement or enhance policies and procedures for regulatory compliance, and other purposes.

Noninterest expense consists of: (i) salaries and employee benefits; (ii) occupancy and equipment expenses; (iii) professional and other services fees; (iv) loan-level derivative expenses; (v) FDIC deposit and business insurance assessments and premiums; (vi) telecommunication and data processing expenses; (vii) depreciation and amortization; (viii) advertising and marketing expenses; (ix) other real estate and repossessed assets, net; (x) losses on sale of assets, and (xi) other operating expenses.

Salaries and employee benefits include compensation (including severance expenses which we generally consider non-routine), employee benefits and employer tax expenses for our personnel. Salaries and employee benefits are partially offset by costs directly related to the origination of loans, which are deferred and amortized over the life of the related loans as adjustments to interest income in accordance with GAAP.

Occupancy expense consists of lease expense on our leased properties, including right-of-use or ROU asset impairment charges, and other occupancy-related expenses. Equipment expense includes furniture, fixtures and equipment related expenses. Rental income associated with subleasing portions of the Company's headquarters building and the subleasing of the New York office space, primarily, is included as a reduction to rent expense under lease agreements under occupancy and equipment cost.

Professional and other services fees include the cost of outsourced services, including technology infrastructure and banking processing services from our new technology provider, and other professional consulting fees associated with our transition to a new core banking platform, legal, accounting and related consulting fees, card

------

processing fees, director's fees, regulatory agency fees, such as OCC examination fees, and other fees related to our business operations.

Loan-level derivative expenses are incurred in back-to-back derivative transactions with commercial loan clients and with brokers. The Company pays a fee upon inception of the back-to-back derivative transactions, corresponding to the spread between a wholesale rate and a retail rate.

Advertising expenses include the costs of promoting the Amerant brand, as well as the costs associated with promoting the Company's products and services to create positive awareness, or consideration to buy the Company's products and services. These costs include expenses to produce, deliver and communicate advertisements using available media and technologies, primarily streaming and other digital advertising platforms. Advertising expenses are expensed as incurred, except for media production costs which are expensed upon the first airing of the advertisement.

FDIC deposit and business insurance assessments and premiums include deposit insurance, net of any credits applied against these premiums, corporate liability and other business insurance premiums.

Telecommunication and data processing expenses include expenses paid to our third-party data processing system providers and other telecommunication and data service providers.

Depreciation and amortization expense includes the value associated with the depletion of the value on our owned properties and equipment, including leasehold improvements made to our leased properties.

OREO and repossessed assets expense includes expenses and revenue (rental income) from the operation of foreclosed property/assets as well as fair value adjustments and gains/losses from the sale of OREO and repossessed assets.

Other operating expenses include earnings credits, business development expenses, community engagement, charitable contributions, mortgage loan origination and servicing expenses, postage and courier expenses, debits which mirror the valuation income on the investment balances held in the non-qualified deferred compensation plan in order to adjust the liability to participants of the deferred compensation plan, and other small operational expenses. Earnings credits are provided to certain commercial depositors primarily in the mortgage banking industry to help offset deposit service charges incurred.

Non-routine noninterest expense items include other non-routine noninterest expenses which include the effect of items such as OREO and loans held for sale valuation allowances, sale of repossessed assets, impairment of investments, losses on sale of loans, amongst other items non-recurrent in nature. *See* "Non-GAAP Financial Measures" for more information on non-routine noninterest expense items.

------

**Primary Factors Used to Evaluate Our Financial Condition**

The primary factors we use to evaluate and manage our financial condition include asset quality, capital and liquidity.

***Asset Quality.*** We manage the diversification and quality of our assets based upon factors that include the level, distribution and risks in each category of assets. Problem assets may be categorized as classified, delinquent, nonaccrual, and nonperforming assets. We also manage the adequacy of our allowance for credit losses, or the allowance, the diversification and quality of loan and investment portfolios, the extent of counterparty risks, credit risk concentrations and other factors.

***Capital.*** Financial institution regulators have established minimum capital ratios for banks and bank holding companies. We manage capital based upon factors that include: (i) the level and quality of capital and our overall financial condition; (ii) the trend and volume of problem assets; (iii) the adequacy of reserves; (iv) the level and quality of earnings; (v) the risk exposures in our balance sheet under various scenarios, including stressed conditions; (vi) the Tier 1 capital ratio, the total capital ratio, the Tier 1 leverage ratio, and the CET1 capital ratio; (vii) the tangible common equity ratio; and (viii) other factors, including market conditions.

***Liquidity.*** Our deposit base consists primarily of personal and commercial accounts maintained by individuals and businesses in our primary markets and select international core depositors. The Company is focused on relationship-driven core deposits. The Company may also use third party providers of domestic sources of deposits as part of its balance sheet management strategies. We define core deposits as total deposits excluding all time deposits. This definition of core deposits differs from the Federal Financial Institutions Examination Council's (the "FFIEC") Uniform Bank Performance Report (the "UBPR") definition of "core deposits," which exclude brokered time deposits and retail time deposits of more than $250,000. *See* "Core Deposits" discussion for more details.

We manage liquidity based upon factors that include the amount of core deposit relationships as a percentage of total deposits, the level of diversification of our funding sources, the allocation and amount of our deposits among deposit types, the short-term funding sources used to fund assets, the amount of non-deposit funding used to fund assets, the availability of unused funding sources, off-balance sheet obligations, the amount of cash and liquid securities we hold, the availability of assets readily convertible into cash without undue loss, the characteristics and maturities of our assets when compared to the characteristics of our liabilities and other factors.

***Seasonality*.** Our loan production, generally, is subject to seasonality, with the lowest volume typically in the first quarter of each year.

------

**Summary Results**

The summary results for the three and nine months ended September 30, 2025 include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total assets were $10.4 billion at September 30, 2025, up $508.5 million, or 5.1%, compared to $9.9 billion at December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total gross loans, which includes all loans held for sale, were $6.9 billion at September 30, 2025, down $329.5 million, or 4.5%, compared to $7.3 billion at December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash and cash equivalents were $630.9 million, up $40.5 million or 6.9%, compared to $590.4 million at December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total deposits were $8.3 billion at September 30, 2025, up $446.4 million, or 5.7%, compared to $7.9 billion at December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total advances from the FHLB were $831.7 million, up $86.7 million or 11.6%, compared to $745.0 million as of December 31, 2024. The Bank had an aggregate borrowing capacity of $3.0 billion from the Federal Reserve or FHLB as of September 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net Interest Margin ("NIM") increased to 3.92% in the three months ended September 30, 2025 compared to 3.49% in the three months ended September 30, 2024. NIM increased to 3.83% in the nine months ended September 30, 2025 from 3.52% in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Average yield on loans decreased to 6.93% in the three months ended September 30, 2025 from 7.08% in the three months ended September 30, 2024. Average yield on loans decreased to 6.89% in the nine months ended September 30, 2025 compared to 7.08% in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Average cost of total deposits decreased to 2.41% in the three months ended September 30, 2025 compared to 2.99% in the three months ended September 30, 2024. Average cost of total deposits decreased to 2.51% in the nine months ended September 30, 2025 compared to 2.99% in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Loan to deposit ratio was 83.6% at September 30, 2025 compared to 92.6% at December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Asset Quality and Allowance for Credit Losses:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Total non-performing assets were $139.9 million at September 30, 2025, up $17.7 million, or 14.5%, compared to $122.2 million at December 31, 2024. As of September 30, 2025, non-performing assets consist of $124.3 million in non-performing loans and $15.6 million in other real estate owned.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ The allowance for credit losses ("ACL") as of September 30, 2025 was $94.9 million, up $10.0 million, or 11.7%, compared to $85.0 million as of December 31, 2024.

.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Assets Under Management and custody ("AUM") totaled $3.2 billion, as of September 30, 2025, up $279.5 million, or 9.7%, from $2.9 billion as of December 31, 2024.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Accumulated Other Comprehensive Loss ("AOCL") as of September 30, 2025 decreased to $6.9 million, an improvement of $32.9 million, or 82.6%, compared to $39.8 million as of December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Pre-provision net revenue ("PPNR")<sup>(1)</sup> was $33.6 million in the three months ended September 30, 2025, an increase of $76.5 million, or 178.4% , compared to negative $42.9 million in the three months ended September 30, 2024. PPNR<sup>(1)</sup> was $103.3 million, in the nine months ended September 30, 2025, an increase of $94.9 million, or 1124.0%, compared to $8.4 million in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net Interest Income ("NII") was $94.2 million in the three months ended September 30, 2025, up $13.2 million, or 16.2%, from $81.0 million in the three months ended September 30, 2024. NII was $270.5 million in the nine months ended September 30, 2025, up $32.2 million, or 13.5%, compared to $238.3 million in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Provision for credit losses was $14.6 million in the three months ended September 30, 2025, down $4.4 million, or 23.16% compared to $19.0 million in the three months ended September 30, 2024. Provision for credit losses was $39.1 million in the nine months ended September 30, 2025, down $11.4 million, or 22.6%, compared to $50.6 million in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-interest income was $17.3 million in the three months ended September 30, 2025, up $65.0 million or 136.3%, from negative $47.7 million in the three months ended September 30, 2024. Non-interest income was $56.6 million in the nine months ended September 30, 2025, up $70.4 million, or 510.9%, compared to negative $13.8 million in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-interest expense was $77.8 million in the three months ended September 30, 2025, up $1.6 million, or 2.1%, from $76.2 million in the three months ended September 30, 2024. Non-interest expense was $223.8 million in the nine months ended September 30, 2025, up $7.7 million, or 3.6%, compared to $216.1 million in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The efficiency ratio was 69.8% in the three months ended September 30, 2025 compared to 228.7% in the three months ended September 30, 2024. The efficiency ratio was 68.41% in the nine months ended September 30, 2025 compared to 96.24% in the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Return on average Assets ("ROA") was 0.57% in the three months ended September 30, 2025, compared to negative 1.92% in the three months ended September 30, 2024. ROA was 0.65% in the nine months ended September 30, 2025, compared to negative 0.44% in the nine months ended September 30, 2024.

 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Return on average equity ("ROE") was 6.21% in the three months ended September 30, 2025 compared to negative 24.98% in the three months ended September 30, 2024. ROE was 7.20% in the nine months ended September 30, 2025, compared to negative 5.79% in the nine months ended September 30, 2024.

<sup>1</sup>Non-GAAP measure, see "Non-GAAP Financial Measures" for more information and for a reconciliation to GAAP.

------

**Results of Operations - Comparison of Results of Operations for the Three and Nine Month Periods Ended September 30, 2025 and 2024** 

***Net income***

The table below sets forth certain results of operations data for the three and nine month periods ended September 30, 2025 and 2024:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Change** | **Change** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Change** | **Change** |
| *(in thousands, except per share amounts and percentages)* | **2025** | **2024** | **2025 vs 2024** | **2025 vs 2024** | **2025** | **2024** | **2025 vs 2024** | **2025 vs 2024** |
| Net interest income | $94152 | $80999 | $13153 | 16.2% | $270535 | $238322 | $32213 | 13.5% |
| Provision for credit losses | 14600 | 19000 | (4400) | (23.2)% | 39106 | 50550 | (11444) | (22.6)% |
| Net interest income after provision for credit losses | 79552 | 61999 | 17553 | 28.3% | 231429 | 187772 | 43657 | 23.3% |
| Noninterest income (loss) | 17291 | (47683) | 64974 | 136.3% | 56594 | (13775) | 70369 | 510.9% |
| Noninterest expense | 77835 | 76208 | 1627 | 2.1% | 223789 | 216104 | 7685 | 3.6% |
| Income (loss) before income tax expense | 19008 | (61892) | 80900 | 130.7% | 64234 | (42107) | 106341 | 252.6% |
| Income tax (expense) benefit | (4252) | 13728 | (17980) | (131.0)% | (14518) | 9474 | (23992) | (253.2)% |
| Net income (loss) attributable to Amerant Bancorp Inc. | $14756 | $(48164) | $62920 | 130.6% | $49716 | $(32633) | $82349 | 252.4% |
| Basic earnings (loss) per common share | $0.35 | $(1.43) | $1.78 | 124.5% | $1.19 | $(0.97) | $2.16 | 222.7% |
| Diluted earnings (loss) per common share (1) | $0.35 | $(1.43) | $1.78 | 124.5% | $1.19 | $(0.97) | $2.16 | 222.7% |

---

__________________&nbsp;&nbsp;&nbsp;&nbsp;

(1)&nbsp;&nbsp;&nbsp;&nbsp;In the three and nine month periods ended September 30, 2025 and 2024, potential dilutive instruments consisted of unvested shares of restricted stock, restricted stock units and performance share units. *See* Note 13 to our unaudited interim consolidated financial statements in this Form 10-Q for details on the dilutive effects of the issuance of restricted stock, restricted stock units and performance share units on earnings per share.

<u>Three Months Ended September 30, 2025 and 2024</u>

In the three months ended September 30, 2025, net income attributable to the Company was $14.8 million, or $0.35 income per diluted share, compared to net loss of $48.2 million, or $1.43 loss per diluted share, in the same quarter of 2024. The increase of $62.9 million, or 130.6%, in the three months ended September 30, 2025 was primarily driven by (i) higher noninterest income in the three months ended September 30, 2025, as the three months ended September 30, 2024 had a net loss which included losses in securities as a result of the investment portfolio repositioning initiated during the same period, (ii) higher net interest income and (iii) lower provision for credit losses.

------

Net interest income was $94.2 million in the three months ended September 30, 2025, an increase of $13.2 million, or 16.2%, from $81.0 million in the three months ended September 30, 2024. This was primarily driven by: (i) increases of $660.4 million, or 50.3%, $119.4 million, or 100.00% and $69.1 million, or 20.05%, in the average balances of debt securities available for sale, securities held for trading, and deposits with banks, respectively, during the period; (ii) a decrease of $125.2 million or 1.7%, in the average balance of total interest-bearing liabilities in the third quarter compared to the same period last year, mainly driven by lower average balances in FHLB advances as well as the redemption of Senior Notes in the second quarter of 2025; and (iii) lower cost of interest bearing liabilities which decreased by 60 basis points in the third quarter of 2025 compared to the same period one year ago. These improvements were partially offset by: (i) decreases of $345.3 million, or 4.7%, $206.0 million, or 100.0%, in the average balances of the loan portfolio and securities held to maturity, respectively, during the period; (ii) an increase of $71.7 million, or 1.12% in total deposits; and (iii) a 17 basis points decrease in the average yield on total interest earning assets, mainly in loans and other short-term investments. Net interest margin was 3.92% in the three months ended September 30, 2025, an increase of 43 basis points from 3.49% in the three months ended September 30, 2024.

Noninterest income was $17.3 million in the three months ended September 30, 2025 compared to noninterest loss of $47.7 million in the three months ended September 30, 2024. The increase was mainly driven by: (i) higher securities gains; (ii) higher brokerage, advisory and fiduciary fees; and (iii) higher change in cash surrender value of BOLI. These increases were partially offset by: (i) lower other noninterest income; (ii) higher derivative losses; and (iii) lower loan-level derivative income. *See* "Noninterest Income" for more details.

In the three months ended September 30, 2025 and 2024, noninterest income included certain non-routine income and loss items. See "Non-GAAP Financial Measures" for more information on non-routine noninterest income items.

Noninterest expense was $77.8 million in the three months ended September 30, 2025, an increase of $1.6 million, or 2.1%, compared to $76.2 million in the same period in 2024. This increase was mainly due to: (i) higher other operating expenses; (ii) higher professional and other services fees; (iii) higher losses on loans held for sale carried at the lower cost or fair value; and (iv) higher advertising expenses. These increases were partially offset by: (i) lower OREO and repossessed assets expense; (ii) lower occupancy and equipment expenses; (iii) lower FDIC assessments and insurance expenses; and (iv) lower depreciation and amortization expenses. *See* "Noninterest Expense*"* for more details.

In the three months ended September 30, 2025 and 2024, noninterest expense included total non-routine items of $2.0 million and $5.7 million, respectively. Non-routine items in noninterest expense in the three months ended September 30, 2025 includes loss on sale of $0.9 million related to the sale of one Substandard owner-occupied loan with an outstanding balance of $30.4 million at the time of sale, $0.6 million in expenses related to the downsizing of Amerant Mortgage and $0.5 million in net losses on sale and valuation expense on OREO. Other non-routine items in noninterest expense in the three months ended September 30, 2024, include $5.7 million related to an OREO valuation expense. See "Non-GAAP Financial Measures" for more information on non-routine noninterest expense items.

In the three months ended September 30, 2025 and 2024, the Company incurred noninterest expenses of $2.1 million and $3.9 million, respectively, related to Amerant Mortgage which consists of salaries and employee benefits expense, mortgage lending costs and professional and other services fees. Amerant Mortgage had 5 full time equivalent employees ("FTEs") at September 30, 2025 compared to 80 at September 30, 2024.

------

<u>Nine Months Ended September 30, 2025 and 2024</u> 

In the nine months ended September 30, 2025, net income attributable to the Company was $49.7 million, or $1.19 income per diluted share, compared to net loss of $32.6 million, or $0.97 loss per diluted share, in the same period of 2024. The increase of $82.3 million, or 252.4%, in the nine months ended September 30, 2025 was primarily driven by (i) higher noninterest income in the nine months ended September 30, 2025, as the nine months ended September 30, 2024 had a net loss with included losses on securities as a result of the investment portfolio repositioning initiated during the same period, (ii) higher net interest income, and (iii) lower provision for credit losses.

Net interest income was $270.5 million in the nine months ended September 30, 2025, an increase of $32.2 million, or 13.5%, from $238.3 million in the nine months ended September 30, 2024. This was primarily driven by an increase of $466.8 million, or 36.6% and $125.1 million or 33.2%, in the average balances of debt securities available for sale, and deposits with banks, respectively, during the period. Additionally, the cost of interest-bearing liabilities decreased 46 basis points in the current year compared to the same period last year. These improvements were partially offset by: (i) decreases of $217.3 million, or 100.0%, and $24.0 million or 0.3% in the average balance of debt securities held to maturity and the loan portfolio, respectively; (ii) a 17 basis points decrease in the average yield on total interest earning assets; and (iii) an increase of $40.8 million, or 0.6%, in the average balance of total interest-bearing liabilities in the current year compared to the same period last year . Net interest margin was 3.83% in the nine months ended September 30, 2025, an increase of 31 basis points from 3.52% in the nine months ended September 30, 2024.

Noninterest income was $56.6 million in the nine months ended September 30, 2025 compared to noninterest loss of $13.8 million in the nine months ended September 30, 2024. The increase was mainly driven by (i) higher securities gains; (ii) higher brokerage, advisory and fiduciary fees; (iii) higher loan-level derivative income; (iv) higher change in cash surrender value of BOLI; (v) higher cards and trade finance servicing fees; and (vi) higher deposits and service fees. These increases were partially offset by: (i) higher derivative losses; and (ii) lower other noninterest income. *See* "Noninterest Income" for more details.

In the nine months ended September 30, 2025 and 2024, noninterest income included non-routine items of $2.6 million and a loss of $68.7 million. See "Non-GAAP Financial Measures" for more information on non-routine noninterest income items.

Noninterest expense was $223.8 million in the nine months ended September 30, 2025, an increase of $7.7 million, or 3.6%, compared to $216.1 million in the same period in 2024. This increase was mainly due to: (i) higher professional and other service fees; (ii) higher other operating expenses; (iii) higher salaries and employee benefits; (iv) advertising expenses; (v) higher loan-level derivative expenses; (vi) higher losses on loans held for sale carried at the lower of cost or fair value; and (vii) higher telecommunications and data processing expenses. These increases were partially offset by: (i) lower occupancy and equipment expenses, and (ii) lower OREO and repossessed assets expense. *See* "Noninterest Expense*"* for more details.

In the nine months ended September 30, 2025 and 2024, noninterest expense included total non-routine items of $3.7 million and $11.2 million, respectively. Non-routine items in noninterest expense in the nine months ended September 30, 2025 includes $1.9 million in net losses on sale and valuation expense on OREO, $1.0 million in expenses related to the downsizing of Amerant Mortgage, and loss on sale of $0.9 million related to the sale of one Substandard owner-occupied loan with an outstanding balance of $30.4 million at the time of sale. Non-routine items in noninterest expense in the nine months ended September 30, 2024, included: (i) $5.7 million in OREO valuation expense, (ii) $3.4 million in fixed assets impairment, (iii) a $1.3 million loss on loans held for sale for valuation expense, (iv) $0.6 million in legal and broker fees, and (v) $0.3 million in goodwill and intangible asset impairment. Items (ii) through (iv) were all in connection with the Houston Sale Transaction completed in 2024. See "Non-GAAP Financial Measures" for more information on non-routine noninterest expense items.

------

In the nine months ended September 30, 2025 and 2024, the Company incurred noninterest expenses of $8.3 million and $10.5 million, respectively, related to Amerant Mortgage which consists of salaries and employee benefits expense, mortgage lending costs and professional and other services fees. Amerant Mortgage had 5 full time equivalent employees ("FTEs") at September 30, 2025 compared to 80 at September 30, 2024.

------

**Average Balance Sheet, Interest and Yield/Rate Analysis**

The following tables present average balance sheet information, interest income, interest expense and the corresponding average yields earned and rates paid for the three and nine month periods ended September 30, 2025 and 2024. The average balances for loans include both performing and non-performing balances. Interest income on loans includes the effects of discount accretion and the amortization of non-refundable loan origination fees, net of direct loan origination costs as well as the amortization of net premiums/discounts on loan purchases, accounted for as yield adjustments. Average balances represent the daily average balances for the periods presented.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *(in thousands, except percentages)* | **Average<br>Balances** | **Income/<br>Expense** | **Yield/<br>Rates** | **Average <br> Balances** | **Income/<br>Expense** | **Yield/ <br>Rates** |
| **Interest-earning assets:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan portfolio, net (1)(2) | $6946370 | $121414 | 6.93% | $7291632 | $129752 | 7.08% |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities available for sale (3) (4) | 1973763 | 24146 | 4.85% | 1313366 | 14273 | 4.32% |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities held to maturity (5) |  |  | —% | 205958 | 1752 | 3.38% |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities held for trading | 119429 | 1665 | 5.53% |  |  | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity securities with readily determinable fair value not held for trading | 2528 | 20 | 3.14% | 2525 | 19 | 2.99% |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal Reserve Bank and FHLB stock | 57681 | 906 | 6.23% | 61147 | 1083 | 7.05% |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposits with banks | 413522 | 4516 | 4.33% | 344469 | 4670 | 5.39% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other short-term investments | 7122 | 76 | 4.23% | 6677 | 88 | 5.24% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total interest-earning assets** | 9520415 | 152743 | 6.37% | 9225774 | 151637 | 6.54% |
| Total non-interest-earning assets (6) | 723510 |  |  | 760198 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $10243925 |  |  | $9985972 |  |  |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *(in thousands, except percentages)* | **Average<br>Balances** | **Income/<br>Expense** | **Yield/<br>Rates** | **Average <br> Balances** | **Income/<br>Expense** | **Yield/ <br>Rates** |
| **Interest-bearing liabilities:** |  |  |  |  |  |  |
| Checking and saving accounts |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest bearing DDA | $2240617 | $10892 | 1.93% | $2294323 | $15345 | 2.66% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money market | 1918534 | 17986 | 3.72% | 1541987 | 16804 | 4.34% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Savings | 236556 | 22 | 0.04% | 247903 | 26 | 0.04% |
| Total checking and saving accounts | 4395707 | 28900 | 2.61% | 4084213 | 32175 | 3.13% |
| Time deposits | 2084940 | 20950 | 3.99% | 2324694 | 27260 | 4.67% |
| Total deposits | 6480647 | 49850 | 3.05% | 6408907 | 59435 | 3.69% |
| Advances from the FHLB (7) | 726520 | 7316 | 4.00% | 863913 | 8833 | 4.07% |
| Senior notes |  |  | —% | 59725 | 942 | 6.27% |
| Subordinated notes | 29731 | 362 | 4.83% | 29561 | 361 | 4.86% |
| Junior subordinated debentures | 64178 | 1063 | 6.57% | 64178 | 1067 | 6.61% |
| **Total interest-bearing liabilities** | 7301076 | 58591 | 3.18% | 7426284 | 70638 | 3.78% |
| Non-interest-bearing liabilities: |  |  |  |  |  |  |
| Non-interest-bearing demand deposits | 1726507 |  |  | 1491406 |  |  |
| Accounts payable, accrued liabilities and other liabilities | 273921 |  |  | 301373 |  |  |
| Total non-interest-bearing liabilities | 2000428 |  |  | 1792779 |  |  |
| Total liabilities | 9301504 |  |  | 9219063 |  |  |
| Stockholders' equity | 942421 |  |  | 766909 |  |  |
| Total liabilities and stockholders' equity | $10243925 |  |  | $9985972 |  |  |
| Excess of average interest-earning assets over average interest-bearing liabilities | $2219339 |  |  | $1799490 |  |  |
| **Net interest income** |  | $94152 |  |  | $80999 |  |
| Net interest rate spread |  |  | 3.19% |  |  | 2.76% |
| Net interest margin (8) |  |  | 3.92% |  |  | 3.49% |
| Cost of total deposits (8) |  |  | 2.41% |  |  | 2.99% |
| Ratio of average interest-earning assets to average interest-bearing liabilities | 130.40% |  |  | 124.23% |  |  |
| Average non-performing loans/ Average total loans | 1.30% |  |  | 1.54% |  |  |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *(in thousands, except percentages)* | **Average<br>Balances** | **Income/<br>Expense** | **Yield/<br>Rates** | **Average <br> Balances** | **Income/<br>Expense** | **Yield/ <br>Rates** |
| **Interest-earning assets:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan portfolio, net (1)(2) | $7078705 | $364601 | 6.89% | $7102716 | $376574 | 7.08% |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities available for sale (3) (4) | 1740625 | 64041 | 4.92% | 1273797 | 41562 | 4.36% |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities held to maturity (5) |  |  | —% | 217272 | 5597 | 3.44% |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt securities held for trading | 60075 | 2008 | 4.47% |  |  | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity securities with readily determinable fair value not held for trading | 2511 | 60 | 3.19% | 2490 | 87 | 4.67% |
| &nbsp;&nbsp;&nbsp;&nbsp;Federal Reserve Bank and FHLB stock | 57359 | 2759 | 6.43% | 55352 | 2922 | 7.05% |
| &nbsp;&nbsp;&nbsp;&nbsp;Deposits with banks | 502191 | 16560 | 4.41% | 377139 | 15681 | 5.55% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other short-term investments | 6870 | 217 | 4.22% | 6337 | 248 | 5.22% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total interest-earning assets** | 9448336 | 450246 | 6.37% | 9035103 | 442671 | 6.54% |
| **Total non-interest-earning assets (6)** | 733305 |  |  | 788240 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $10181641 |  |  | $9823343 |  |  |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| *(in thousands, except percentages)* | **Average<br>Balances** | **Income/<br>Expense** | **Yield/<br>Rates** | **Average <br> Balances** | **Income/<br>Expense** | **Yield/ <br>Rates** |
| **Interest-bearing liabilities:** |  |  |  |  |  |  |
| Checking and saving accounts |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest bearing DDA | $2221543 | $32913 | 1.98% | $2382548 | $49860 | 2.80% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Money market | 1884975 | 52651 | 3.73% | 1462034 | 46611 | 4.26% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Savings | 237764 | 62 | 0.03% | 254661 | 79 | 0.04% |
| Total checking and saving accounts | 4344282 | 85626 | 2.64% | 4099243 | 96550 | 3.15% |
| Time deposits | 2153720 | 67093 | 4.17% | 2291539 | 79355 | 4.63% |
| Total deposits | 6498002 | 152719 | 3.14% | 6390782 | 175905 | 3.68% |
| Securities sold under agreements to repurchase | 35 | 1 | 3.82% | 41 | 2 | 6.52% |
| Advances from the FHLB (7) | 722493 | 21746 | 4.02% | 749195 | 21357 | 3.81% |
| Senior notes | 19742 | 1020 | 6.91% | 59646 | 2826 | 6.33% |
| Subordinated notes | 29689 | 1084 | 4.88% | 29519 | 1083 | 4.90% |
| Junior subordinated debentures | 64178 | 3141 | 6.54% | 64178 | 3176 | 6.61% |
| **Total interest-bearing liabilities** | 7334139 | 179711 | 3.28% | 7293361 | 204349 | 3.74% |
| Non-interest-bearing liabilities: |  |  |  |  |  |  |
| Non-interest-bearing demand deposits | 1636816 |  |  | 1459325 |  |  |
| Accounts payable, accrued liabilities and other liabilities | 287021 |  |  | 318273 |  |  |
| Total non-interest-bearing liabilities | 1923837 |  |  | 1777598 |  |  |
| Total liabilities | 9257976 |  |  | 9070959 |  |  |
| Stockholders' equity | 923665 |  |  | 752384 |  |  |
| Total liabilities and stockholders' equity | $10181641 |  |  | $9823343 |  |  |
| Excess of average interest-earning assets over average interest-bearing liabilities | $2114197 |  |  | $1741742 |  |  |
| **Net interest income** |  | $270535 |  |  | $238322 |  |
| Net interest rate spread |  |  | 3.09% |  |  | 2.80% |
| Net interest margin (8) |  |  | 3.83% |  |  | 3.52% |
| Cost of total deposits (8) |  |  | 2.51% |  |  | 2.99% |
| Ratio of average interest-earning assets to average interest-bearing liabilities | 128.83% |  |  | 123.88% |  |  |
| Average non-performing loans/ Average total loans | 1.36% |  |  | 0.93% |  |  |

---

__________________&nbsp;&nbsp;&nbsp;&nbsp;

(1)&nbsp;&nbsp;&nbsp;&nbsp;Includes loans held for investment net of the allowance for credit losses, and loans held for sale. The average balance of the allowance for credit losses was $88.1 million and $92.1 million in the three months ended September 30, 2025 and September 30, 2024, respectively, and $88.8 million and $93.2 million in the nine months ended September 30, 2025 and 2024, respectively. The average balance of total loans held for sale was $8.9 million and $612.9 million in the three months ended September 30, 2025 and September 30, 2024, respectively, and $36.1 million and $352.8 million in the nine months ended September 30, 2025 and 2024, respectively.

(2) Includes average non-performing loans of $91.2 million and $113.5 million for the three months ended September 30, 2025 and September 30, 2024, respectively, and $97.5 million and $66.3 million in the nine months ended September 30, 2025 and 2024, respectively.

(3)&nbsp;&nbsp;&nbsp;&nbsp;Includes the average balance of net unrealized gains and losses in the fair value of debt securities available for sale. The average balance includes average net unrealized losses of $32.7 million and $89.4 million in the three months ended September 30, 2025 and September 30, 2024, respectively, and $41.0 million and $102.2 million in the nine months ended September 30, 2025 and 2024, respectively.

(4)&nbsp;&nbsp;&nbsp;&nbsp;Includes nontaxable securities with average balances of $54.2 million and $19.9 million for the three months ended September 30, 2025 and September 30, 2024, respectively, and $54.6 million and $19.9 million in the nine months ended September 30, 2025 and 2024, respectively. The tax equivalent yield for these nontaxable securities was 4.60% and 4.33% for the three months ended September 30, 2025 and September 30, 2024, respectively, and 4.68% and 4.28% for the nine months ended September 30, 2025 and 2024, respectively. In 2025 and 2024, the tax equivalent yields were calculated assuming a 21% tax rate and dividing the actual yield by 0.79.

(5) We had no average held to maturity balances in the three and nine months ended September 30, 2025. Includes nontaxable securities with average balances of $44.5 million and $47.8 million for the three and nine months ended September 30, 2024, respectively. The tax

------

equivalent yield for these nontaxable securities were 4.43% and 4.23% for the three and nine months ended September 30, 2024, respectively. In 2024, the tax equivalent yield was calculated assuming a 21% tax rate and dividing the actual yield by 0.79.

(6) Excludes the allowance for credit losses.

(7)&nbsp;&nbsp;&nbsp;&nbsp;The terms of the FHLB advance agreements require the Bank to maintain certain investment securities or loans as collateral for these advances.

(8) Net interest margin, or NIM: defined as net interest income, or NII, divided by average interest-earning assets, which are loans, securities, deposits with banks and other financial assets which yield interest or similar income.. Cost of total deposits: calculated based upon the average balance of total noninterest bearing and interest bearing deposits, which includes time deposits.

------

***Net Interest Income***

<u>Three Months Ended September 30, 2025 and 2024</u>

The Company was able to reprice the cost of its interest-bearing deposits to offset lower yields on the loan portfolio we recorded during the third quarter of 2025 compared to the same period last year. Additionally, we continued investing in higher-yielding, fixed rate, debt securities available for sale, and maintaining a high average balance in funds at the Federal Reserve. *See* discussions further below for more details.

Net interest income in the three months ended September 30, 2025, was $94.2 million, an increase of $13.2 million, or 16.2%, from $81.0 million in the three months ended September 30, 2024. This was primarily driven by: (i) increases of $660.4 million, or 50.28%, $119.4 million, or 100.00% and $69,053, or 20.05%, in the average balances of debt securities available for sale, securities held for trading, and deposits with banks, respectively, during the period; (ii) a decrease of $125.2 million or 1.7%, in the average balance of total interest-bearing liabilities in the third quarter compared to the same period last year, mainly driven by lower average balances in FHLB advances as well as the redemption of Senior Notes in the second quarter of 2025; and (iii) lower cost of interest bearing liabilities which decreased by 60 basis points in the third quarter of 2025 compared to the same period one year ago. These improvements were partially offset by: (i) decreases of $345.3 million, or 4.7%, $206.0 million, or 100.0%, in the average balances of the loan portfolio and securities held to maturity, respectively, during the period; (ii) an increase of $71.7 million, or 1.12% in total deposits; and (iii) a 17 basis points decrease in the average yield on total interest earning assets, mainly in loans and other short-term investments. Net interest margin was 3.92% in the three months ended September 30, 2025, an increase of 43 basis points from 3.49% in the three months ended September 30, 2024. *See* discussions further below for more details.

*Interest Income*

Total interest income was $152.7 million in the three months ended September 30, 2025, an increase of $1.1 million, or 0.7%, compared to $151.6 million for the same period of 2024. The increase was driven by: increases of $660.4 million, or 50.3%, $119.4 million, or 100.00%, and $69.1 million or 20.0%, in the average balances of debt securities available for sale, securities held for trading, and deposits with banks, respectively, during the period. These were partially offset by: (i) a decrease of $345.3 million, or 4.7%, and $206.0 million, or 100.0%, in the average balances of loans and debt securities held to maturity; and (ii) a 17 basis points decrease in the average yield on total interest earning assets, mainly in loans and other short-term investments.

Interest income on loans in the three months ended September 30, 2025 was $121.4 million, a decrease of $8.3 million, or 6.4%, compared to $129.8 million in the same period last year, primarily due to a 15 basis points decrease in average yields. The decrease in interest income on loans was also due to the decreases in the average balance of the total loan portfolio during the quarter compared to the same period in 2024. *See* "-Average Balance Sheet, Interest and Yield/Rate Analysis" for detailed information.

Interest income on debt securities available for sale was $24.1 million in the three months ended September 30, 2025, an increase of $9.9 million, or 69.2%, compared to $14.3 million in the same period of 2024. This was mainly due to an increase of $660.4 million, or 50.3% in the average balance of these securities as well as an increase of 53 basis points in average yields, primarily as a result of the investment portfolio repositioning that was completed in October 2024 as well as additional purchases of higher-yielding, fixed rate investments during the quarter. In the three months ended September 30, 2025, the average balance of accumulated net unrealized loss included in the carrying value of these securities was $32.7 million compared to $89.4 million in the same period last year.

------

Interest income on debt securities held for trading was $1.7 million in the three months ended September 30, 2025, an increase of $1.7 million or 100.0%, which was mainly due to the increase $119.4 million in the average balances of these securities compared to having none in the same period of 2024.

As of September 30, 2025, floating rate investments, which are entirely comprised of available for sale debt securities, represent 15.4% of our total investment portfolio compared to 14.3% at September 30, 2024. In addition, the expected overall duration decreased to 4.4 years at September 30, 2025 from 4.9 years at September 30, 2024 due to higher estimated prepayment assumptions and investment portfolio mix of larger proportion of floating rate securities that have a lower duration versus fixed rate securities.

*Interest Expense*

Interest expense was $58.6 million in the three months ended September 30, 2025, a decrease of $12.0 million or 17.1%, compared to $70.6 million in the same period of 2024. This was primarily due to a decrease of 60 basis points in average rates on total interest-bearing liabilities, mainly due to a decrease of 64 basis points in the average rates paid on total deposits, and the redemption of Senior Notes in the second quarter of 2025. These decreases were partially offset by higher average balance of total deposits, mainly money market deposit accounts.

Interest expense on interest-bearing deposits was $49.9 million in the three months ended September 30, 2025, a decrease of $9.6 million, or 16.1%, compared to $59.4 million for the same period of 2024. This was mainly driven by a decrease of 64 basis points in the average rates paid on total deposits, partially offset by an increase of $71.7 million, or 1.1%, in their average balance. *See* below for a detailed explanation of changes by major deposit category:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Time deposit*s. Interest expense on total time deposits decreased $6.3 million, or 23.1%, in the three months ended September 30, 2025 compared to the same period in 2024. This was mainly due to a decrease of 68 basis points in the average cost of total time deposits. In addition, there was a decrease of $239.8 million, or 10.3%, in the average balance of these deposits, which includes a $82.1 million decrease in the average balance of customer CDs and a $157.7 million decrease in the average balance of brokered time deposits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Interest bearing checking and savings accounts*. Interest expense on checking and savings accounts decreased $3.3 million, or 10.2% in the three months ended September 30, 2025 compared to the same period one year ago. This was mainly due to a decrease of 52 basis points in the average costs on these deposits coupled with decreases of $53.7 million, or 2.3%, and $11.3 million, or 4.6%, in the average balances of interest bearing demand deposits and savings accounts, respectively. This was partially offset by an increase of $376.5 million, or 24.4%, in the average balance of money market deposit accounts in the three months ended September 30, 2025 compared to the same period in 2024.

Interest expense on advances from the FHLB decreased $1.5 million, or 17.2%, in the three months ended September 30, 2025 compared to the same period of 2024, primarily driven by a decrease of 7 basis points in average rates paid. In the first nine months of 2025, the Company borrowed $380.0 million and repaid $293.4 million of advances from the FHLB. In addition, the Company restructured $210.0 million of its fixed-rate FHLB advances. This restructuring consisted of changing the original maturity at lower interest rates. *See* "Capital Resources and Liquidity Management" for more details on the repayment and restructuring of advances from the FHLB.

<u>Nine Months Ended September 30, 2025 and 2024</u>

The Company was able to reprice the cost of its interest-bearing deposits to offset lower yields on the loan portfolio we recorded during the first nine months of 2025 compared to the same period last year. Additionally, we continued investing in higher-yielding, fixed rate, debt securities available for sale, and maintaining a high average balance in funds at the Federal Reserve. *See* discussions further below for more details

------

Net interest income in the nine months ended September 30, 2025, was $270.5 million, an increase of $32.2 million, or 13.5%, from $238.3 million in the nine months ended September 30, 2024. This was primarily driven by an increase of $466.8 million, or 36.6% and $125.1 million or 33.2%, in the average balances of debt securities available for sale, and deposits with banks, respectively, during the period. Additionally, the cost of interest-bearing liabilities decreased 46 basis points in the current year compared to the same period last year. These improvements were partially offset by: (i) decreases of $217.3 million, or 100.0%, and $24.0 million or 0.3% in the average balance of debt securities held to maturity and the loan portfolio, respectively; (ii) a 17 basis points decrease in the average yield on total interest earning assets; and (ii) an increase of $40.8 million or 0.6%, in the average balance of total interest-bearing liabilities in the current year compared to the same period last year . Net interest margin was 3.83% in the nine months ended September 30, 2025, an increase of 31 basis points from 3.52% in the nine months ended September 30, 2024. *See* discussions further below for more details.

During the nine months ended September 30, 2025, we had higher average balance of debt securities available for sale compared to the same period last year. In addition, we had no debt securities held to maturity at September 30, 2025, compared to an average balance of $217.3 million at September 30, 2024. .

*Interest Income*

Total interest income was $450.2 million in the nine months ended September 30, 2025, an increase of $7.6 million, or 1.7%, compared to $442.7 million for the same period of 2024. This was primarily driven by an increase of $466.8 million, or 36.6%, and $125.1 million or 33.2%, in the average balances of debt securities available for sale and deposits with banks, respectively, during the period. These increases were partially offset by: (i) a 17 basis points decrease in the average yield on total interest earning assets, and (ii) decreases of $217.3 million, or 100.0%, $24.0 million, or 0.3% in the average balance of debt securities held to maturity and the loan portfolio, respectively.

Interest income on loans in the nine months ended September 30, 2025 was $364.6 million, a decrease of $12.0 million, or 3.2%, compared to $376.6 million in the same period last year, primarily due to a 19 basis points decrease in average yields. The decrease in interest income on loans was also due to the decrease of $24.0 million or 0.3%, in the average balances of the loan portfolio compared to the same period 2024. *See* "-Average Balance Sheet, Interest and Yield/Rate Analysis" for detailed information.

Interest income on debt securities available for sale was $64.0 million in the nine months ended September 30, 2025, an increase of $22.5 million, or 54.1%, compared to $41.6 million in the same period of 2024. This was mainly due to new purchases at higher rates in 2025, which primarily drove the increase of $466.8 million, or 36.6% in the average balance of these securities as well as an increase of 56 basis points in average yields. In the nine months ended September 30, 2025, the average balance of accumulated net unrealized losses included in the carrying value of these securities was $41.0 million compared to $102.2 million in the same period last year.

Interest income on debt securities held for trading was $2.0 million in the nine months ended September 30, 2025, an increase of $2.0 million or 100.00%, which was mainly due to the increase of $60.1 million, or 100.00% in the average balances of these securities compared to having none in the same period of 2024.

*Interest Expense*

Interest expense was $179.7 million in the nine months ended September 30, 2025, a decrease of $24.6 million or 12.06%, compared to $204.3 million in the same period of 2024. This was primarily due to: (i) decreases of $39.9 million, or 66.90%, and $26.7 million, or 3.56%, in the average balances of the Senior Notes and FHLB advances, respectively, and (ii) a decrease of 46 basis points in the average rates paid on total interest-bearing liabilities. These decreases were partially offset by a higher average balance of total deposits mainly in money market accounts.

------

&nbsp;&nbsp;&nbsp;&nbsp;Interest expense on interest-bearing deposits was $152.7 million in the nine months ended September 30, 2025, a decrease of $23.2 million, or 13.18%, compared to $175.9 million for the same period of 2024. This was mainly driven by a decrease of 54 basis points in the average rates paid on total deposits. These decreases were partially offset by an increase of $107.2 million, or 1.7%, in their average balance. *See* below for a detailed explanation of changes by major deposit category:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Time deposit*s. Interest expense on total time deposits decreased $12.3 million, or 15.5%, in the nine months ended September 30, 2025 compared to the same period in 2024. This was mainly due to a decrease of 46 basis points in the average cost of total time deposits. In addition, there was a decrease of $137.8 million, or 6.0%, in the average balance of these deposits, which includes a decrease of $68.7 million in the average balance of customer CDs and a decrease of $69.1 million in the average balance of brokered time deposits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Interest bearing checking and savings accounts*. Interest expense on checking and savings accounts decreased $10.9 million, or 11.3% in the nine months ended September 30, 2025 compared to the same period one year ago, mainly due to a decrease of 51 basis points in the average costs on these deposits. In addition, there was a decrease of $161.0 million, or 6.8%, and $16.9 million, or 6.6%, in the average balances of interest bearing demand deposits and savings accounts, respectively. The decreases in interest bearing demand deposits and savings accounts were partially offset by an increase of $422.9 million, or 28.9%, in the average balance of money market accounts in the nine months ended September 30, 2025 compared to the same period in 2024.

Interest expense on advances from the FHLB increased $0.4 million, or 1.8%, in the nine months ended September 30, 2025 compared to the same period of 2024, primarily driven by an increase of 21 basis points in average rates paid, this was partially offset by a decrease of $26.7 million in the average balance during the period.

------

***Analysis of the Allowance for Credit Losses***

Set forth in the table below are the changes in the allowance for credit losses for each of the periods presented.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| *(in thousands)* | **2025** | **2024** | **2025** | **2024** |
| Balance at the beginning of the period | $86519 | $94400 | $84963 | $95504 |
| **Charge-offs** |  |  |  |  |
| Real estate loans |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial Real Estate (CRE) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential | (1268) |  | (1268) | (591) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Single-family residential | (33) |  | (249) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner occupied |  |  | (130) |  |
|  | (1301) |  | (1647) | (591) |
| Commercial | (6244) | (31416) | (24571) | (47294) |
| Consumer and others | (1991) | (4175) | (7277) | (21122) |
| **Total Charge-offs** | $(9536) | $(35591) | $(33495) | $(69007) |
| **Recoveries** |  |  |  |  |
| Real estate loans |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial Real Estate (CRE) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Owner occupied | $67 | $— | $67 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans | 10 | 15 | 28 | 51 |
|  | 77 | 15 | 95 | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Single-family residential | 3 | 12 | 3 | 36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Owner occupied |  |  | 40 | 17 |
|  | 80 | 27 | 138 | 104 |
| Commercial | 1876 | 1944 | 5480 | 2908 |
| Consumer and others | 729 | 1240 | 1826 | 2461 |
| **Total Recoveries** | $2685 | $3211 | $7444 | $5473 |
| Net charge-offs | (6851) | (32380) | (26051) | (63534) |
| Provision for credit losses - loans | 15250 | 17870 | 36006 | 47920 |
| **Balance at the end of the period** | $94918 | $79890 | $94918 | $79890 |

---

------

<u>Three Months Ended September 30, 2025 and 2024</u>

The Company recorded a provision for credit losses on loans of $15.3 million in the three months ended September 30, 2025, compared to $17.9 million in the same period last year. In the third quarter of 2025, the provision for credit losses on loans was comprised of $7.8 million in additional specific reserves, $8.9 million to cover charge-offs, and $3.6 million due to credit quality and macro-economic factors. This was partially offset by a release of $2.3 million due to the reduction in loan balances and $2.7 million due to recoveries.

During the three months ended September 30, 2025, charge-offs decreased $26.1 million, or 73.2%, compared to the same period of the prior year. In the three months ended September 30, 2025, charge-offs included: (i) $4.1 million related to two commercial loans, (ii) $1.8 million related to several small business commercial loans, (iii) $1.3 million related to one commercial real estate loan, (iv) $1.8 million related to purchased indirect consumer loans, and (v) $0.5 million related to other smaller balance loans, including retail and business banking and consumer loans. This was partially offset by $2.7 million in recoveries.

In the three months ended September 30, 2024, charge-offs included: (i) $28.8 million related to six commercial loans; (ii) $4.1 million in consumer loans, primarily purchased indirect consumer loans, and (iii) $2.7 million in multiple smaller balance commercial and consumer loans. Charge-offs in the third quarter of 2024 were partially offset by $3.2 million in recoveries, which include $1.6 million related to one commercial loan and $1.6 million related to multiple commercial and consumer loan recoveries.

The ratio of net charge-offs over the average total loan portfolio held for investment was 0.39% in the third quarter of 2025, compared to 1.90% in the third quarter of 2024.

On October 24, 2025, the Company collected $11.8 million on a commercial loan that had been previously charged off. The collection of this loan resulted in a loan recovery of $8.7 million and interest income recovery of $0.3 million in the fourth quarter of 2025.

 <u>Nine Months Ended September 30, 2025 and 2024</u>

The Company recorded a provision for credit losses on loans of $36.0 million in the nine months ended September 30, 2025, compared to $47.9 million in the same period last year. During this period, the provision for credit losses on loans includes $21.9 million for specific reserves for commercial loans, $18.8 million to cover net charge-offs, $4.7 million due to model adjustments for macroeconomic factors, and $2.5 million due to credit quality and other macroeconomic updates, partially offset by releases of $4.6 million due to lower loan balances and $7.5 million due to recoveries.

During the nine months ended September 30, 2025, charge-offs decreased $35.5 million, or 51.5%, compared to the same period of the prior year. In the nine months ended September 30, 2025, charge-offs included: (i) $19.9 million related to five commercial loans; (ii) $6.8 million related to purchased indirect consumer loans; (iii) $4.7 million related to several small business commercial loans; (iv) $1.3 million related to one commercial real estate loan and (v) $0.8 million related to other smaller balance loans, including retail and business banking and consumer loans. This was partially offset by $7.4 million in recoveries.

------

In the nine months ended September 30, 2024, charge-offs included: (i) $38.7 million related to seven commercial loans; (ii) $21.1 million related to multiple consumer and overdraft loans, primarily purchased indirect consumer loans, and (iii) $9.2 million in connection with multiple smaller commercial and real estate loans. Charge-offs in the nine months ended September 30, 2024 were partially offset by $5.2 million in recoveries, which include $2.7 million of a commercial loan and $2.4 million related to multiple commercial and consumer loan recoveries. The downgrades were not concentrated in a specific industry or geography.

In the second quarter of 2025, the Company sold a participation in a Quick Service Restaurant ("QSR")-related loan with carrying value of $6.9 million and ACL of $4.8 million as of March 31, 2025. Proceeds from the sale were $2.2 million which resulted in a charge off against the ACL of $4.8 million in the second quarter 2025.

The ratio of net charge-offs over the average total loan portfolio held for investment was 0.49% in the first nine months of 2025, compared to 1.24% in the first nine months of 2024.

On October 24, 2025, the Company collected $11.8 million on a commercial loan that had been previously charged off. The collection of this loan resulted in a loan recovery of $8.7 million and interest income recovery of $0.3 million in the fourth quarter of 2025.

During the nine months ended September 30, 2025 and 2024, consistent with the Company's applicable policy, the Company has requested independent third-party collateral valuations on all real estate securing non-performing loans with existing valuations older than 12-months and outstanding balances in excess of $1.0 million. As of September 30, 2025, there were three loans recently downgraded totaling $19.6 million with appraisals older than 12 months, for which new appraisals have been ordered. No additional provision for credit losses was deemed necessary in both periods as a result of these valuations.

We continue to proactively and carefully monitor the Company's credit quality practices, including examining and responding to patterns or trends that may arise across certain industries or regions.

------

***Noninterest Income (loss)***

The table below sets forth a comparison for each of the categories of noninterest income (loss) for the periods presented.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Change** | **Change** |
| | **2025** | **2025** | **2024** | **2024** | **2025 vs 2024** | **2025 vs 2024** |
| (in thousands, except percentages) | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** |
| Deposits and service fees | $5056 | 29.2% | $5046 | 10.6% | $10 | 0.2% |
| Brokerage, advisory and fiduciary activities | 4995 | 28.9% | 4466 | 9.4% | 529 | 11.9% |
| Change in cash surrender value of bank owned life insurance ("BOLI") (1) | 2554 | 14.8% | 2332 | 4.9% | 222 | 9.5% |
| Loan-level derivative income (2) | 2372 | 13.7% | 3515 | 7.4% | (1143) | (32.5)% |
| Cards and trade finance servicing fees | 1321 | 7.6% | 1430 | 3.0% | (109) | (7.6)% |
| Derivative losses, net (3) | (1383) | (8.0)% |  | —% | (1383) | N/M |
| Securities gains (losses), net (4) | 1203 | 7.0% | (68484) | (143.6)% | 69687 | N/M |
| Other noninterest income (5) | 1173 | 6.8% | 4012 | 8.3% | (2839) | (70.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Total noninterest income | $17291 | 100.0% | $(47683) | (100.0)% | $64974 | 136.3% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Change** | **Change** |
| | **2025** | **2025** | **2024** | **2024** | **2025 vs 2024** | **2025 vs 2024** |
| *(in thousands, except percentages)* | **Amount** | **%** | **Amount** | **%** | **Amount** | &nbsp;&nbsp;**%** |
| Deposits and service fees | 15161 | 26.8% | 14652 | 106.4% | 509 | 3.5% |
| Brokerage, advisory and fiduciary activities | 14717 | 26.0% | 13331 | 96.8% | 1386 | &nbsp;&nbsp;10.4% |
| Change in cash surrender value of bank owned life insurance ("BOLI") (1) | 7494 | 13.2% | 6916 | 50.2% | 578 | 8.4% |
| Loan-level derivative income (2) | 7084 | 12.5% | 6338 | 46.0% | 746 | 11.8% |
| Cards and trade finance servicing fees | 4517 | 8.0% | 3984 | 28.9% | 533 | 13.4% |
| Gain on early extinguishment of FHLB advances, net |  | —% | 189 | 1.4% | (189) | (100.0)% |
| Derivative losses, net (3) | (3235) | (5.7)% | (196) | (1.4)% | (3039) | N/M |
| Securities gains (losses), net (4) | 3046 | 5.4% | (68655) | (498.4)% | 71701 | N/M |
| Other noninterest income (5) | 7810 | 13.8% | 9666 | 70.1% | (1856) | (19.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp; Total noninterest income | $56594 | 100.00% | $(13775) | (100.00)% | $70369 | 510.85% |

---

__________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Changes in cash surrender value of BOLI are not taxable.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Income from interest rate swaps and other derivative transactions with customers. The Company incurs expenses related to derivative transactions with customers which are included as part of noninterest expenses under loan-level derivative expense. *See* Noninterest Expense section for more details.

(3)&nbsp;&nbsp;&nbsp;&nbsp;In the three and nine months ended September 30, 2025, includes net unrealized losses in connection with TBA MBS derivative contracts. We enter into these contracts to economically offset changes in market valuation on the trading securities portfolio. In the three and nine months ended September 30, 2024, amounts are in connection with net unrealized gains and losses on uncovered interest rate caps with clients.

(4) In the three and nine month periods ended September 30, 2025, amounts are primarily in connection with gains on market valuation of trading securities. In the three and nine months ended September 30, 2024, includes a total net loss of $68.5 million as a result of the investment portfolio repositioning initiated during the third quarter of 2024.

(5)&nbsp;&nbsp;&nbsp;&nbsp;Includes mortgage banking loss of $0.4 million in the three months ended September 30, 2025 and mortgage banking income of $2.8 million in the three months ended September 30, 2024, and $0.8 million and $5.8 million in the nine months ended September 30, 2025 and 2024, respectively, primarily consisting of net gains/losses on sale, valuation and derivative transactions associated with mortgage loans held for sale activity, and other smaller sources of income related to the operations of Amerant Mortgage. In addition, includes $0.5 million BOLI death benefits received in the nine months ended September 30, 2024. Other sources of income in the periods shown include net gains/(losses) on sales of loans that are originated for investment, foreign currency exchange transactions with customers and valuation income on the investment balances held in the non-qualified deferred compensation plan.

N/M - Not Meaningful

------

<u>Three Months Ended September 30, 2025 and 2024</u> 

Total noninterest income increased $65.0 million, or 136.3%, in the three months ended September 30, 2025, compared to the same period last year, mainly due to: (i) higher securities gains; (ii) higher brokerage, advisory and fiduciary fees; and (iii) higher change in cash surrender value of BOLI. These increases were partially offset by: (i) lower other noninterest income; (ii) higher derivative losses; and (iii) lower loan-level derivative income.

Securities gains in the three months ended September 30, 2025, were $1.2 million, which were mainly unrealized gains on market valuation of the trading securities portfolio, in comparison to the three months ended September 30, 2024 having securities losses of $68.5 million related to the investment portfolio repositioning. Securities gains in the third quarter of 2025 were offset by derivatives losses of $1.4 million which consisted of net losses on the TBA MBS derivative contracts.

Brokerage, advisory and fiduciary fees increased $0.5 million, or 11.9%, in the three months ended September 30, 2025, compared to the same period one year ago. This was mainly driven by higher fees from equity and structured product trading in the third quarter of 2025 compared to the third quarter of 2024.

Our AUMs totaled $3.17 billion at September 30, 2025, an increase of $279.5 million, or 9.7%, from $2.89 billion at December 31, 2024, primarily driven by higher market valuations.

Other noninterest income decreased $2.8 million, or 70.8%, in the three months ended September 30, 2025 compared to the same period in 2024, primarily driven by a decrease in mortgage banking income of $3.2 million and a decrease in the gain on sale of loans of approximately $0.3 million. This was partially offset by a combined increase in other smaller sources of income of approximately $0.4 million, and a $0.3 million gain on the sale of operating lease equipment.

Loan-level derivative income decreased $1.1 million, or 32.5%, in the three months ended September 30, 2025 compared to the same period in 2024, mainly driven by fewer new swap contracts during the period compared to the same period last year.

<u>Nine Months Ended September 30, 2025 and 2024</u>

Total noninterest income increased $70.4 million, or 510.9%, in the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024 mainly due to: (i) higher securities gains; (ii) higher brokerage, advisory and fiduciary fees; (iii) higher loan-level derivative income; (iv) higher change in cash surrender value of BOLI; (v) higher cards and trade finance servicing fees; and (vi) higher deposits and service fees. These increases were partially offset by: (i) higher derivative losses and (ii) lower other noninterest income.

In the nine months ended September 30, 2025, securities gains were $3.0 million, mainly unrealized gains on market valuation of the trading securities portfolio, compared to a $68.7 million loss in the same period in 2024. In the nine months ended September 30, 2024, these losses were primarily related to the investment portfolio repositioning. Securities gains in the first nine months of 2025 were offset by derivatives losses of $3.2 million which consisted of net losses on the TBA MBS derivative contracts.

Brokerage, advisory and fiduciary fees increased $1.4 million, or 10.4%, in the nine months ended September 30, 2025, compared to the same period in 2024. This was mainly driven by higher fees from equity and structured product trading in the first nine months of 2025 versus the first nine months of 2024, as well as higher fiduciary fees.

------

Loan-level derivative income increased $0.7 million, or 11.8%, in the nine months ended September 30, 2025 compared to the same period in 2024, mainly driven by new swap contracts during the period compared to the same period last year.

Cards and trade finance servicing fees increased $0.5 million, or 13.4% in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, mainly driven by higher commissions from the issuance of letters of credits. This increase was partially offset by a decrease in cards fee income.

Deposits and service fees increased $0.5 million, or 3.5%, in the nine months ended September 30, 2025, compared to the same period in 2024, primarily driven by an increase in statement fees on business accounts and higher digital payment fees which were partially offset by lower wire transfer service fees.

Other noninterest income decreased $1.9 million, or 19.2%, in the nine months ended September 30, 2025 compared to the same period in 2024, primarily driven by a decrease of $5.0 million in mortgage banking income and a combined decrease of $0.2 million in other smaller sources of income, offset by a $3.3 increase in the net gain on sale of loans.

------

***Noninterest Expense***

The table below presents a comparison for each of the categories of noninterest expense for the periods presented.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Change** | **Change** |
| | **2025** | **2025** | **2024** | **2024** | **2025 vs 2024** | **2025 vs 2024** |
| *(in thousands, except percentages)* | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** |
| Salaries and employee benefits (1) | $35094 | 45.1% | $34979 | 45.9% | $115 | 0.3% |
| Professional and other services fees | 15997 | 20.6% | 13711 | 18.0% | 2286 | 16.7% |
| Occupancy and equipment (3) | 5211 | 6.7% | 5891 | 7.7% | (680) | (11.5)% |
| Telecommunications and data processing | 3155 | 4.1% | 2991 | 3.9% | 164 | 5.5% |
| Depreciation and amortization | 1487 | 1.9% | 1737 | 2.3% | (250) | (14.4)% |
| FDIC assessments and insurance | 2549 | 3.3% | 2863 | 3.8% | (314) | (11.0)% |
| Losses on loans held for sale carried at the lower of cost or fair value  | 881 | 1.1% |  | —% | 881 | 100.0% |
| Advertising expenses | 3987 | 5.1% | 3468 | 4.6% | 519 | 15.0% |
| Loan-level derivative expense (5) | 1834 | 2.4% | 1802 | 2.4% | 32 | 1.8% |
| Other real estate owned and repossessed assets expense (income), net (6) | 215 | 0.3% | 5535 | 7.3% | (5320) | (96.1)% |
| Other operating expenses(7) | 7425 | 9.4% | 3231 | 4.1% | 4194 | 129.8% |
| &nbsp;&nbsp;&nbsp;&nbsp; Total noninterest expenses (8) | $77835 | 100.0% | $76208 | 100.0% | $1627 | 2.1% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Change** | **Change** |
| | **2025** | **2025** | **2024** | **2024** | **2025 vs 2024** | **2025 vs 2024** |
| *(in thousands, except percentages)* | **Amount** | **%** | **Amount** | **%** | **Amount** | **%** |
| Salaries and employee benefits (1) | 104477 | 46.6% | 101794 | 47.1% | 2683 | 2.6% |
| Professional and other services fees (2) | 44228 | 19.7% | 36784 | 17.0% | 7444 | 20.2% |
| Occupancy and equipment (3) | 16838 | 7.4% | 21408 | 9.9% | (4570) | (21.4)% |
| Telecommunications and data processing | 9559 | 4.1% | 9256 | 4.3% | 303 | 3.3% |
| Depreciation and amortization | 4626 | 2.1% | 4866 | 2.3% | (240) | (4.9)% |
| FDIC assessments and insurance | 8681 | 3.8% | 8643 | 4.0% | 38 | 0.4% |
| Losses on loans held for sale carried at the lower of cost or fair value (4)  | 881 | 1.1% | 1258 | 0.6% | (377) | (30.0)% |
| Advertising expenses | 12441 | 5.5% | 10789 | 5.0% | 1652 | 15.3% |
| Loan-level derivative expense (5) | 3307 | 1.5% | 2386 | 1.1% | 921 | 38.6% |
| Other real estate owned and repossessed assets expense (income), net (6) | 980 | 0.4% | 5033 | 2.3% | (4053) | (80.5)% |
| Other operating expenses(7) | 17771 | 7.8% | 13887 | 6.4% | 3884 | 28.0% |
| &nbsp;&nbsp;&nbsp;&nbsp; Total noninterest expenses (8) | $223789 | 100.0% | $216104 | 100.0% | $7685 | 3.6% |

---

____

(1) In the three and nine month periods ended September 30, 2025, includes $0.6 million and $1.0 million, respectively, in expenses in connection with the Amerant Mortgage downsizing.

(2) In the nine month period ended September 30, 2024, includes $0.3 million in legal expenses in connection with the

&nbsp;&nbsp;&nbsp;&nbsp;Houston Transaction. Additionally, includes recurring service fees in connection with the engagement of FIS in all periods shown.

(3) In the nine month period ended September 30, 2024, includes fixed assets impairment charge of $3.4 million in

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;connection with the Houston Transaction.

(4) In the nine month period ended September 30, 2024 amounts shown are in connection with the Houston Transaction.

(5) Includes service fees in connection with our loan-level derivative income generation activities.

------

(6) Includes OREO valuation expense of $0.5 million and $5.7 million in the three months ended September 30, 2025 and 2024, respectively, and $1.1 million and $5.7 million in the nine month periods ended September 30, 2025, and 2024, respectively. In addition, includes net loss on the sale of two OREO properties of $0.8 million in the nine months ended September 30, 2025. *See* Non-GAAP Financial Measures section for more information.

(7) In the nine month period ended September 30, 2024, includes broker fees of $0.3 million in connection with the

&nbsp;&nbsp;&nbsp;&nbsp;Houston Transaction. Additionally, in all of the periods shown, *see* Primary Factors Used to Evaluate Our Business for more information on other operating expenses.

(8) Includes $2.1 million and $3.9 million in the three months ended September 30, 2025 and 2024, respectively, and $8.3 million and $10.5 million in the nine months ended September 30, 2025 and 2024, respectively, related to Amerant Mortgage, primarily consisting of salaries and employee benefits, mortgage lending costs and professional and other services fees.

<u>Three Months Ended September 30, 2025 and 2024</u>

Noninterest expense increased $1.6 million, or 2.1%, in the three months ended September 30, 2025 compared to the same period in 2024, mainly due to: (i) higher other operating expenses; (ii) higher professional and other services fees; (iii) higher losses on loans held for sale carried at the lower cost or fair value; and (iv) higher advertising expenses.These increases were partially offset by: (i) lower OREO and repossessed assets expense; (ii) lower occupancy and equipment expenses; (iii) lower FDIC assessments and insurance expenses; and (iv) lower depreciation and amortization expenses.

Other operating expenses increased $4.2 million, or 129.8%, in the three months ended September 30, 2025 compared to the same period a year ago, mainly driven by driven by: (i) earning credits of $3.5 million in the three months ended September 30, 2025 compared to no earnings credits in the three months ended September 30, 2024, and (ii) an increase in charitable contributions and donations compared to the same period last year. *See* Primary Factors Used to Evaluate Our Business section for more details on earnings credits.

Professional and other services fees increased $2.3 million, or 16.7%, in the three months ended September 30, 2025 compared to the same period last year. This was mainly driven by an overall increase in other professional fees related to outsourced core software and technology services and legal and consulting fees related to various projects.

Losses on loans held for sale carried at the lower cost or fair value increased $0.9 million, or 100.0%, in the three months ended September 30, 2025 as we recognized a loss on sale of one substandard loan during the period while we did not record any losses on loans held for sale in the same period last year.

Advertising expenses increased $0.5 million, or 15.0%, in the three months ended September 30, 2025 compared to the same period last year. This was mainly driven by higher expenses related to traditional media and marketing professional fees.

Other real estate owned and repossessed assets expenses decreased $5.3 million, or 96.1%, in the three months ended September 30, 2025, compared to the same period last year. In the three months ended September 30, 2025, we recorded a valuation allowance on a single family residential OREO property in Texas in the amount of $0.5 million and other OREO expenses of approximately $0.2 million, which were offset by $0.5 million in OREO rental income, while in the three months ended September 30, 2024, we recorded a $5.7 valuation allowance on an OREO property and other OREO expenses of $0.3 million offset by approximately $0.5 million in OREO rental income.

Occupancy and equipment expenses decreased $0.7 million, or 11.5%, in the three months ended September 30, 2025 compared to the same period one year ago mainly driven by lower lease expenses.

FDIC assessments and insurance expenses decreased $0.3 million, or 11.0%, in the three months ended September 30, 2025 compared to the same period last year mainly due to lower FDIC assessment rates.

Depreciation and amortization expenses decreased $0.3 million, or 14.4%, in the three months ended September 30, 2025 compared to the same period last year mainly due to having less depreciable assets in the period.

------

<u>Nine Months Ended September 30, 2025 and 2024</u>

Noninterest expense increased $7.7 million, or 3.6%, in the nine months ended September 30, 2025 compared to the same period in 2024, mainly due to:(i) higher professional and other service fees; (ii) higher other operating expenses; (iii) higher salaries and employee benefits; (iv) higher advertising expenses; (v) higher loan-level derivative expenses; and (vi) higher telecommunications and data processing expenses. These increases were partially offset by: (i) lower occupancy and equipment expenses; (ii) lower OREO and repossessed assets expense; (iii) lower losses on loans held for sale; and (iv) lower depreciation and amortization expenses.

Professional and other services fees increased $7.4 million, or 20.2%, in the nine months ended September 30, 2025 compared to the same period last year. This was mainly driven by an overall increase in other professional fees related to outsourced core software and technology services, mortgage servicing expenses, accounting fees in connection with outsourced audit fees and consulting and legal fees related to various projects.

Other operating expenses increased $3.9 million, or 28.0%, in the nine months ended September 30, 2025 compared to the same period last year. This was mainly driven by: (i) earning credits of $7.4 million in the nine months September 30, 2025 compared to no earnings credits the nine months ended September 30, 2024; and (ii) increased expenses related to business development. These increases were partially offset by combined decreases in operating charge-offs, loan servicing and origination costs and other miscellaneous expenses. *See* Primary Factors Used to Evaluate Our Business section for more details on earnings credits.

Salaries and employee benefits increased $2.7 million, or 2.6%, in the nine months ended September 30, 2025 compared to the same period one year ago, mainly driven by: (i) higher salary expense as a result of the new hires at higher rates; (ii) higher severance expenses related to the downsizing of Amerant Mortgage; and (iii) higher health insurance expenses. These increases were partially offset by lower bonus variable compensation attributable to lower performance, lower commissions due to lower loan production in connection with the Amerant Mortgage downsizing and lower expenses related to the long-term incentive program attributable to the effect of forfeitures during the period.

Advertising expenses increased $1.7 million, or 15.3%, in the nine months ended September 30, 2025 compared to the same period last year. This was mainly driven by higher expenses related to traditional media and professional sports agreements, higher marketing professional fees, as well as higher expenses related to community engagement events.

Loan-level derivative expenses increased $0.9 million, or 38.6% in the nine months ended September 30, 2025, compared to the same period last year due to higher expenses during the period associated with payments for opening and terminations of new swaps and caps with clients.

Losses on loans held for sale carried at the lower of cost or fair value decreased $0.4 million, or 30.0%, in the nine months ended September 30, 2025 compared to the same period one year ago due to having lower losses during the period as we recorded a loss on sale of $0.9 million related to the sale of one Substandard owner-occupied loan with an outstanding balance of $30.4 million at the time of sale, while in the nine months ended September 30, 2024, the loss on sale of $1.3 million was due to the transfer of approximately $553.1 million in loans in connection with the Houston Transaction.

Telecommunication and data processing expenses increased $0.3 million, or 3.3%, in the nine months ended September 30, 2025 compared to the same period one year ago primarily due to increases in computer expenses which were partially offset by a decrease in telephone usage and data infrastructure expenses.

Occupancy and equipment expenses decreased $4.6 million, or 21.4%, in the nine months ended September 30, 2025 compared to the same period one year ago primarily due to: (i) the absence of a $3.4 million fixed assets impairment charge in the nine months ended September 30, 2024 in connection with the Houston Transaction, (ii) fewer banking centers as a result of the Houston Sale Transaction, and (iii) an increase in sublease income from additional subleasing of portions of the headquarter building.

------

Other real estate owned and repossessed assets expenses decreased $4.1 million, or 80.5%, in the nine months ended September 30, 2025, compared to the same period last year. In the nine months ended September 30, 2025, we recorded approximately $1.0 million in combined OREO activity in comparison to $5.0 million in combined OREO activity in the nine months ended September 30, 2024, mainly driven by a lower valuation allowance in the nine months ended September 30, 2025 compared to the same period last year.

Depreciation and amortization expenses decreased $0.2 million, or 4.9% in the nine months ended September 30, 2025, compared to the same period last year mainly due to having less depreciable assets during the period.

------

***Income Taxes***

The table below sets forth information related to our income taxes for the periods presented.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Change** | **Change** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Change** | **Change** |
| | **2025** | **2024** | **2025 vs 2024** | **2025 vs 2024** | **2025** | **2024** | **2025 vs 2024** | **2025 vs 2024** |
| *(in thousands, except effective tax rates and percentages)* |  |  |  |  |  |  |  |  |
| Income (loss) before income tax expense | $19008 | $(61892) | $80900 | 130.7% | $64234 | $(42107) | $106341 | 252.6% |
| Income tax expense (benefit) | $4252 | $(13728) | $17980 | 131.0% | $14518 | $(9474) | $23992 | (253.2)% |
| Effective income tax rate | 22.37% | 22.18% | 0.19% | 0.9% | 22.60% | 22.50% | 0.10% | 0.4% |

---

Income tax expense increased to $4.3 million for the third quarter of 2025, compared to an income tax benefit of $13.7 million for the same period in 2024. For the nine months ended September 30, 2025, income tax expense was $14.5 million, compared to an income tax benefit of $9.5 million for the first nine months of 2024. The increase in both periods was mainly driven by higher income before income taxes in 2025.

As of September 30, 2025, the Company's net deferred tax assets were $46.9 million, a decrease of $6.7 million, or 12.4%, compared to $53.5 million as of December 31, 2024. This was primarily driven by a decrease of $11.3 million in connection with $44.4 million in net unrealized holding gains on debt securities available for sale during the period, partially offset by the tax effect of an increase in the allowance for credit losses.

On July 4, 2025, federal legislation generally referred to as H.R. 1 - One Big Beautiful Bill Act (the "Act") was signed into law. The Act includes a variety of tax provisions including permanently extending and modifying certain key aspects of existing tax law. U.S. GAAP requires the effects of changes in tax laws and rates to be recognized in its financial statements in the period in which legislation is enacted. The Company evaluated the impact of the Act on its consolidated financial statements and determined there is not a material impact resulting from the Act.

------

**Non-GAAP Financial Measures**

The Company supplements its financial results that are determined in accordance with accounting principles generally accepted in the United States of America ("GAAP") with non-GAAP financial measures, such as "pre-provision net revenue (PPNR)", "core pre-provision net revenue (Core PPNR)", "core noninterest income", "tangible common equity ratio", "tangible stockholders' equity (book value) per common share", and "core noninterest expense". This supplemental information is not required by, or is not presented in accordance with GAAP. The Company refers to these financial measures and ratios as "non-GAAP financial measures".

We use certain non-GAAP financial measures, including those mentioned above, both to explain our results to shareholders and the investment community and in the internal evaluation and management of our business. Management believes that these supplementary non-GAAP financial measures and the information they provide are useful to investors since these measures permit investors to view our performance using the same tools that our management uses to evaluate our past performance and prospects for future performance. These non-GAAP financial measures have been adjusted for the effect of non-core banking activities such as the sale of loans and securities and other repossessed assets, the Amerant Mortgage downsizing, the Houston Transaction, the valuation of securities, derivatives, loans held for sale and other real estate owned and repossessed assets, the early repayment of FHLB advances, and other non-routine actions intended to improve customer service and operating performance. While we believe that these non-GAAP financial measures are useful in evaluating our performance, this information should be considered as supplemental and not as a substitute for or superior to the related financial information prepared in accordance with GAAP. Additionally, these non-GAAP financial measures may differ from similar measures presented by other companies.

------

The following table is a reconciliation of the Company's PPNR, Core PPNR, core noninterest income and core noninterest expense, non-GAAP financial measures, as of the dates presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| *(in thousands)* | **2025** | **2024** | **2025** | **2024** |
| Net income (loss) attributable to Amerant Bancorp Inc. | $14756 | $(48164) | $49716 | $(32633) |
| Plus: provision for credit losses (1) | 14600 | 19000 | 39106 | 50550 |
| Plus: provision for income tax expense | 4252 | (13728) | 14518 | (9474) |
| **Pre-provision net revenue (PPNR)** | 33608 | (42892) | 103340 | 8443 |
| Plus: non-routine noninterest expense items | 1977 | 5672 | 3703 | 11234 |
| Less: non-routine noninterest income items | 180 | 68484 | (2610) | 68662 |
| **Core pre-provision net revenue (Core PPNR)** | $35765 | $31264 | $104433 | $88339 |
| **Total noninterest income** | $17291 | $(47683) | $56594 | $(13775) |
| Less: Non-routine noninterest income items: |  |  |  |  |
| &nbsp;&nbsp;Derivatives losses, net (2) | (1383) |  | (3235) | (196) |
| &nbsp;&nbsp;Securities gain (losses), net (3)  | 1203 | (68484) | 3046 | (68655) |
| &nbsp;&nbsp;Gain on sale of loans (4) |  |  | 2799 |  |
| &nbsp;&nbsp;Gains on early extinguishment of FHLB advances, net |  |  |  | 189 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-routine noninterest income (loss) items | $(180) | $(68484) | $2610 | $(68662) |
| **Core noninterest income** | $17471 | $20801 | $53984 | $54887 |
| **Total noninterest expenses** | $77835 | $76208 | $223789 | $216104 |
| Less: non-routine noninterest expense items |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Other non-routine noninterest expense items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Losses on loans held for sale carried at the lower of cost or fair value (5) | 881 |  | 881 | 1258 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill and intangible assets impairment (5) |  |  |  | 300 |
| &nbsp;&nbsp;&nbsp;&nbsp;Legal and broker fees (5) |  |  |  | 561 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net losses on sale and valuation expense on other real estate owned (6) | 516 | 5672 | 1872 | 5672 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amerant Mortgage Downsize costs (7) | 580 |  | 950 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed assets impairment (5)(8) |  |  |  | 3443 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total non-routine noninterest expense items | $1977 | $5672 | $3703 | $11234 |
| **Core noninterest expenses** | $75858 | $70536 | $220086 | $204870 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Includes provision for credit losses on loans and provision for loan contingencies.

&nbsp;&nbsp;&nbsp;&nbsp;(2) In the three and nine months ended September 30, 2025, includes net unrealized losses in connection with to-be-announced (TBA) mortgage back-securities (MBS) derivative contracts. We enter into these contracts to economically offset changes in market valuation on the trading securities portfolio. In the three and nine months ended September 30, 2024, amounts are related to uncovered interest rate caps with clients.

&nbsp;&nbsp;&nbsp;&nbsp;(3) In the three and nine months ended September 30, 2025, amounts are primarily in connection with unrealized gains on market valuation of trading securities. In the three and nine months ended September 30, 2024, includes losses as a result of the investment portfolio repositioning. *See* Noninterest Income section for more details.

&nbsp;&nbsp;&nbsp;&nbsp;(4) In the nine months ended September 30, 2025, includes gain on sale of $3.2 million, related to the sale of a loan that had been charged off in prior periods.

&nbsp;&nbsp;&nbsp;&nbsp;(5) In the three and nine month periods ended September 30, 2024, amounts shown are in connection with the sale of the Company's Houston franchise which were disclosed on a Form 8-K on April 17, 2024 (the "Houston Transaction").

&nbsp;&nbsp;&nbsp;&nbsp;(6) In the nine months ended September 30, 2025, includes a net loss on the sale of two OREO properties of $0.8 million. Also, includes an OREO valuation expense of $0.5 million in the three and nine month periods ended September 30, 2025, and $5.7 million in the three and nine month periods ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;(7) In the three and nine month periods ended September 30, 2025, includes salaries and employee benefit expenses in connection with Amerant Mortgage downsizing costs.

&nbsp;&nbsp;&nbsp;&nbsp;(8) Related to Houston branches and included as part of occupancy and equipment expenses.

------

The following table is a reconciliation of the Company's tangible common equity and tangible assets, non- GAAP financial measures, to total equity and total assets, respectively, as of the dates presented:

---

| | | |
|:---|:---|:---|
| *(in thousands, except percentages, share data and per share amounts)* | **As of September 30, 2025** | **As of December 31, 2024** |
| Stockholders' equity | $944940 | $890467 |
| Less: goodwill and other intangibles (1) | (23784) | (24314) |
| Tangible common stockholders' equity | $921156 | $866153 |
| Total assets | 10410199 | 9901734 |
| Less: goodwill and other intangibles (1) | (23784) | (24314) |
| Tangible assets | $10386415 | $9877420 |
| Common shares outstanding | 41265378 | 42127316 |
| **Tangible common equity ratio** | 8.87% | 8.77% |
| **Stockholders' book value per common share** | $22.90 | $21.14 |
| **Tangible stockholders' equity book value per common share** | $22.32 | $20.56 |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;At September 30, 2025 and December 31, 2024, other intangible assets consist primarily of naming rights of $1.6 million and $2.0 million, respectively, and mortgage servicing rights ("MSRs") of $1.4 million and $1.5 million, respectively, at the end of each period.

------

**Financial Condition - Comparison of Financial Condition as of September 30, 2025 and December 31, 2024**

***Assets.*** Total assets were $10.4 billion as of September 30, 2025, an increase of $508.5 million, or 5.1%, compared to $9.9 billion at December 31, 2024. This result was primarily driven by increases of: (i) $809.8 million, or 54.1%, in total securities, mainly debt securities available for sale and trading securities; (ii) $40.5 million, or 6.9%, in cash and cash equivalents; (iii) $14.5 million, or 6.0%, in BOLI mainly driven by a newly purchased policy and the change in cash surrender values during the first nine months of 2025. The increases were partially offset by decreases of: (i) $339.5 million, or 4.7%, in total loans held for investment and loans held for sale, net of the ACL, (ii) decrease in deferred tax assets of $6.7 million, or 12.4%, resulting from tax-effect of improvements in the valuation of securities available for sale, and (iii) $11.5 million, or 6.4%, in accrued interest receivable and other assets. *See* "-Average Balance Sheet, Interest and Yield/Rate Analysis" for detailed information, including changes in the composition of our interest-earning assets.

***Cash and Cash Equivalents.*** Cash and cash equivalents increased to $630.9 million at September 30, 2025 from $590.4 million at December 31, 2024, primarily as a result of an increase in interest earning cash balances.

At September 30, 2025 and December 31, 2024, interest earning deposits with banks, mainly cash balances held at the Federal Reserve, were $570.6 million and $519.9 million, respectively. In addition, at September 30, 2025 and December 31, 2024, the Company's cash and cash equivalents included restricted cash of $6.9 million and $24.4 million, respectively, which was held primarily to cover margin calls on derivative transactions with certain brokers. Furthermore, at September 30, 2025 and December 31, 2024, the Company's cash and cash equivalents included other short-term investments of $7.2 million and $6.9 million, respectively, which consist of US Treasury Bills that mature in 90 days or less.

Cash and cash equivalents provided by operating activities were $100.5 million in the nine months ended September 30, 2025, mainly driven by: (i) net sales over originations and purchases of $35.0 million in loans held for sale at a fair value; (ii) a non-cash adjustment of $39.1 million for the provision for credit losses, and (iii) net income of $49.7 million. These results were partially offset by a net decrease of $20.5 million in operating assets and liabilities and other non-cash adjustments of $2.8 million.

Net cash used in investing activities was $501.1 million during the nine months ended September 30, 2025, mainly driven by: (i) purchases of investment securities totaling $921.4 million, mainly comprised of debt securities available for sale and trading securities; and (ii) purchases of BOLI of $7.0 million. These disbursements were partially offset by: (i) a net decrease in loans originated for investment of $211.6 million; (ii) maturities, sales, calls and paydowns of investment securities totaling $157.2 million, and (iii) proceeds from the sale of loans originated for investment of $58.3 million.

------

In the nine months ended September 30, 2025, net cash provided by financing activities was $441.1 million, mainly due to: (i) a net increase in total demand, savings and money market deposit balances of $582.9 million, and (ii) net proceeds from advances from the FHLB of $86.6 million. This was partially offset by: (i) a net decrease of $136.5 million in time deposits; (ii) the redemption of $60.0 million of senior notes that were due June 30, 2025; (iii) an aggregate of $20.0 million of Class A common stock repurchased in the nine months ended September 30, 2025; and (iv) $11.4 million of dividends declared and paid by the Company in the nine months ended September 30, 2025. *See* "-Capital Resources and Liquidity Management" for more details on changes in FHLB advances and common stock transactions in the nine months ended September 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;**Loans**

Loans are our largest component of interest-earning assets. The table below depicts the trend of loans as a percentage of total assets and the allowance for loan losses as a percentage of total loans for the periods presented.

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| *(in thousands, except percentages)* |  |  |
| Total loans, gross (1) | $6941792 | $7271322 |
| Total loans, gross / total assets | 66.7% | 73.4% |
| Allowance for credit losses | $94918 | $84963 |
| Allowance for credit losses / total loans held for investment, gross <sup>(1) (2)</sup> | 1.37% | 1.18% |
| Total loans, net (3) | $6846874 | $7186359 |
| Total loans, net / total assets | 65.8% | 72.6% |

---

_______________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Total loans, gross is the principal balance of outstanding loans, including loans held for investment, loans held for sale at the lower of cost or fair value, and mortgage loans held for sale, net of unamortized deferred nonrefundable loan origination fees and loan origination costs, and unamortized premiums paid on purchased loans, excluding the allowance for credit losses on loans. There were no loans held for sale as of September 30, 2025 while as of December 31, 2024 we had $42.9 million in mortgage loans held for sale carried at fair value in connection with the Company's mortgage banking activities.

(2)&nbsp;&nbsp;&nbsp;&nbsp;*See* Note 5 of our audited consolidated financial statements included in the 2024 Form 10-K and our unaudited interim consolidated financial statements included in this Form 10-Q for more details on our credit loss estimates.

(3)&nbsp;&nbsp;&nbsp;&nbsp;Total loans, net is the principal balance of outstanding loans, including loans held for investment, loans held for sale carried at the lower of cost or fair value, and mortgage loans held for sale, net of unamortized deferred nonrefundable loan origination fees and loan origination costs, and unamortized premiums paid on purchased loans, excluding the allowance for credit losses.

------

The table below summarizes the composition of our loans held for investment by type of loan as of the end of each period presented. International loans include transactions in which the debtor or customer is domiciled outside the U.S., even when the collateral is U.S. property. All international loans are denominated and payable in U.S. Dollars.

---

| | | |
|:---|:---|:---|
| *(in thousands)* | **September 30, 2025** | **December 31, 2024** |
| **Domestic Loans:** |  |  |
| Real Estate Loans |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate (CRE) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | $1656180 | $1678473 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential | 361650 | 336229 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans | 544727 | 483210 |
|  | 2562557 | 2497912 |
| &nbsp;&nbsp;Single-family residential | 1517192 | 1489121 |
| &nbsp;&nbsp;&nbsp;Owner occupied | 900596 | 1007074 |
|  | 4980345 | 4994107 |
| Commercial loans  | 1519778 | 1751602 |
| Loans to financial institutions and acceptances | 164974 | 170435 |
| Consumer loans and overdrafts (1) | 241823 | 271586 |
| **Total Domestic Loans** | 6906920 | 7187730 |
| **International Loans:** |  |  |
| Real Estate Loans |  |  |
| &nbsp;&nbsp;&nbsp;Single-family residential (2) | 33532 | 38959 |
| Commercial loans |  | 300 |
| Consumer loans and overdrafts (3) | 1340 | 1422 |
| **Total International Loans (4)** | 34872 | 40681 |
| **Total Loans held for investment** | $6941792 | $7228411 |

---

__________________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Includes customers' overdraft balances totaling $1.7 million and $4.4 million as of September 30, 2025 and December 31, 2024, respectively.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Secured by real estate properties located in the U.S.

(3)&nbsp;&nbsp;&nbsp;&nbsp;International customers' overdraft balances were de minimis at each of the dates presented.

(4)&nbsp;&nbsp;&nbsp;&nbsp;Mainly consist of loans for which the country of risk is Venezuela.

------

The composition of our CRE loan portfolio held for investment by industry segment at September 30, 2025 and December 31, 2024 is depicted in the following table:

---

| | | |
|:---|:---|:---|
| *(in thousands)* | **September 30, 2025** | **December 31, 2024** |
| Retail (1) | $621178 | $718869 |
| Multifamily | 361650 | 336229 |
| Office Space | 485284 | 446747 |
| Specialty (2) | 185065 | 145290 |
| Land and Construction | 544727 | 483210 |
| Hospitality | 286707 | 288788 |
| Industrial and Warehouse | 77946 | 78779 |
| **Total CRE Loans Held for Investment (3)** | $2562557 | $2497912 |

---

_________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Includes loans generally granted to finance the acquisition or operation of non-owner occupied properties such as retail shopping centers, free-standing single-tenant properties, and mixed-use properties primarily dedicated to retail, where the primary source of repayment is derived from the rental income generated from the use of the property by its tenants.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Includes marinas, nursing and residential care facilities, and other specialty type CRE properties.

(3) &nbsp;&nbsp;&nbsp;&nbsp;Includes loans held for investment in the NY loan portfolio, which were $197.0 million at September 30, 2025 and $221.8 million at December 31, 2024.

The Company had no loans held for sale as of September 30, 2025. The table below summarizes the composition of our loans held for sale by type of loan as of December 31, 2024:

---

| | | |
|:---|:---|:---|
| *(in thousands)* | **September 30, 2025** | **December 31, 2024** |
| **<u>Mortgage loans held for sale at fair value</u>** |  |  |
| &nbsp;&nbsp;Land development and construction loans |  | 10768 |
| &nbsp;&nbsp;Single-family residential |  | 32143 |
| Total mortgage loans held for sale at fair value (1)(2) |  | 42911 |
| Total loans held for sale | $— | $42911 |

---

___________

(1)As of December 31, 2024, mortgage loans held for sale were in connection with Amerant Mortgage's ongoing business.

(2)All loans remained in accrual status as of December 31, 2024.

------

As of September 30, 2025, total loans held for investment were $6.9 billion, down $286.6 million, or 4.0%, compared to December 31, 2024. Domestic loans held for investment decreased $280.8 million, or 3.9%, as of September 30, 2025, compared to December 31, 2024. The decrease in total domestic loans held for investment includes: (i) $231.8 million, or 13.2%, in domestic commercial loans, mainly driven by prepayments and paydowns during the period; (ii) $106.5 million, or 10.6%, in domestic owner occupied loans; (iii) $29.8 million, or 11.0%, in domestic consumer loans, mainly purchased indirect consumer loans as the Company discontinued purchases of these loans in 2023 and this portfolio is set to runoff over time; and (iv) $5.5 million, or 3.2% in loans to financial institutions and acceptances. The decrease in domestic owner occupied loans in the first nine months of 2025 includes the sale of one loan classified as Substandard, which had an outstanding balance of $30.4 million at the time of sale. These decreases were partially offset by net increases of $64.6 million, or 2.6% in domestic CRE loans and $28.1 million, or 1.9% in domestic single-family residential loans.

In the nine months ended September 30, 2025, the Company added approximately $94.9 million in single-family residential and construction loans through Amerant Mortgage, which includes loans originated and purchased from different channels.

Loans to international customers, primarily from Venezuela and other customers in Latin America decreased $5.8 million, or 14.3%, in the nine months ended September 30, 2025, mainly driven by repayments totaling $5.3 million to existing single family residential loans.

&nbsp;&nbsp;&nbsp;&nbsp;As of September 30, 2025, loans under syndication facilities, included in loans held for investment, were $368.3 million, a decrease of $25.4 million, or 6.5%, compared to $393.7 million at December 31, 2024. This was mainly driven by the paydown of five commercial loans totaling $45.3 million, net balance paydowns of $22.8 partially offset by an increase of two commercial loan and three construction loans totaling $23.6 million and $19.1 million, respectively. As of September 30, 2025 and December 31, 2024, there were no SNC loans that financed highly leveraged transactions.

------

**Loan Quality**

**Allocation of Allowance for Credit Losses**

In the following table, we present the allocation of the ACL by loan segment at the end of the periods presented. The amounts shown in this table should not be interpreted as an indication that charge-offs in future periods will occur in these amounts or percentages. These amounts represent our best estimates of expected credit losses to be collected throughout the life of the loans, at the reported dates, derived from historical events, current conditions and reasonable and supportable forecasts at the dates reported. Our allowance for credit losses is established using estimates and judgments, which consider the views of our regulators in their periodic examinations. Re-evaluation of the ACL estimate in future periods, in light of changes in composition and characteristics of the loan portfolio, changes in the reasonable and supportable forecast and other factors then prevailing may result in material changes in the amount of the ACL and credit loss expense in those future periods. We also show the percentage of each loan class, which includes loans in nonaccrual status.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Allowance** | **% of Loans in Each Category to Total Loans Held for Investment** | **Allowance** | **% of Loans in Each Category to Total Loans Held for Investment** |
| *(in thousands, except percentages)* |  |  |  |  |
| **Total Loans** |  |  |  |  |
| Real estate (1) | $24384 | 40.1% | $16668 | 38.2% |
| Commercial | 48458 | 35.2% | 44732 | 38.3% |
| Financial institutions (2) |  | —% |  | 0.2% |
| Consumer and others (3) | 22076 | 24.7% | 23563 | 23.3% |
| **Total Allowance for Credit Losses** | $**94918** | **100.0%** | $**84963** | **100.0%** |
| **% of Total Loans held for investment** | 1.37% |  | 1.18% |  |

---

__________________

(1) &nbsp;&nbsp;&nbsp;&nbsp;Includes transactions in which the debtor or customer is domiciled outside the U.S. and all collateral is located in the U.S.

(2) &nbsp;&nbsp;&nbsp;&nbsp;Excludes loans to non-depository financial institutions evaluated under Real Estate or Commercial allowance models.

(3) &nbsp;&nbsp;&nbsp;&nbsp;Includes (i) indirect consumer loans purchased, and (ii) mortgage loans for and secured by single-family residential properties located in the U.S.

The ACL was determined utilizing a reasonable and supportable forecast period. The ACL was determined using a weighted-average of various macroeconomic scenarios provided by a third-party, and incorporated qualitative components. During the nine months ended September 30, 2025, the Company enhanced certain of its modeled macroeconomic factors to improve the stability of the model.

------

**Non-Performing Assets**

In the following table, we present a summary of our non-performing assets by loan class, which includes non-performing loans by portfolio segment, both domestic and international, and other real estate owned, or OREO and other repossessed assets, at the dates presented. Non-performing loans consist of: (i) nonaccrual loans where the accrual of interest has been discontinued; and (ii) accruing loans 90 days or more contractually past due as to interest or principal.

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| (in thousands) |  |  |
| **Non-Accrual Loans** |  |  |
| &nbsp;&nbsp;Real Estate Loans |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commercial real estate (CRE) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | $4374 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential | 7018 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land development and construction loans | 19577 | 4119 |
|  | 30969 | 4119 |
| &nbsp;&nbsp;&nbsp;&nbsp;Single-family residential | 8838 | 8140 |
| &nbsp;&nbsp;&nbsp;&nbsp;Owner occupied | 15287 | 23191 |
|  | 55094 | 35450 |
| Commercial loans | 67081 | 64572 |
| Consumer loans and overdrafts | 725 |  |
| **Total Non-Accrual Loans** | $122900 | $100022 |
| **Past Due Accruing Loans**  |  |  |
| Real Estate Loans |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Single-family residential | $— | $1201 |
| &nbsp;&nbsp;&nbsp;&nbsp;Owner occupied |  | 837 |
| Commercial | 1392 | 2033 |
| Consumer loans and overdrafts (1) |  | 8 |
| **Total Past Due Accruing Loans (2)** | 1392 | 4079 |
| **Total Non-Performing Loans** | $124292 | $104101 |
| **OREO and other repossessed assets** | 15606 | 18074 |
| **Total Non-Performing Assets** | $139898 | $122175 |

---

______________

(1) In the second quarter of 2025, the Company changed its charge-off policy for unsecured consumer loans from 90 days to 120 days past due. This change in policy had no material impact to the Company's consolidated financial statements in the first nine months of 2025.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Loans past due 90 days or more but still accruing.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table presents the activity of non-performing assets by type of loan in the nine months ended September 30, 2025:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| *(in thousands)* | **Commercial Real Estate** | **Single-family Residential** | **Owner-occupied** | **Commercial** | **Financial Institutions** | **Consumer and Others** | **OREO and Other Repossessed Assets** | **Total** |
| **Balance at beginning of period** | $4119 | $9341 | $24028 | $66605 | $— | $8 | $18074 | $122175 |
| Plus: loans placed in nonaccrual status | 32237 | 14176 | 5881 | 71322 |  | 7942 |  | 131558 |
| Less: nonaccrual loan charge-offs | (1268) | (249) | (130) | (24571) |  | (7277) |  | (33495) |
| Less: nonaccrual loans sold, net of charge offs | (4119) | (8339) | (1075) | (2100) |  |  |  | (15633) |
| Less: nonaccrual loan collections and others |  | (2956) | (12042) | (42142) |  | 60 |  | (57080) |
| Less: net decrease in past-due accruing loans |  | (1201) | (837) | (641) |  | (8) |  | (2687) |
| Loans returned to accrual status |  | (41) | (538) |  |  |  |  | (579) |
| Transferred from Loans to OREO  |  | (1893) |  |  |  |  | 1893 |  |
| OREO sales and write downs |  |  |  |  |  |  | (4361) | (4361) |
| **Balances at end of period** | $30969 | $8838 | $15287 | $68473 | $— | $725 | $15606 | $139898 |

---

The increase in nonperforming assets during the nine months ended September 30, 2025 was primarily due to downgrades based on receipt of recent borrower financial information as well as missed contractual milestones and CRE properties with debt coverage below contractual terms. This was partially offset by loan charge offs, repayments and sales. The Company also sold two OREO properties in the period.

All non-performing loans are rated Classified. See discussion on Classified and Special Mention Loans below for more details, including details about new loans downgraded during period.

We recognized no interest income on nonaccrual loans during the nine months ended September 30, 2025 and 2024.

------

The Company's loans by credit quality indicators are summarized in the following table. We have no purchased-credit-impaired loans.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| *(in thousands)* | **Special Mention** | **Substandard** | **Doubtful** | **Total (1)** | **Special Mention** | **Substandard** | **Doubtful** | **Total (1)** |
| **Loans held for investment** |  |  |  |  |  |  |  |  |
| Real Estate Loans |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Commercial Real <br>Estate (CRE) |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-owner <br>occupied | $53284 | $42406 | $— | $95690 | $361 | $21430 | $— | $21791 |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential |  | 29430 |  | 29430 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Land development <br>and <br>construction<br> loans | 3959 | 19577 |  | 23536 |  | 4119 |  | 4119 |
|  | 57243 | 91413 |  | 148656 | 361 | 25549 |  | 25910 |
| &nbsp;&nbsp;Single-family residential  | 738 | 8717 |  | 9455 |  | 9438 |  | 9438 |
| &nbsp;&nbsp;Owner occupied  | 45365 | 35085 |  | 80450 | 5047 | 64876 |  | 69923 |
|  | 103346 | 135215 |  | 238561 | 5408 | 99863 |  | 105271 |
| Commercial loans | 120997 | 105905 |  | 226902 |  | 66605 |  | 66605 |
| Consumer loans and <br>overdrafts |  | 725 |  | 725 |  | 8 |  | 8 |
| Total | $**224343** | $**241845** | $**—** | $**466188** | $**5408** | $**166476** | $**—** | $**171884** |

---

__________

(1) There are no loans categorized as a "Loss" as of the dates presented.

------

***Classified Loans***. Classified loans include substandard and doubtful loans. The following table presents the activity of classified loans in the nine months ended September 30, 2025:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| *(in thousands)* | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
|  | **Commercial Real Estate** | **Single-family Residential** | **Owner-occupied** | **Commercial** | **Financial Institutions** | **Consumer and Others** | **Total** |
| **Balance at beginning of period** | $25549 | $9438 | $64876 | $66605 | $— | $8 | $166476 |
| Plus: loans downgraded to substandard and doubtful | 115061 | 13203 | 24873 | 109897 |  | 7940 | 270974 |
| Less: classified loan charge-offs | (1268) | (249) | (130) | (24571) |  | (7277) | (33495) |
| Less: classified loans sold, net of charge offs | (4119) | (8339) | (31509) | (2100) |  |  | (46067) |
| Less: classified loan collections and others | (43810) | (3174) | (22461) | (43804) |  | 54 | (113195) |
| Less: loans upgraded |  | (269) | (564) | (122) |  |  | (955) |
| Less: Transferred from Loans to OREO |  | (1893) |  |  |  |  | (1893) |
| **Balances at end of period** | $91413 | $8717 | $35085 | $105905 | $— | $725 | $241845 |

---

Classified loans increased $75.4 million, or 45.3%, primarily due to: (i) five CRE loans totaling $91.6 million downgraded to substandard accrual, (ii) 11 commercial loans downgraded to non-performing totaling $55.9 million, (iii) six commercial loans downgraded to substandard accrual totaling $48.3 million, (iv) one construction loan totaling $19.5 million downgraded to non-performing, (v) two Owner-Occupied loans downgraded to substandard accrual totaling $19 million, (vi) two Owner-Occupied loans downgraded to non-performing totaling $2.7 million, and (vii) one residential loan downgraded to non-performing totaling $5.9 million. The remaining downgrades included other smaller classified loans. The downgrades of the CRE loans were primarily due to the loss of tenants, missed contractual milestones or debt coverage below contractual terms, while the downgrades to commercial loans were primarily due to the receipt of updated borrowers' financial information or missed contractual milestones.

<u>Composition of Classified Loans at September 30, 2025</u>

Classified loans include 20 large balance loans totaling $178.4 million that remain in accruing status. Classified accruing loans include: (i) 1 CRE loan to a customer in the hospitality service sector in Florida totaling $27.1 million; (ii) 2 CRE properties in Florida totaling $25.5 million; (iii) 2 CRE properties in New York totaling $17.9 million; (iv) 1 Land and Construction loan in Texas; and (v) 14 commercial and owner-occupied loans totaling $88.3 million diversified in several industries.

<u>New downgrades to Substandard Accrual and Subsequent activity</u>

In July 2025, the Company downgraded to substandard accrual a total of $55.6 million, which included one CRE loan from Pass, one CRE loan from Special Mention, and two commercial loans from Pass. Additionally, the Company collected a total of $53.0 million in full satisfaction, which included two CRE accruing loans and one commercial non-performing loan. There were no additional charges as a result of this activity.

In the first quarter of 2025, the Company downgraded a $40.6 million owner-occupied loan to a customer in the restaurant services sector in Florida to Substandard accrual status. In February 2025, the Company decided to sell the loan. As a result, the loan was transferred from loans held for investment to loans held for sale at the lower of cost or fair value. At the time of transfer, we determined that no valuation allowance was required. In April 2025, the Company decided not to proceed with the sale and reclassified the loan back to its held-for-investment portfolio. Subsequently, in the third quarter of 2025, we collected a partial payment of $10.1 million and sold the remaining balance of $30.4 million. The Company recognized a loss of $0.9 million in connection with this transaction in the third quarter and the first nine months of 2025.

------

**Special Mention Loans.** The following table presents the activity of special mention loans by type of loan in the nine months ended September 30, 2025:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| *(in thousands)* | **Commercial Real Estate** | **Single-family Residential** | **Owner-occupied** | **Commercial** | **Financial Institutions** | **Consumer and Others** | **Total** |
| **Balance at beginning of period** | $361 | $— | $5047 | $— | $— | $— | $5408 |
| Downgrades to Special Mention | 116551 | 738 | 44730 | 180891 |  |  | 342910 |
| Upgrades to Pass |  |  |  |  |  |  |  |
| Downgrades to Substandard | (40221) |  | (1545) | (26852) |  |  | (68618) |
| Payoffs/Paydowns | (19448) |  | (2867) | (33042) |  |  | (55357) |
| **Balances at end of period** | $57243 | $738 | $45365 | $120997 | $— | $— | $224343 |

---

All special mention loans remained current at September 30, 2025.

The increase in Special Mention loans was mainly driven by 10 Commercial loans and 5 owner-occupied loans in multiple industries totaling $178.7 million and $44.7 million, respectively. These loans were downgraded based on receipt of recent financial information, or missed contractual milestones. In addition, the increase in special mention loans include eight CRE loans totaling $117.3 million. While certain milestones were missed by the borrowers, there are acceptable mitigating factors in place, such as adequate loan-to-value, interest reserves or other structural enhancements. These increases were partially offset by $55.4 million in payoffs and $68.6 million in downgrades to Substandard.

Potential problem loans, which are accruing loans classified as substandard and are less than 90 days past due, at September 30, 2025 and December 31, 2024, are as follows:

---

| | | |
|:---|:---|:---|
| *(in thousands)* | **September 30, 2025** | **December 31, 2024** |
| Real estate loans |  |  |
| &nbsp;&nbsp;&nbsp;Commercial real estate (CRE) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-owner occupied | $38032 | $21430 |
| &nbsp;&nbsp;&nbsp;&nbsp;Multi-family residential | 22413 |  |
|  | 60445 | 21430 |
| &nbsp;&nbsp;&nbsp;Single-family residential (1) |  | 227 |
| &nbsp;&nbsp;Owner occupied | 19799 | 40847 |
|  | 80244 | 62504 |
| Commercial loans | 38824 |  |
|  | $119068 | $62504 |

---

__________

(1) Corresponds to both domestic and international single-family residential loans.

------

At September 30, 2025 total potential problem loans increased to $119.1 million compared to $62.5 million at December 31, 2024. This was primarily driven by the downgrade to substandard of two CRE retail loans totaling $33.3 million, two CRE multifamily loans totaling $30.7 million, one hotel loan totaling $27.1 million, three owner-occupied loans totaling $19.8 million, and seven commercial loans totaling $48.5 million across the transportation, construction, and restaurant industries. These downgrades were partially offset by paydowns of three CRE loans totaling $43.4 million, one commercial loan totaling $1.3 million, and the partial payoff and sale of an owner-occupied loan totaling $39.6 million, in addition to further downgrades of other loans.

------

***Securities***

The following table sets forth the book value and percentage of each category of securities at September 30, 2025 and December 31, 2024. The book value for trading securities, debt securities classified as available for sale and equity securities with readily determinable fair value not held for trading represents fair value. The Company determined that an ACL on its debt securities available for sale at September 30, 2025 and December 31, 2024 was not required. There are no debt securities held to maturity as of September 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Amount** | **%** | **Amount** | **%** |
| *(in thousands, except percentages)* |  |  |  |  |
| **Debt securities available for sale:** |  |  |  |  |
| U.S. Treasury Securities | $2492 | 0.1% | $1933 | 0.1% |
| U.S. Government Agency and Sponsored Enterprise Residential MBS | 1943709 | 84.3% | 1262640 | 84.3% |
| U.S. Government Agency and Sponsored Enterprise Commercial MBS | 154990 | 6.7% | 142538 | 9.5% |
| U.S. Government Agency and Sponsored Enterprise Obligations | 12471 | 0.5% | 16682 | 1.1% |
| Non-Agency Commercial MBS (1) | 7144 | 0.3% | 11792 | 0.8% |
| Municipal bonds | 1610 | 0.1% | 1585 | 0.1% |
|  | $2122416 | 92.0% | $1437170 | 95.9% |
| **Equity securities with readily determinable fair value not held for trading (2)** | $2542 | 0.1% | $2477 | 0.2% |
| **Trading securities (3)** | $119935 | 5.2% | $— | —% |
| **Other securities (4):** | $62808 | 2.7% | $58278 | 3.9% |
|  | $2307701 | 100.0% | $1497925 | 100.0% |

---

__________________

(1) Issued by a financial institution.

(2) In 2023, the Company purchased an investment in an open-end fund incorporated in the U.S. with an original cost of $2.5 million. The Fund's objective is to provide a high level of current income consistent with the preservation of capital and investments deemed to be qualified under the Community Reinvestment Act.

(3) In 2025, the Company began participating in trading of MBS as part of its investment portfolio strategy.

(4)&nbsp;&nbsp;&nbsp;&nbsp;Includes investments in FHLB and Federal Reserve stock. Amounts correspond to original cost at the date presented. Original cost approximates fair value because of the nature of these investments.

As of September 30, 2025, total securities increased $809.8 million, or 54.1%, to $2.31 billion compared to $1.50 billion at December 31, 2024. The increase in the nine months ended September 30, 2025 was mainly driven by: (i) purchases of debt securities held for sale, trading securities and FHLB stock totaling $921.4 million; and (ii) net pre-tax unrealized gains of $44.4 million on debt securities available for sale primarily attributable to changes in market interest rates during the current period. This increase was partially offset by maturities, sales, calls and pay downs, totaling $157.2 million.

------

Debt securities available for sale had net unrealized holding losses of $27.0 million and net unrealized holding gains of $16.5 million at September 30, 2025, compared to December 31, 2024 when net unrealized holding losses were $55.7 million and net unrealized holding gains were $0.9 million. The Company does not intend to sell these debt securities and it is more likely than not that it will not be required to sell the securities before their anticipated recovery. The Company believes these securities are not credit-impaired because the change in fair value is attributable to changes in interest rates and investment securities markets, generally, and not credit quality. As a result, the Company did not record an ACL on these securities as of September 30, 2025 and December 31, 2024.

The Company does not have any debt securities classified as held to maturity at September 30, 2025.

The following tables set forth the book value, scheduled maturities and weighted average yields for our securities portfolio at September 30, 2025 and December 31, 2024. Similar to the table above, the book value for securities available for sale, trading securities and equity securities with readily determinable fair value not held for trading is equal to fair market value.

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| *(in thousands, except percentages)* | **Total** | **Total** | **Less than a year** | **Less than a year** | **One to five years** | **One to five years** | **Five to ten years** | **Five to ten years** | **Over ten years** | **Over ten years** | **No maturity** | **No maturity** |
| *(in thousands, except percentages)* | **Amount** | **Yield** | **Amount** | **Yield** | **Amount** | **Yield** | **Amount** | **Yield** | **Amount** | **Yield** | **Amount** | **Yield** |
| **Debt securities available for sale** |  |  |  |  |  |  |  |  |  |  |  |  |
| Non agency commercial MBS | $7144 | 3.81% | $— | —% | $— | —% | $— | —% | $7144 | 3.81% | $— | —% |
| U.S. Government agency and sponsored enterprise obligations | 12471 | 5.17% |  | —% | 2680 | 5.25% | 1049 | 5.57% | 8742 | 5.10% |  | —% |
| Municipal bonds | 1610 | 2.46% |  | —% |  | —% | 356 | 1.92% | 1254 | 2.61% |  | —% |
| U.S. Treasury Securities | 2492 | 4.10% | 1993 | 4.22% | 499 | 3.63% |  | —% |  | —% |  | —% |
| U.S. Government agency and sponsored enterprise commercial MBS | 154990 | 4.19% |  | —% | 47500 | 3.56% | 41020 | 3.90% | 66470 | 4.81% |  | —% |
| U.S. Government agency and sponsored enterprise residential MBS | 1943709 | 4.97% |  | —% | 848 | 5.38% | 6031 | 4.56% | 1936830 | 4.97% |  | —% |
|  | $2122416 | 4.92% | $1993 | 4.22% | $51527 | 3.68% | $48456 | 4.00% | $2020440 | 4.96% | $— | —% |
| **Equity securities with readily determinable fair value not held for trading** | 2542 | 3.41% |  | —% |  | —% |  | —% |  | —% | 2542 | 3.41% |
| **Trading securities** | 119935 | 5.52% |  | —% |  | —% |  | —% | 119935 | 5.52% |  | —% |
| **Other securities** | $62808 | 6.46% | $— | —% | $— | —% | $— | —% | $— | —% | $62808 | 6.46% |
|  | $2307701 | 4.99% | $1993 | 4.22% | $51527 | 3.68% | $48456 | 4.00% | $2140375 | 4.99% | $65350 | 6.34% |

---

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| *(in thousands, except percentages)* | **Total** | **Total** | **Less than a year** | **Less than a year** | **One to five years** | **One to five years** | **Five to ten years** | **Five to ten years** | **Over ten years** | **Over ten years** | **No maturity** | **No maturity** |
| *(in thousands, except percentages)* | **Amount** | **Yield** | **Amount** | **Yield** | **Amount** | **Yield** | **Amount** | **Yield** | **Amount** | **Yield** | **Amount** | **Yield** |
| **Debt securities available for sale** |  |  |  |  |  |  |  |  |  |  |  |  |
| Non-Agency Commercial MBS | $11792 | 3.51% | $— | —% | $— | —% | $— | —% | $11792 | 3.51% | $— | —% |
| U.S. Government Agency and Sponsored Enterprise Obligations | 16682 | 5.45% | 11 | —% | 2146 | 5.42% | 2346 | 5.59% | 12179 | 5.41% |  | —% |
| Municipal Bonds | 1585 | 2.38% |  | —% |  | —% | 343 | 1.79% | 1242 | 2.54% |  | —% |
| U.S. Treasury Securities | 1933 | 4.22% | 1933 | 4.22% |  | —% |  | —% |  | —% |  | —% |
| U.S. Government Agency and Sponsored Enterprise Commercial MBS | 142538 | 4.17% | 206 | 2.87% | 37972 | 3.70% | 43051 | 3.72% | 61309 | 4.77% |  | —% |
| U.S. Government Agency and Sponsored Enterprise Residential MBS | 1262640 | 4.86% | $42 | 3.10% | 1154 | 5.42% | 6844 | 4.61% | 1254600 | 4.86% |  | —% |
|  | $1437170 | 4.78% | $2192 | 4.05% | $41272 | 3.84% | $52584 | 3.91% | $1341122 | 4.85% | $— | —% |
| **Equity securities with readily determinable fair value not held for trading** | 2477 | 3.03% |  | —% |  | —% |  | —% |  | —% | 2477 | 3.03% |
| **Other securities** | $58278 | 6.95% | $— | —% | $— | —% | $— | —% | $— | —% | $58278 | 6.95% |
|  | $1497925 | 4.87% | $2192 | 4.05% | $41272 | 3.84% | $52584 | 3.91% | $1341122 | 4.85% | $60755 | 6.79% |

---

The investment portfolio's weighted expected average effective duration decreased to 4.4 years at September 30, 2025 compared to 5.2 years at December 31, 2024, due to higher prepayment assumptions due to projections of lower market rates that result in a lower weighted average duration.

------

***Liabilities***

Total liabilities were $9.47 billion at September 30, 2025, an increase of $454.0 million, or 5.0%, compared to $9.0 billion at December 31, 2024. This was primarily driven by an increase of $446.4 million, or 5.7%, in total deposits, mainly due to an increase in core deposits, and (ii) $86.7 million, or 11.6%, in advances from the FHLB. This increase was partially offset by: (i) the redemption in April 2025 of $60 million of senior notes that were due June 30, 2025; and (ii) $23.0 million, or 15.1%, in accounts payable, accrued liabilities and other liabilities. *See* "Capital Resources and Liquidity Management" and "Deposits" for more details on the changes in advances from the FHLB and total deposits. *See* "Our Company- Business Developments" for additional information.

***Deposits***

We continue with our efforts in growing our deposits. Our efforts include the additions of new team members to our business development teams across South Florida and Tampa in the first nine months of 2025.

Total deposits were $8.30 billion at September 30, 2025, an increase of $446.4 million, or 5.7%, compared to December 31, 2024. The increase in deposits in the nine months ended September 30, 2025 was mainly due to a increase of: (i) $264.0 million, or 17.5%, in noninterest bearing demand deposits, (ii) $254.0 million, or 13.5%, in savings and money market deposits, and (iii) $64.8 million, or 2.9%, in interest-bearing deposits. These increases were partially offset by a decrease of $136.5 million, or 6.1%, in time deposits.

The $136.5 million, or 6.1%, net decrease in time deposits includes a decrease of $151.7 million, or 21.6%, in brokered time deposits, which was partially offset by an increase of $15.2 million, or 1.0% in customer CDs.

As of September 30, 2025 total brokered deposits were $550.2 million, a decrease of $151.6 million, or 21.6%, compared to $701.9 million at December 31, 2024.

***Deposits by Country of Domicile***

The following table shows deposits by country of domicile of the depositor as of the dates presented and the changes during the period.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | **Change** | **Change** |
| *(in thousands, except percentages)* | **September 30, 2025** | **December 31, 2024** | **Amount** | **%** |
| **Deposits** |  |  |  |  |
| Domestic (1) | $5732799 | $5278289 | $454510 | 8.6% |
| Foreign: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Venezuela (2) | 1881871 | 1889331 | (7460) | (0.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Others (3) | 686299 | 686975 | (676) | (0.1)% |
| Total foreign | 2568170 | 2576306 | (8136) | (0.3)% |
| Total deposits | $8300969 | $7854595 | $446374 | 5.7% |

---

_________________

(1)&nbsp;&nbsp;&nbsp;&nbsp;Includes brokered deposits of $550.2 million and $701.9 million at September 30, 2025 and December 31, 2024, respectively.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Based upon the diligence we customarily perform to "know our customers" for anti-money laundering, OFAC and sanctions purposes, we believe that the U.S. economic embargo on certain Venezuelan persons will not adversely affect our Venezuelan customer relationships, generally.

(3) Our other foreign deposits do not include deposits from Venezuelan resident customers.

------

Our domestic deposits increased $454.5 million, or 8.6%, in the nine months ended September 30, 2025, primarily driven by increases of: (i) $243.5 million in domestic noninterest bearing accounts; (ii) $233.5 million in savings and money market accounts; and (iii) $141.8 million in domestic interest-bearing accounts. These increases were partially offset by decreases of: (i) $161.7 million in domestic brokered time deposits; and (ii) $2.6 million in domestic customer time deposits.

During the nine months ended September 30, 2025, total foreign deposits decreased $8.1 million, or 0.3%, primarily driven by decreases in interest-bearing deposits from customers domiciled in Venezuela and other foreign counties. The decreases were partially offset by increases in time deposits, savings and money market deposits as well as noninterest bearing deposits from both customers domiciled in Venezuela and other foreign countries.

 ***Core Deposits***

Our core deposits were $6.2 billion and $5.6 billion as of September 30, 2025 and December 31, 2024, respectively. Core deposits represented 74.7% and 71.6% of our total deposits at those dates, respectively. The increase of $582.9 million, or 10.4%, in core deposits in the nine months ended September 30, 2025 was mainly driven by increases in noninterest bearing demand deposits, savings and money market deposits, as well as interest bearing demand deposits. We define "core deposits" as total deposits excluding all time deposits.

 ***Brokered Deposits***

We utilize brokered deposits primarily as an asset/liability management tool. As of September 30, 2025, we had $550.2 million in brokered deposits, which represented 6.6% of our total deposits at that date (8.9% as of December 31, 2024). As of September 30, 2025, brokered deposits decreased $151.6 million, or 21.6%, compared to $701.9 million as of December 31, 2024, mainly resulting from our planned strategy of reducing these high-cost deposits. As of September 30, 2025 and December 31, 2024, brokered deposits included time deposits of $550.2 million and $701.9 million, respectively. As of September 30, 2025, brokered non-time deposits were not significant, while there were no brokered non-time deposits as of December 31, 2024. The Company has not historically sold brokered CDs in individual denominations over $100,000.

 ***Large Fund Providers***

Large fund providers consist of third party relationships with balances over $20 million. At September 30, 2025 and December 31, 2024, our large fund providers included 18 and 20 deposit relationships, respectively, with total balances of $1.1 billion and $942.3 million, respectively. The increase in balances from large fund providers in the nine months ended September 30, 2025 was mainly driven by an increase in large deposits from commercial customers as the Company continues its focus on depository relationships.

------

***Large Time Deposits by Maturity***

The following table sets forth the maturities of our time deposits with individual balances equal to or greater than $100,000 as of September 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| *(in thousands, except percentages)* |  |  |  |  |
| Less than 3 months | $513088 | 40.1% | $386857 | 30.4% |
| 3 to 6 months | 366766 | 28.7% | 349673 | 27.5% |
| 6 to 12 months | 336339 | 26.3% | 464812 | 36.6% |
| 1 to 3 years | 48426 | 3.8% | 53745 | 4.2% |
| Over 3 years | 14850 | 1.1% | 15386 | 1.3% |
| Total | $1279469 | 100.0% | $1270473 | 100.0% |

---

***Short-Term Borrowings***

In addition to deposits, we use short-term borrowings from time to time, such as advances from the FHLB and borrowings from other banks, as a source of funds to meet the daily liquidity needs of our customers and fund growth in earning assets. Short-term borrowings have maturities of 12 months or less as of the reported period-end.

Short-term borrowings outstanding at September 30, 2025 totaled $100 million, wherein $20 million matured in the fourth quarter of 2025, $20 million will mature in the first quarter of 2026 and $60 million will mature in the third quarter of 2026. Balance outstanding at December 31, 2024 matured in January 2025. All of our outstanding short-term borrowings at December 31, 2024 corresponded to advances from the FHLB. There were no other borrowings or repurchase agreements outstanding at September 30, 2025 and December 31, 2024.

The following table sets forth information about the outstanding amounts of our short-term borrowings at the close of, and for the three months ended September 30, 2025 and for the year ended December 31, 2024.

---

| | | |
|:---|:---|:---|
| | **September 30,<br>2025** | **December 31,<br>2024** |
| *(in thousands, except percentages)* |  |  |
| Outstanding at period-end | $100000 | $30000 |
| Average amount | 17778 | 2500 |
| Maximum amount outstanding at any month-end | 100000 | 30000 |
| Weighted average interest rate: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; During period | 4.20% | 4.44% |
| &nbsp;&nbsp;&nbsp;&nbsp; End of period | 3.94% | 4.44% |

---

------

**Return on Equity and Assets**

The following table shows annualized return on average assets, return on average equity, and average equity to average assets ratio for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| *(in thousands, except percentages and per share data)* |  |  |  |  |
| Net income (loss) attributable to the Company | $14756 | $(48164) | $49716 | $(32633) |
| Basic earnings (loss) per common share | 0.35 | (1.43) | 1.19 | (0.97) |
| Diluted earnings (loss) per common share (1) | 0.35 | (1.43) | 1.19 | (0.97) |
| Average total assets | $10243925 | $9985972 | $10181641 | $9823343 |
| Average stockholders' equity | 942421 | 766909 | 923665 | 752384 |
| Net income attributable to the Company / Average total assets (ROA) | 0.57% | (1.92)% | 0.65% | (0.44)% |
| Net income attributable to the Company / Average stockholders' equity (ROE) | 6.21% | (24.98)% | 7.20% | (5.79)% |
| Average stockholders' equity / Average total assets ratio | 9.20% | 7.68% | 9.07% | 7.66% |

---

__________________

(1)In the three and nine month periods ended September 30, 2025 and 2024, potential dilutive instruments consisted of unvested shares of restricted stock, restricted stock units and performance share units. S*ee* Note 13 to our unaudited interim consolidated financial statements in this Form 10-Q for details on the dilutive effects of the issuance of restricted stock, restricted stock units and performance share units on earnings per share for the nine month periods ended September 30, 2025 and 2024.

During the three and nine month periods ended September 30, 2025, basic and diluted earnings per share increased compared to the same period one year ago, primarily driven by improved net income in the current periods compared to the same periods last year. These results were partially offset by an increase in the weighted average number of shares as a result of the Company's public offering of its Class A common stock that was completed in September 2024.

**Capital Resources and Liquidity Management**

***Capital Resources***

Stockholders' equity is influenced primarily by earnings, dividends, if any, and changes in accumulated other comprehensive income or loss (AOCI/AOCL) caused primarily by fluctuations in unrealized holding gains or losses, net of taxes, on debt securities available for sale and derivative instruments. AOCI or AOCL are not included in stockholders' equity for purposes of determining our capital for bank regulatory purposes.

Total stockholders' equity was $944.9 million as of September 30, 2025, an increase of $54.5 million, or 6.1%, compared to $890.5 million as of December 31, 2024. This increase was primarily driven by: (i) a net income of $49.7 million in the first nine months of 2025, and (ii) $32.9 million of other comprehensive income in the first nine months of 2025. This was partially offset by: (i) an aggregate of $20.0 million of Class A common stock repurchased in the first nine months of 2025, and (ii) $11.4 million of dividends declared and paid by the Company in the first nine months of 2025.

------

***Common Stock Transactions***

In the three and nine month periods ended September 30, 2025, the Company repurchased an aggregate of 487,657 and 978,750 shares, respectively, of Class A common stock at a weighted average price of $20.51 and $20.43 per share, under the 2023 Class A Common Stock Repurchase Program. The aggregate purchase price for these transactions was $10.0 million and $20.0 million in the three and nine months ended September 30, 2025, including transaction costs.

***Dividends***

Set forth below are the details of dividends declared and paid by the Company for the first nine months ended September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Declaration Date</u>** | **<u>Record Date</u>** | **<u>Payment Date</u>** | **<u>Dividend Per Share</u>** | **<u>Dividend Amount</u>** |
| 07/23/2025 | 08/15/2025 | 08/29/2025 | $0.09 | $3.8 million |
| 04/23/2025 | 05/15/2025 | 05/30/2025 | $0.09 | $3.8 million |
| 01/22/2025 | 02/14/2025 | 02/28/2025 | $0.09 | $3.8 million |

---

On October 22, 2025, the Company's Board of Directors declared a cash dividend of $0.09 per share of the Company's common stock. The dividend is payable on November 28, 2025, to shareholders of record at the close of business on November 14, 2025.

***Liquidity Management***

We manage our liquidity based on several factors that include the amount of core deposit relationships as a percentage of total deposits, the level of diversification of our funding sources, the allocation and amount of our deposits among deposit types, the short-term funding sources used to fund assets, the amount of non-deposit funding used to fund assets, the availability of unused funding sources, off-balance sheet obligations, the amount of cash and liquid securities we hold, the availability of assets readily convertible into cash without undue loss, the characteristics and maturities of our assets when compared to the characteristics of our liabilities and other factors.

Liquidity risk management is a relevant element of our asset/liability management. Our contingency funding plan is constantly monitored by our Assets and Liabilities Committee and serves as the basis to identify our liquidity needs. The contingency funding plan models several liquidity stress scenarios to evaluate different potential liquidity outflows or funding gaps resulting from economic disruptions and volatility in the financial markets, among other factors.

Customer deposits have been our principal source of funding, supplemented by our investment securities portfolio, our short-term and long-term borrowings as well as loan repayments and amortizations. The Company's liquidity position includes cash and cash equivalents of $630.9 million at September 30, 2025, compared to $590.4 million at December 31, 2024.

------

At September 30, 2025 and December 31, 2024, the Company had $831.7 million and $745.0 million, respectively, of outstanding advances from the FHLB. At September 30, 2025 and December 31, 2024, we had an additional $2.1 billion and $1.6 billion, respectively, of remaining borrowing capacity with the FHLB. This additional borrowing capacity is determined by the FHLB. In the nine months ended September 30, 2025, the Company borrowed $380.0 million and repaid $293.4 million in advances from the FHLB. In the nine months ended September 30, 2025, the Company had no significant gains or losses on the repayments of the advances from the FHLB. These repayments are part of the Company's asset/liability management strategies. In the third quarter of 2025, the Company restructured $210.0 million of its fixed-rate FHLB advances. This restructuring consisted of changing the original maturity at lower interest rates. The new maturity for each contract was approximately three years, consistent with their original maturity. The Company incurred an early termination and modification penalty of $3.4 million which was deferred and is being amortized over the term of the new advances, as an adjustment to the yields. In each of the third quarter and first nine months of 2025, the Company recognized $0.1 million, included as part of interest expense, as a result of this amortization. The modifications were not considered a substantial modification in accordance with GAAP.

There were no other borrowings as of September 30, 2025 and December 31, 2024.

We also have available uncommitted federal funds lines with several banks. We had no outstanding borrowings under uncommitted federal funds lines with banks at September 30, 2025 and December 31, 2024.

*Holding Company*

We are a corporation separate and apart from the Bank and, therefore, must provide for our own liquidity. Historically, our main source of funding has been dividends declared and paid to us by the Bank. The Company is the obligor and guarantor on our junior subordinated debt and the guarantor of the Subordinated Notes.

The Company held cash and cash equivalents mainly at the Bank of $34.7 million as of September 30, 2025 in funds available to service Subordinated Notes and junior subordinated debt and for general corporate purposes, as a separate stand-alone entity ($99.5 million as of December 31, 2024 in funds available to service Subordinated Notes, Senior Notes and junior subordinated debt and for general corporate purposes).

On April 1, 2025, the Company redeemed $60.0 million in aggregate principal amount of its 5.75% Senior Notes that were due June 30, 2025. The Notes were redeemed in full at a redemption price equal to 100% of the principal amount of the Notes, plus accrued and unpaid interest. The aggregate redemption price, including accrued interest, totaled approximately $60.9 million.

<u>Subsidiary Dividends</u> 

There are statutory and regulatory limitations that affect the ability of the Bank to pay dividends to the Company. These limitations exclude the effects of AOCI/AOCL. Management believes that these limitations will not affect the Company's ability to meet its ongoing short-term cash obligations. See "Supervision and Regulation" in the 2024 Form 10-K.

In July 2025, the Board of Directors of the Bank approved the payment of a cash dividend of $40.0 million by the Bank to the Company.

Based on our current outlook, we believe that net income, advances from the FHLB, available other borrowings and any dividends paid to us by the Bank will be sufficient to fund liquidity requirements for the foreseeable future.

------

**Regulatory Capital Requirements**

The Company's consolidated regulatory capital amounts and ratios are presented in the following table:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Actual** | **Actual** | **Required for Capital Adequacy Purposes** | **Required for Capital Adequacy Purposes** | **Regulatory Minimums To be Well Capitalized** | **Regulatory Minimums To be Well Capitalized** |
| (in thousands, except percentages) | **Amount** | **Ratio** | **Amount** | **Ratio** | **Amount** | **Ratio** |
| **September 30, 2025** |  |  |  |  |  |  |
| Total capital ratio | $1130070 | 13.89% | $650700 | 8.00% | $813374 | 10.00% |
| Tier 1 capital ratio | 998618 | 12.28% | 488025 | 6.00% | 650700 | 8.00% |
| Tier 1 leverage ratio | 998618 | 9.73% | 410510 | 4.00% | 513138 | 5.00% |
| Common Equity Tier 1 (CET1) | 937999 | 11.53% | 366018 | 4.50% | 528693 | 6.50% |
| **December 31, 2024** |  |  |  |  |  |  |
| Total capital ratio | $1096882 | 13.43% | $653446 | 8.00% | $816807 | 10.00% |
| Tier 1 capital ratio | 976360 | 11.95% | 490084 | 6.00% | 653446 | 8.00% |
| Tier 1 leverage ratio | 976360 | 9.66% | 404480 | 4.00% | 505600 | 5.00% |
| Common Equity Tier 1 (CET1) | 915658 | 11.21% | 367563 | 4.50% | 530925 | 6.50% |

---

The Bank's consolidated regulatory capital amounts and ratios are presented in the following table:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Actual** | **Actual** | **Required for Capital Adequacy Purposes** | **Required for Capital Adequacy Purposes** | **Regulatory Minimums to be Well Capitalized** | **Regulatory Minimums to be Well Capitalized** |
| **(in thousands, except percentages)** | **Amount** | **Ratio** | **Amount** | **Ratio** | **Amount** | **Ratio** |
| **September 30, 2025** | | | | | | |
| Total capital ratio | $1079242 | 13.29% | $649458 | 8.00% | $811823 | 10.00% |
| Tier 1 capital ratio | 977733 | 12.04% | 487094 | 6.00% | 649458 | 8.00% |
| Tier 1 leverage ratio | 977733 | 9.57% | 408574 | 4.00% | 510717 | 5.00% |
| Common Equity Tier 1 (CET1) | 977733 | 12.04% | 365320 | 4.50% | 527685 | 6.50% |
| **December 31, 2024** |  |  |  |  |  |  |
| Total capital ratio | $1047759 | 12.84% | $645644 | 8.00% | $815805 | 10.00% |
| Tier 1 capital ratio | 956861 | 11.73% | 489483 | 6.00% | 652644 | 8.00% |
| Tier 1 leverage ratio | 956861 | 9.50% | 402892 | 4.00% | 503615 | 5.00% |
| Common Equity Tier 1 (CET1) | 956861 | 11.73% | 367112 | 4.50% | 530273 | 6.50% |

---

------

**Off-Balance Sheet Arrangements**

The following table shows the outstanding balance of financial instruments whose contracts represent off-balance sheet credit risk as of the end of the periods presented. Except as disclosed below, we are not involved in any other off-balance sheet contractual relationships that are reasonably likely to have a current or future material effect on our financial condition, a change in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources. For more details on the Company's off-balance sheet arrangements, *see* Note 19 to our audited consolidated financial statements included in the 2024 Form 10-K.

---

| | | |
|:---|:---|:---|
| *(in thousands)* | **September 30, 2025** | **December 31, 2024** |
| Commitments to extend credit | $1633799 | $1389894 |
| Letters of credit | 178428 | 149029 |
|  | $1812227 | $1538923 |

---

------

**Contractual Obligations**

In the normal course of business, we and our subsidiaries enter into various contractual obligations that may require future cash payments. Significant commitments for future cash obligations include capital expenditures related to operating leases, certain binding agreements we have entered into for services including outsourcing of technology services, advertising and other services, and other borrowing arrangements which are not material to our liquidity needs. We currently anticipate that our available funds, credit facilities, and cash flows from operations will be sufficient to meet our operational cash needs for the foreseeable future. Other than the changes discussed herein, there have been no material changes to the contractual obligations previously disclosed in the 2024 Form 10-K.

In the nine months ended September 30, 2025, the Company redeemed $60.0 million in aggregate principal amount of its 5.75% senior notes that were due June 30, 2025.

In the nine months ended September 30, 2025, the Company borrowed $380.0 million and repaid $293.4 million of FHLB advances.

In the nine months ended September 30, 2025, total time deposits decreased $136.5 million, or 6.1%. *See* "Deposits" for additional information.

On October 21, 2025, the Company entered into a Wind-down and Settlement Agreement (the "Wind-down Agreement") with a commercial borrower to resolve an existing loan participation agreement. Under the Wind-down Agreement, the Company assumes the risk of future credit losses under the participation agreement, up to a cumulative cap of $7.7 million through June 30, 2026 (the "Loss Cap"). If actual credit losses are below the Loss Cap as of that date, the Company will pay the difference to the borrower by June 30, 2026. The Company is currently unable to estimate the difference between the actual credit losses that may be incurred through June 30, 2026 and the Loss Cap. As of September 30, 2025, the amount remaining to be covered towards the "Loss Cap" was $5.9 million. As part of the Wind-down Agreement, the borrower has agreed to irrevocably and unconditionally guarantee the full and timely payment of all amounts due to the Company under the loan participation agreement that exceed the Loss Cap, up to a maximum of $13.9 million.

**Critical Accounting Policies and Estimates**

For our critical accounting policies and estimates disclosure, *see* the 2024 Form 10-K where such matters are disclosed for the Company's latest fiscal year ended December 31, 2024.

***Recently Issued Accounting Pronouncements.*** For a description of recently issued accounting pronouncements, *see* Note 1 to the Company's audited consolidated financial statements in the 2024 Form 10-K.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

We believe interest rate and price risks are the most significant market risks impacting us. We monitor and evaluate these risks using sensitivity analyses to measure the effects on earnings, equity and the available for sale portfolio mark-to-market exposure, of changes in market interest rates. Exposures are managed to a set of limits previously approved by our Board of Directors and monitored by management. See discussions below for material changes in our market risk exposure as compared to those discussed in our 2024 Form 10-K, Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk".

------

***Earnings Sensitivity***

The following table shows the sensitivity of our net interest income as a function of modeled interest rate changes:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Change in earnings** <sup>(1)</sup> | **Change in earnings** <sup>(1)</sup> | **Change in earnings** <sup>(1)</sup> | **Change in earnings** <sup>(1)</sup> |
| | **September 30,** | **September 30,** | **December 31,** | **December 31,** |
| *(in thousands, except percentages)* | **2025** | **2025** | **2024** | **2024** |
| **Change in Interest Rates (Basis points)** |  |  |  |  |
| Increase of 200 | $25930 | 7.4% | $24427 | 6.8% |
| Increase of 100 | 22212 | 6.3% | 19262 | 5.3% |
| Decrease of 100 | (15657) | (4.4)% | (13550) | (3.8)% |
| Decrease of 200 | (33715) | (9.6)% | (30120) | (8.3)% |

---

__________________

(1) Represents the change in net interest income, and the percentage that change represents of the base scenario net interest income. The base scenario assumes (i) flat interest rates over the next 12 months, (ii) that total financial instrument balances are kept constant over time and (iii) that interest rate shocks are instant and parallel to the yield curve, for the various interest rates and indices that affect our net interest income.

Net interest income in the base scenario decreased to approximately $352.6 million in the nine months ended September 30, 2025 compared to $361.0 million as of December 31, 2024. This decrease is mainly driven by prepayments of higher-yielding loans in the first nine months of 2025, which were replaced with lower yielding debt securities available for sale. The decrease was partially offset by a reduction in the cost of funds as the model includes an assumption of lower level of short term rates for the next 12 months.

The Company periodically reviews the scenarios used for earnings sensitivity to reflect market conditions.

*Economic Value of Equity (EVE) Analysis*

The following table shows the sensitivity of our EVE as a function of interest rate changes as of the periods presented:

---

| | | |
|:---|:---|:---|
| | **Change in equity** <sup>(1)</sup> | **Change in equity** <sup>(1)</sup> |
| | **September 30,** | **December 31,** |
| | **2025** | **2024** |
| **Change in Interest Rates (Basis points)** |  |  |
| Increase of 200 | (13.21)% | (13.61)% |
| Increase of 100 | (3.49)% | (4.86)% |
| Decrease of 100 | 2.06% | 3.82% |
| Decrease of 200 | (0.30)% | 4.50% |

---

__________________

(1) Represents the percentage of equity change in a static balance sheet analysis assuming interest rate shocks are instant and parallel to the yield curves for the various interest rates and indices that affect our net interest income.

During the periods reported, the modeled effects on the EVE remained within established Company risk limits.

------

*Available for Sale Portfolio mark-to-market exposure*

The Company measures the potential change in the market price of its investment portfolio, and the resulting potential change on its equity for different interest rate scenarios. This table shows the result of this test as of September 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **Change in market value** <sup>(1)</sup> | **Change in market value** <sup>(1)</sup> |
| | **September 30,** | **December 31,** |
| *(in thousands)* | **2025** | **2024** |
| **Change in Interest Rates** |  |  |
| **(Basis points)** |  |  |
| Increase of 200 | $(161371) | $(150674) |
| Increase of 100 | (78829) | (72777) |
| Decrease of 100 | 76540 | 68177 |
| Decrease of 200 | 144074 | 122109 |

---

__________________

(1) Represents the amounts by which the investment portfolio mark-to-market would change assuming rate shocks are instant and parallel to the yield curves for the various interest rates and indices that affect our net interest income.

The estimated average effective duration of our investment portfolio decreased to 4.4 years at September 30, 2025 compared to 5.2 years at December 31, 2024, due to higher prepayment assumptions due to projections of lower market rates that result in a lower weighted average duration.

Additionally, the floating rate portfolio decreased to 15.4% at September 30, 2025 from 16.8% at December 31, 2024.

------

The following table sets forth information regarding our interest rate sensitivity due to the maturities of our interest bearing assets and liabilities as of September 30, 2025. This information may not be indicative of our interest rate sensitivity position at other points in time.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| *(in thousands except percentages)* | **Total** | **Less than one year** | **One to three years** | **Four to Five Years** | **More than five years** | **Non-rate** |
| Earning Assets |  |  |  |  |  |  |
| Cash and cash equivalents | $630858 | $570612 | $— | $— | $— | $60246 |
| Securities: |  |  |  |  |  |  |
| Trading securities | 119935 | 7286 | 27520 | 22824 | 62305 |  |
| Debt available for sale, at fair value | 2122416 | 527014 | 409751 | 322522 | 863129 |  |
| Federal Reserve and FHLB stock | 62808 | 46722 |  |  |  | 16086 |
| Marketable equity securities | 2542 | 2542 |  |  |  |  |
| Loans held for investment-performing <sup>(1)</sup> | 6817500 | 4798766 | 950814 | 458938 | 608982 |  |
| **Earning Assets** | $9756059 | $5952942 | $1388085 | $804284 | $1534416 | $76332 |
| Liabilities |  |  |  |  |  |  |
| Interest bearing demand deposits | 2294310 | 2294310 |  |  |  |  |
| Saving and money market | 2139964 | 2139964 |  |  |  |  |
| Time deposits | 2097931 | 1704740 | 348130 | 44565 | 496 |  |
| FHLB advances | 831699 | 100000 | 226699 | 505000 |  |  |
| Subordinated Notes | 29752 |  |  |  | 29752 |  |
| Junior subordinated debentures | 64178 | 64178 |  |  |  |  |
| **Interest bearing liabilities** | 7457834 | 6303192 | 574829 | 549565 | 30248 |  |
| Interest rate sensitivity gap |  | (350250) | 813256 | 254719 | 1504168 | 76332 |
| Cumulative interest rate sensitivity gap |  | (350250) | 463006 | 717725 | 2221893 | 2298225 |
| Earnings assets to interest bearing liabilities (%) |  | 94.4% | 241.5% | 146.3% | 5072.8% | N/M |

---

__________________

(1) &nbsp;&nbsp;&nbsp;&nbsp;"Loan held for investment-performing" excludes $124.3 million of non-performing loans (non-accrual loans and loans 90 days or more past-due and still accruing).

N/M&nbsp;&nbsp;&nbsp;&nbsp;Not meaningful

------

**ITEM 4. CONTROLS AND PROCEDURES**

**Disclosure Controls and Procedures**

The Company maintains a set of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), as appropriate, to allow timely decisions regarding required disclosures. The CEO and the CFO, with assistance from other members of management, have evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2025, and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.

**Limitations on Effectiveness of Controls and Procedures**

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

**Changes in Internal Control over Financial Reporting**

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II. OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

In the normal course of business, we become involved in litigation and other legal proceedings arising from the banking, financial, and other activities we conduct. Based on the information presently available, and after consultation with legal counsel, management believes that the ultimate outcome in such litigation and legal proceedings, in the aggregate, will not have a material adverse effect on our business, our financial condition, or the results of our operations. Where appropriate, reserves for these various matters of litigation and/or other legal proceedings are established, under FASB ASC Topic 450, Contingencies, based in part upon management's judgment and the advice of legal counsel.

**ITEM 1A. RISK FACTORS**

For detailed information about certain risk factors that could materially affect our business, financial condition or future results see "Risk Factors" in Part I, Item 1A of the 2024 Form 10-K. There have been no material changes to the risk factors previously disclosed in the 2024 Form 10-K.

 **ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS** 

The following table provides information regarding repurchases of the Company's common stock by the Company during the three months ended September 30, 2025:

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **(a)** | **(b)** | **(c)** | **(d)** |
| **Period** | **Total Number of Shares Purchased** | **Average Price Paid Per Share** | **Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs** <sup>(1)</sup> | **Maximum Dollar Value of Shares that May Yet Be Purchased Under the Current Program**<sup>(2)</sup> |
| July 1 - July 31 | 10000 | 20.02 | 10000 | 22799779 |
| August 1 - August 31 | 205534 | 19.95 | 205534 | 18698841 |
| September 1 - September 30 | 272123 | 20.94 | 272123 | 13000012 |
| **Total** | **487657** | **20.51** | **487657** | **13000012** |

---

________________

(1) On December 19, 2022, the Company announced that the Board of Directors authorized a repurchase program pursuant to which the Company may purchase, from time to time, up to an aggregate amount of $25 million of its shares of Class A common stock (the "Stock Repurchase Program"). On December 15, 2023, the Company announced that on December 6, 2023, the Board approved to extend the expiration date of the Stock Repurchase Program that was set to expire on December 31, 2023 to December 31, 2024. As of the date the extension of the Stock Repurchase Program was approved, the Company had approximately $20 million available for repurchases under the program. On December 11, 2024, the Company announced that the Board approved to extend the expiration date to December 31, 2025. As of the date of the extension approval, the Company had approximately $12.4 million available for repurchases under the program. In the three months ended September 30, 2025, the Company repurchased an aggregate of 487,657 shares of Class A common stock at a weighted average price of $20.51 per share, under the Stock Repurchase Program.

(2)&nbsp;&nbsp;&nbsp;&nbsp;On May 28, 2025, the Company announced that the Board of Directors approved an increase in the amount available for repurchases of the Company' shares of Class A common stock under the Stock Repurchase Program to $25 million.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

------

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

**ITEM 5. OTHER INFORMATION**

**Securities Trading Plans of Directors and Executive Officers**

Our directors and executive officers may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended September 30, 2025, none of the Company's directors or officers (as defined in Rule 16a-1(f)) adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement".

------

**ITEM 6. EXHIBITS**

---

| | |
|:---|:---|
| **Exhibit** <br>**Number** | **Description** |
| 10.1 | <u>[Form of Change in Control Agreement EMC members - Approved September 2025](formofchangeincontrolagr.htm)</u> |
| 10.2 | <u>[S](https://www.sec.gov/Archives/edgar/data/1734342/000173434225000059/exhibit101-jeseparationa.htm)[e](https://www.sec.gov/Archives/edgar/data/1734342/000173434225000059/exhibit101-jeseparationa.htm)[paration Agreement and General Release, dated September 23, 2025 (incorporated by refe](https://www.sec.gov/Archives/edgar/data/1734342/000173434225000059/exhibit101-jeseparationa.htm)[rence to Ex](https://www.sec.gov/Archives/edgar/data/1734342/000173434225000059/exhibit101-jeseparationa.htm)[hibit 10.1 to Form 8](https://www.sec.gov/Archives/edgar/data/1734342/000173434225000059/exhibit101-jeseparationa.htm)[-K/A filed on September 26, 2025).\*](https://www.sec.gov/Archives/edgar/data/1734342/000173434225000059/exhibit101-jeseparationa.htm)</u> |
| 31.1 | <u>[Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002, by Gerald P. Plush, Chairman, President and Chief Executive Officer.](ex31109302025.htm)</u>\*\* |
| 31.2 | <u>[Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002, by Sharymar Calderon, Senior Executive Vice President, Chief Financial Officer.](ex31209302025.htm)</u> \*\* |
| 32.1 | <u>[Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act of 2002, by Gerald P. Plush, Chairman, President and Chief Executive Officer. \*](ex32109302025.htm)</u>\* |
| 32.2 | <u>[Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act of 2002, by Sharymar Calderon, Senior Executive Vice President, Chief Financial Officer. \*](ex32209302025.htm)</u>\* |
| 101.INS | XBRL Instance Document |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| 104 | Cover Page Interactive Data (embedded within XBRL documents) |

---

\* An exhibit of the agreement has been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of such omitted exhibit will be furnished supplementally to the U.S. Securities and Exchange Commission upon request; provided, however, that the parties may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any document so furnished. Additionally, portions of this agreement have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because such portions are (i) not material and (ii) are the type of information the registrant customarily and actually treats as private or confidential.

\*\* Furnished herewith

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | AMERANT BANCORP INC.<br>(Registrant) | AMERANT BANCORP INC.<br>(Registrant) |
| Date: | October 31, 2025 | By: | /s/ Gerald P. Plush |
|  |  |  | Gerald P. Plush |
|  |  |  | Chairman, President and Chief Executive Officer<br>(Principal Executive Officer) |
| Date: | October 31, 2025 | By: | /s/ Sharymar Calderon |
|  |  |  | Sharymar Calderon |
|  |  |  | Senior Executive Vice-President, Chief Financial Officer<br>(Principal Financial Officer) |

---

## Exhibit 10.1

![](formofchangeincontrolagr001.jpg)

FORM CHANGE IN CONTROL AGREEMENT This Severance and Change in Control Agreement (the "Agreement") is made and entered into by and between ("Executive") (as defined in the signature page) and Amerant Bank, N.A., a national banking association (the "Bank") and Amerant Bancorp, Inc. ("Amerant Bancorp") (the Bank and Amerant Bancorp collectively hereinafter shall be referred to as the "Company"), as of the Effective Date (as defined in the signature page). RECITALS WHEREAS, The Board of Directors of Amerant Bancorp and the Bank (the "Board") has determined that it is in the best interests of the Company to assure that the Company will incentivize the Executive to continue his/her dedicated employment with the Company, notwithstanding other opportunities, the possibility, threat or occurrence of a termination of employment or the occurrence of a Change in Control (as defined herein) of the Company; WHEREAS, The Board believes that it is important to provide Executive with certain severance benefits upon Executive's termination of employment and with certain additional benefits following a Change in Control to encourage the Executive to remain with the Company, notwithstanding the possibility of a Change in Control; and WHEREAS, The Company and Executive wish to terminate any and all rights and obligations the Company and/or Executive had under any prior employment, severance or change in control agreement, plan or practice in exchange for this Agreement. AGREEMENT NOW, THEREFORE, in consideration of the mutual covenants contained herein, the Company and Executive (each, the "Party," and together, the "Parties") hereto agree as follows: 1. Term of Agreement. The Initial Term of this Agreement will begin on the Effective Date and continue for two (2) years (the "Initial Term"), unless sooner terminated pursuant to Section 3 of this Agreement. The term of this Agreement shall renew automatically for successive one-year periods after the Initial Term (the "Renewal Terms"), unless and until non-renewed by either the Company or Executive upon not less than ninety (90) days' prior written notice given by either party prior to the end of the Initial Term or any Renewal Term, as applicable. The Initial Term and all Renewal Terms, if any, shall constitute the "Term." Notwithstanding the foregoing, in the event of the consummation of a "Change in Control" of the Company (as defined below), the Term shall be the one-year period following the consummation of such Change in Control. 2. At-Will Employment. The Company and Executive acknowledge that Executive's employment is and will continue to be at-will, as defined under applicable law. If Executive's employment terminates for any reason, including (without limitation) any termination of employment not set forth in Section 3, Executive will not be entitled to any payments, benefits, damages, awards or compensation other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses or pursuant to written agreements with the Company, including equity award agreements. 3. Severance Benefits upon Change in Control. a) Compensation/Benefits. Except as expressly provided in this Section 3, Executive shall have no right to receive any compensation or other benefits under this Agreement.

------

![](formofchangeincontrolagr002.jpg)

2 b) Termination Without Cause, or Resignation for Good Reason in Connection with a Change in Control. If, during a Change-in-Control Period, (x) the Company terminates Executive's employment with the Company without Cause, or (y) Executive resigns from such employment for Good Reason, then, subject to the terms of this Agreement, Executive will receive the following severance benefits from the Company: i. Severance Payments. Executive will receive severance in an amount equal to twenty four (24) months of Executive's base salary as in effect immediately prior to the date of Executive's termination of employment payable in substantially equal consecutive installments, no less frequently than monthly, in accordance with Section 3(f). Notwithstanding the foregoing, the Company or its successor in its sole and absolute discretion may accelerate any installment payment or portion thereof to be paid on any date prior to the date the installment payment would otherwise be paid, subject to the limitations of Section 6. ii. Termination Bonus Payments. Executive will receive: (a) if three (3) or more annual bonuses have been paid to the Executive, a lump sum severance payment equal to the average of Executive's annual bonus amounts paid for the three (3) full fiscal years preceding the year of the Change in Control; if only two (2) years of annual bonuses have been paid to the Executive, Executive will receive a lump sum equal to the average of Executive's annual bonus amounts paid for the two (2) full fiscal years; if one (1) year of annual bonus has been paid to the Executive, Executive will receive a lump sum equal to that annual bonus for the full fiscal year; or, "if less than one (1) year of annual bonuses has been paid to Executive, Executive will receive a lump sum equal to Executive's target annual bonus in effect for the full year in which Executive's termination of employment occurs, and (b) an amount equal to the bonus incentive amount due the Executive under the normal course of business pro-rated through the date of termination. Average bonus calculations shall be based on the number of full fiscal years during the calculation period. If Executive has been employed by the Company for less than a full fiscal year at the time of termination during any three (3) year employment period, Executive's average bonus calculation shall be calculated based on the Executive's full target annual cash incentive bonus opportunity for such partial fiscal year (i.e. any proration shall be ignored for purposes of performing this calculation). Annual bonuses shall be considered paid for a fiscal year if paid or payable in the next calendar year for performance in the applicable (prior) calendar year. Such amounts shall be paid following Executive's termination of employment, but in no event later than March 15th of the year following the year of Executive's termination of employment. iii. Continued Group Health Benefits. COBRA Continuation Benefit. If Executive timely and properly elects COBRA continuation coverage, the Company shall reimburse the Executive for the portion of the Executive's monthly COBRA payment that is equal to the amount that the Company paid as a monthly premium for Executive and any of the Executive's dependents' participation in such plan immediately prior to the Qualifying Termination (the "COBRA Continuation Benefit"). Subject to compliance with Section 6, the Bank shall make any such reimbursement within thirty (30) days following receipt of evidence from Executive of Executive's payment of the COBRA Continuation Benefit. Executive shall be eligible to receive such COBRA Continuation Benefit until the earliest of: (a) the eighteen (18) month anniversary of Executive's termination of employment; (b) the date Executive is no longer eligible to receive COBRA Coverage; or (c) the date on which Executive otherwise becomes eligible to receive substantially similar coverage from another employer. The Company reserves the right to modify or terminate the COBRA Continuation Benefit provided hereunder to the extent necessary to comply with applicable law.

------

![](formofchangeincontrolagr003.jpg)

3 c) Termination Due to Executive's Death or Disability, Termination by the Company for Cause or Voluntary Termination by Executive Without Good Reason. Except to the extent Other Vested Benefits apply to the Executive, if, during the Term, the Executive's employment is terminated: (1) by reason of Executive's death or Disability; (2) by the Company for Cause; or (3) voluntarily by Executive without Good Reason, the Company's obligations to Executive shall be limited to the payment of the Accrued Obligations, as defined below, and the timely payment or provision of the Other Vested Benefits, as defined below. The Accrued Obligations shall be paid to Executive or his/her estate or beneficiary in the event of his/her death, as applicable, in a lump sum in cash within thirty (30) days of the date of termination. Other than the Accrued Obligations and Other Vested Benefits, Executive shall have no right to receive any compensation or other benefits as a result of or in connection with the termination of his/her employment with the Company due to the Executive's death or Disability, by the Company for Cause, or by resignation by Executive without Good Reason. d) Cessation of Payments and Benefits. Notwithstanding any other provision of this Agreement to the contrary, the obligation of the Company to pay or provide the benefits under this Section 3 shall automatically and immediately terminate upon a breach by Executive of this Agreement, including without limitation a breach of Executive's obligations under Section 5, other than an immaterial and inadvertent breach of any provision other than those set forth in Section 5 that is discontinued and/or remedied (to the extent subject to cure) by Executive promptly to the Company's satisfaction. e) Accrued Obligations and Other Vested Benefits. Upon Executive's separation of employment for any reason, the Company shall pay: (1) Executive's accrued and unpaid Base Salary through the date of termination, to the extent not theretofore paid (the "Accrued Obligations"), which payments shall not be subject to the Release (as defined below) and shall be paid within thirty (30) days of the date of termination; and (2) any other benefits that are otherwise required to be provided to Executive or to which Executive is otherwise eligible to receive through the date of termination under the terms of the applicable Company plan shall be provided to Executive consistent with the terms of the applicable Company plan (the "Other Vested Benefits"). Such payment of the Other Vested Benefits shall not be subject to the Executive's execution of the Release unless otherwise called for in the applicable governing Company plan. f) Timing of Payments. Subject to any specific timing provisions in this Section 3 or Section 7, as applicable, payment of severance under this Section 3 shall be made or commence to be made within sixty (60) days following Executive's termination of employment in accordance with the Company's general policies and procedures for the payment of salaries to its executive officers. If such sixty (60) day period spans two (2) calendar years, Executive shall not have the right to designate the calendar year of payment or commencement of payment. g) Full Settlement. If the Executive receives benefits under Section 3(b) of this Agreement and the Company has other programs or plans in place during the Term, Executive shall be eligible for benefits under any such programs or plans only to the extent such programs or plans payout a higher amount and only for said differential. 4. Conditions to Receipt of Severance. Executive agrees that in order to be eligible to receive the benefits provided in Section 3 (as applicable, the "Severance Benefits"): a) Executive must execute and not thereafter revoke his/her signature to a general release of all claims against the Company and its affiliates, successors, assigns and its related persons in a form provided by and acceptable to the Company (the "Release") by the deadline set by the Company for the return of the Release. The Company will set a deadline for return of the Release (the "Release

------

![](formofchangeincontrolagr004.jpg)

4 Deadline") that will be no later than 60 days following the termination of employment. If the termination of employment occurs at a time during the calendar year where the Release Deadline could occur in the calendar year following the calendar year in which Executive's termination of employment occurs, then any severance payments or benefits under this Agreement that are not exempt from Section 409A of the Code ("Section 409A") will be paid on the first payroll date to occur during the calendar year following the calendar year in which such termination occurs, or such later time as required by (i) the payment schedule applicable to each payment or benefit as set forth in Section 3; (ii) the date the Release becomes effective; or (iii) Section 6, provided that the first payment shall include all amounts that would have been paid to Executive if payment had commenced on the date of Executive's termination of employment. b) The Executive shall comply with requirements of Section 5 both during and after his/ her employment. 5. Non-Competition, Non-Solicitation, Confidential Information. a) Non-competition. The Parties agree that a condition precedent for the application of this Section 5.a) is the Executive receiving benefits under Section 3.b). During Executive's employment, Executive has and the Company agrees that Executive will continue to have access to Confidential Information. In order to protect Confidential Information and the goodwill of the Company and to help enforce non-disclosure obligations in this Agreement, Executive agrees that during the Executive's employment with the Company or any Affiliated Companies (as defined below) and for a period of twenty four (24) consecutive months after Executive is no longer employed by the Company or any Affiliated Companies, Executive shall not directly or indirectly, whether individually or as a shareholder or other owner, partner, member, director, officer, employee, independent contractor, creditor or agent of any person (other than for the Company), enter into, engage, or promote or assist (financially or otherwise), directly or indirectly, in the business of banking; fiduciary, trust and custody services; securities, insurance brokerage, investment management, advice and related services; payments; money transmissions; lending; extending credit and deposit taking; all of the foregoing, whether domestic, international or both, and all services related or incidental to any of the foregoing (collectively, "Competitive Services") anywhere in any county in which any of the Company or any Affiliated Companies operate banking offices (which includes but is not limited to branches, loan production offices, deposit production offices, operation centers, and any similar office used by the Company or any Affiliated Companies) (the "Restricted Territory"). The Restricted Territory shall be determined at the commencement of the Change-in-Control Period. Notwithstanding the foregoing, ownership, for personal investment purposes only, of 3% or less of the outstanding capital stock of a publicly traded Company shall not constitute a violation hereof. b) Non-solicitation of Clients. During the Executive's employment with the Company or any Affiliated Companies (as defined below) and for a period of twelve (12) consecutive months after Executive is no longer employed by the Company or any Affiliated Companies, Executive shall not, directly or indirectly, whether individually or as a shareholder or other owner, partner, member, director, officer, employee, independent contractor, creditor or agent of any person (other than for the Company or any Affiliated Companies): (i) Solicit or attempt in any manner to persuade any Client of the Company or any Affiliated Companies to cease to do business, to refrain from doing business or to reduce the amount of business that any Client has customarily done or contemplates doing with the Company or any of the Affiliated Companies; or

------

![](formofchangeincontrolagr005.jpg)

5 (ii) Interfere with or damage (or attempt to interfere with or damage) any relationship between the Company or any Affiliated Companies and any Client. c) Non-solicitation of Employees; No Hire. During the Executive's employment with the Company or any Affiliated Companies (as defined below) and for a period of twelve (12) consecutive months after Executive is no longer employed by the Company or any Affiliated Companies, Executive shall not, directly or indirectly, whether individually or as a shareholder or other owner, partner, member, director, officer, employee, independent contractor, creditor or agent of any person (other than for the Company or any Affiliated Companies): (i) Solicit any employee, officer, director, agent or independent contractor of the Company or any Affiliated Companies to terminate his/her relationship with, or otherwise refrain from rendering services to, the Company or any Affiliated Companies, or otherwise interfere or attempt to interfere in any way with the Company or any Affiliated Companies' relationship with any of its employees, officers, directors, agents or independent contractors; or (ii) Hire, attempt to hire, employ or engage any person who, at any time within the one-year period immediately preceding such hire, or attempt to hire, employment or engagement, was an employee, officer or director of the Company or any Affiliated Companies. d) Non-disclosure of Confidential Information. (i) During Executive's employment with Company or any Affiliated Companies and thereafter, Executive shall not communicate or divulge any Confidential Information to any person or entity other than Company or an Affiliated Company, their employees, and those designated by Company or an Affiliated Company, or use any Confidential Information except for the benefit of the Company or any Affiliated Companies, which Executive agrees is the exclusive property of the Company or applicable Affiliated Company. Executive agrees that Executive will not remove any hard copies of Confidential Information, from the Company's or any Affiliated Companies' premises, will not download, upload, or otherwise transfer copies of Confidential Information to any external storage media, cloud storage, personal email address of Executive, or email address that is not owned by the Company or an Affiliated Company. (ii) Immediately upon the termination of Executive's employment with Company or an Affiliated Company for any reason, or earlier upon demand by the Company, Executive shall return to Company or the applicable Affiliated Company all Confidential Information in Executive's possession, including but not limited to any and all copies, reproductions, notes, or extracts of Confidential Information in paper or electronic form, as well as all Company property in the possession of Executive. Upon service to Executive of any subpoena, court order or other legal process requiring Executive to disclose Confidential Information at any time, Executive shall immediately provide written notice to Company of such service and the content of any Confidential Information to be disclosed. (iii) Immunity Notice: Executive acknowledges that an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that: (i) is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and made solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Executive further acknowledges that an individual who files a lawsuit against an employer for retaliation for reporting a suspected violation of law may disclose the trade secret to the attorney

------

![](formofchangeincontrolagr006.jpg)

6 representing the individual and use the trade secret information in the court proceeding, if the individual: (a) files any document containing the trade secret under seal; and (b) does not disclose the trade secret, except pursuant to court order. e) Non-disparagement. Executive shall not, directly or indirectly, at any time (whether during Executive's employment or thereafter), make any public statement (oral or written), or take any other action, that is disparaging to the Company or any Affiliated Company. This Agreement shall not preclude Executive from making truthful statements to correct any false statements made by the Company, any Affiliated Company or any person acting on behalf thereof about Executive or prohibit Executive from reporting possible violations of federal law or regulations, including any possible securities laws violations, to any governmental agency or entity, including but not limited to bank regulatory agencies, the U.S. Department of Justice or the U.S. Securities and Exchange Commission, or from participating in any investigation by such governmental agency or entity. f) Enforcement; Remedies; Reformation/Modification. Executive acknowledges that: (1) the provisions of this Section 5 are fundamental and essential for the protection of the Company's and the Affiliated Companies' legitimate business and proprietary interests, and the Affiliated Companies (other than the Company) are intended third-party beneficiaries of such provisions; (2) such provisions are reasonable and appropriate in all respects and impose no undue hardship on Executive; and (3) in the event of any violation by Executive of any of such provisions, the Company and, if applicable, the Affiliated Companies, will suffer irreparable harm and their remedies at law may be inadequate. In the event of any violation or attempted violation of any provision of this Section 5 by Executive, the Company and the Affiliated Companies, or any of them, as the case may be, shall be entitled to a temporary restraining order, temporary and permanent injunctions, specific performance, and other equitable relief, without any showing of irreparable harm or damage or the posting of any bond, in addition to any other rights or remedies that may then be available to them, including, without limitation, money damages and the cessation of the payments contemplated under Section 3. The parties agree that the applicable periods of non- competition and/or non-solicitation of clients and employees, as described in in Sections 5(a)-(c) above, shall be extended by the length of time during which Executive is in breach of any of the covenants in this Section 5. If any of the covenants set forth in this Section 5 are finally held to be invalid, illegal or unenforceable (whether in whole or in part), such covenant shall be deemed modified or reformed to the extent, but only to the extent, of such invalidity, illegality or unenforceability, and the remaining such covenants shall not be affected thereby. 6. Section 409A. a) Although the Company does not guarantee the tax treatment of any payments under the Agreement, the intent of the Parties is that the payments and benefits under this Agreement be exempt from, or comply with, Section 409A and to the maximum extent permitted the Agreement shall be limited, construed and interpreted in accordance with such intent. In no event whatsoever shall the Company or its affiliates or their respective officers, directors, employees or agents be liable for any additional tax, interest or penalties that may be imposed on Executive by Section 409A or damages for failing to comply with Section 409A. b) Notwithstanding any other provision of this Agreement to the contrary, to the extent that any reimbursement of expenses constitutes "deferred compensation" under Section 409A, such reimbursement shall be provided no later than December 31 of the year following the year in which the expense was incurred. The amount of expenses reimbursed in one year shall not affect the

------

![](formofchangeincontrolagr007.jpg)

7 amount eligible for reimbursement in any subsequent year. The amount of any in-kind benefits provided in one year shall not affect the amount of in-kind benefits provided in any other year. c) For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), the right to receive payments in the form of installment payments shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment shall at all times be considered a separate and distinct payment. Whenever a payment under this Agreement may be paid within a specified period, the actual date of payment within the specified period shall be within the sole discretion of the Company. d) Notwithstanding any other provision of this Agreement to the contrary, if at the time of Executive's separation from service (as defined in Section 409A), Executive is a "Specified Employee," then the Company will defer the payment or commencement of any nonqualified deferred compensation subject to , and not exempt from, Section 409A payable upon separation from service (without any reduction in such payments or benefits ultimately paid or provided to Executive) until the date that is six (6) months following separation from service or, if earlier, the earliest other date as is permitted under Section 409A (and any amounts that otherwise would have been paid during this deferral period will be paid in a lump sum on the day after the expiration of the six (6) month period or such shorter period, if applicable). Executive will be a "Specified Employee" for purposes of this Agreement if, on the date of Executive's separation from service, Executive is an individual who is, under the method of determination adopted by the Company designated as, or within the category of employees deemed to be, a "Specified Employee" within the meaning and in accordance with Treasury Regulation Section 1.409A-1(i). The Company shall determine in its sole discretion all matters relating to who is a "Specified Employee" and the application of and effects of the change in such determination. e) Notwithstanding anything in this Agreement or elsewhere to the contrary, a termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits that constitute "non-qualified deferred compensation" within the meaning of Section 409A upon or following a termination of the Executive's employment unless such termination is also a "separation from service" within the meaning of Section 409A and, for purposes of any such provision of this Agreement, references to a "termination," "termination of employment" or like terms shall mean "separation from service" and the date of such separation from service shall be the date of termination for purposes of any such payment or benefits. 7. Limitation on Payments Under Certain Circumstances. a) Anything in this Agreement to the contrary notwithstanding, in the event the Qualified Firm (as defined below) shall determine that receipt of all Payments (as defined below) would subject Executive to the excise tax under Section 4999 of the Code ("Section 4999"), the Qualified Firm shall determine whether to reduce any of the Severance Benefits paid or payable pursuant to this Agreement so that the Parachute Value of all Payments, in the aggregate, equals the Safe Harbor Amount (as defined below). The Severance Benefits shall be so reduced only if the Qualified Firm determines that Executive would have a greater Net After-Tax Receipt (as defined below) of aggregate Payments if the Severance Benefits were so reduced. If the Qualified Firm determines that Executive would not have a greater Net After-Tax Receipt of aggregate Payments if the Severance Benefits were so reduced, Executive shall receive all Severance Benefits to which Executive is entitled hereunder. b) If the Qualified Firm determines that the aggregate Agreement Payments should be reduced so that the Parachute Value of all Payments, in the aggregate, equals the Safe Harbor Amount, the

------

![](formofchangeincontrolagr008.jpg)

8 Company shall promptly give Executive notice to that effect and a copy of the detailed calculation thereof. All determinations made by the Qualified Firm under this Section 7 shall be binding upon the Company and Executive and shall be made as soon as reasonably practicable and in no event later than thirty (30) days following the date of termination. For purposes of reducing the Severance Benefits so that the Parachute Value of all Payments, in the aggregate, equals the Safe Harbor Amount, only amounts payable under this Agreement (and no other payments) shall be reduced. The reduction of the amounts payable hereunder, if applicable, shall be made by reducing the payments and benefits under the following sections in the following order: (1) first, any payments under Section 3(b)(ii); (2) second, any payments under Section 3(b)(i); and (3) third, any payments under Section 3(b)(iii). If payments to be reduced are payable at different times, the amounts shall be reduced (but not below zero) on a pro rata basis. All fees and expenses of the Qualified Firm shall be borne solely by the Company. c) As a result of the uncertainty in the application of Section 4999 at the time of the initial determination by the Qualified Firm hereunder, it is possible that amounts will have been paid or distributed by the Company to or for the benefit of Executive pursuant to this Agreement that should not have been so paid or distributed ("Overpayment") or that additional amounts which will have not been paid or distributed by the Company to or for the benefit of Executive pursuant to this Agreement could have been so paid or distributed ("Underpayment"), in each case, consistent with the calculation of the Safe Harbor Amount hereunder. In the event that the Qualified Firm, based upon the assertion of a deficiency by the Internal Revenue Service against either the Company or Executive that the Qualified Firm believes has a high probability of success, determines that an Overpayment has been made, Executive shall promptly (and in no event later than sixty (60) days following the date on which the Overpayment is determined) pay any such Overpayment to the Company together with interest at the rate used to calculate present value under Section 280G of the Code ("Section 280G"); provided, however, that no amount shall be payable by Executive to the Company if and to the extent such payment would not either reduce the amount on which Executive is subject to tax under Sections 1 and 4999 or generate a refund of such taxes. If the Qualified Firm, based upon controlling precedent or substantial authority, determines that an Underpayment has occurred, any such Underpayment shall be paid promptly (and in no event later than sixty (60) days following the date on which the Underpayment is determined) by the Company to or for the benefit of Executive together with interest at the rate used to calculate present value under Section 280G. Executive shall have no right to any Underpayment unless and until the Qualified Firm determines that an Underpayment is due. d) The Company shall cooperate with Executive in good faith in valuing, and the Qualified Firm shall take into account the value of, services provided or to be provided by Executive (including without limitation Executive's agreeing to refrain from performing services pursuant to a covenant not to compete or similar covenant, including those set forth in Section 5 of this Agreement) before, on or after the date of a change in ownership or control of the Company (within the meaning of Q&A- 2(b) of the final regulations under Section 280G), such that payments in respect of such services may be considered reasonable compensation within the meaning of Q&A-9 and Q&A-40 to Q&A- 44 of the regulations under Section 280G of the Code and/or exempt from the definition of the term "parachute payment" within the meaning of Q&A-2(a) of the regulations under Section 280G in accordance with Q&A-5(a) of the regulations under Section 280G. e) Definitions. For purposes of this Section, the following terms shall have the meaning set forth below: "Qualified Firm" shall mean a nationally recognized certified public accounting or consulting firm that is selected by the Company for purposes of making the applicable determinations under Section 7 and is reasonably acceptable to Executive, which firm shall

------

![](formofchangeincontrolagr009.jpg)

9 not, without Executive's consent, be a firm serving as accountant, auditor or consultant for the individual, entity or group effecting the change in control or ownership. "Net After-Tax Receipt" shall mean the present value (as determined in accordance with Sections 280G(b)(2)(A)(ii) and 280G(d)(4) of the Code) of a Payment net of all taxes imposed on Executive with respect thereto under Sections 1 and 4999 of the Code and under applicable state and local laws, determined by applying the highest marginal rate under Section 1 of the Code, and under state and local laws which applied to Executive's taxable income for the immediately preceding taxable year, or such other rate(s) as the Qualified Firm determined to be likely to apply to Executive in the relevant tax year(s). "Parachute Value" of a Payment means the present value as of the date of the change of control for purposes of Section 280G of the portion of such Payment that constitutes a "parachute payment" under Section 280G(b)(2) of the Code, as determined by the Qualified Firm for purposes of determining whether and to what extent the excise tax under Section 4999 will apply to such Payment. "Payment" means any payment or distribution in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of Executive, whether paid or payable pursuant to this Agreement or otherwise. "Safe Harbor Amount" means (1) 3.0 times Executive's "base amount," within the meaning of Section 280G(b)(3) of the Code, minus (2) $1.00. 8. Defined Terms. For purposes of this Agreement, the following terms shall have the meaning set forth below: a) "Affiliated Companies" shall mean all of the Bank's and/or Amerant Bancorp's direct or indirect subsidiaries, and any other entities controlled by, controlling, or under common control with the Bank and/or Amerant Bancorp, including any successors thereof. b) "Cause" shall mean, as determined in the sole discretion of the Company, any one or more of the following: (i) (I) indictment of Executive, or plea of guilty or plea of nolo contendere by Executive, to a charge of an act constituting a felony under the federal laws of the United States, the laws of any state, or any other applicable law; (II) fraud, embezzlement, or misappropriation of assets; (III) or willful misfeasance, dishonesty, or other actions or criminal conduct that materially and adversely affects the business (including business reputation) or financial condition of the Company; (ii) material violation by Executive of any law or regulation applicable to the business of the Company; or (iii) violation by Executive of any material covenant or obligation under this Agreement. c) "Change in Control" shall mean the occurrence of any of the following events: (i) any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 35% or more of the combined voting power of the then-outstanding voting securities (the "Outstanding Company Voting

------

![](formofchangeincontrolagr010.jpg)

10 Securities"); provided, however, that, for purposes of this definition, the following acquisitions shall not constitute a Change in Control: (1) any acquisition directly from the Company, (2) any acquisition by the Company which reduces the number of Outstanding Company Voting Securities and thereby results in any person acquiring beneficial ownership of more than 35% of the Outstanding Company Voting Securities; provided, that, if after such acquisition by the Company such person becomes the beneficial owner of additional Company voting securities that increases the percentage of Outstanding Company Voting Securities beneficially owned by such person, a Change in Control of the Company shall then occur, (3) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any subsidiary, (4) an acquisition by an underwriter temporarily holding securities pursuant to a bona fide public offering of such securities, (5) an acquisition pursuant to a Business Combination (as defined in paragraph (iii) below) (6) a transaction (other than the one described in paragraph (iii) below) in which Outstanding Company Voting Securities are acquired from the Company, if a majority of the members of the Incumbent Board (defined below) approve a resolution providing expressly that the acquisition pursuant to this clause (6) does not constitute a Change in Control of the Company under this paragraph (i), or (7) any acquisition pursuant to a transaction that complies with paragraph (iii) below; (ii) individuals who as of the Effective Date, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the stockholders was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (either by specific vote or by approval of the proxy statement of the Company in which such individual is named as a nominee for director, without objection to such nomination) shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; (iii) consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving the Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company in one or a series of transactions, or the acquisition of assets or securities of another entity by the Company or any of its subsidiaries (each a "Business Combination"), in each case unless, following such Business Combination, (I) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of voting common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities, as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Company's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Voting Securities, as the case may be, (II) no Person (excluding any entity resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such entity resulting from such Business Combination) beneficially owns, directly or indirectly, 25% or more of, respectively, the then-outstanding shares of common stock (or, for a non- corporate entity, equivalent securities) of the entity resulting from such Business

------

![](formofchangeincontrolagr011.jpg)

11 Combination or the combined voting power of the then-outstanding voting securities of such entity, except to the extent that such ownership existed prior to the Business Combination, and (III) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the Board providing for such Business Combination; or (iv) approval by the stockholders of a complete liquidation or dissolution of the Company. A Change in Control shall not occur unless such transaction constitutes a change in the ownership of the Company, a change in effective control of the Company, or a change in the ownership of a substantial portion of the Company's assets under Code Section 409A. d) "Change-in-Control Period" shall mean the time period commencing immediately prior to a Change in Control (as determined in the sole discretion of the Company) and ending on the one- year anniversary after the Change in Control. e) "Client" shall mean the customers or clients of the Company or any Affiliated Companies and shall include any and all individuals, organizations, or business entities that: (i) were actual customers or clients of the Company or any Affiliated Company during Executive's employment by the Company or any Affiliated Company, or which were prospective customers of the Company or any Affiliated Company during Executive's employment; and (ii) with which or whom Executive had contact, had responsibility for those employees who had such contact, or about whom Executive obtained Confidential Information during the Term from the Company or any Affiliated Company. For purposes of this definition, an individual, organization, or business entity is a "prospective" client or customer of the Company or any Affiliated Company if the Executive or any other the Company or any Affiliated Company employee, officer or manager took steps to obtain or secure the business of the individual, organization, or business entity. f) "Code" means the Internal Revenue Code of 1986, as amended. g) "Confidential Information" shall mean all trade secrets, proprietary data, and other confidential information of or relating to the Company and/or any Affiliated Company, including without limitation, unique selling, origination and servicing methods and business techniques; training, service and business manuals; promotional materials, and other training and instructional materials; vendor and product information; client, customer and prospective customer or client lists, other customer and prospective customer and client information; and other business information; financial information; proprietary computer programs, software, applications, directories, databases, passwords and access codes; marketing plans, materials, strategies and information; information regarding corporate opportunities; operating and business plans and strategies; research and development; policies and manuals; training materials; personnel information of employees that is private and confidential and is unrelated to wages, hours and other terms and conditions of employment; and information concerning planned or pending acquisitions or divestitures. Notwithstanding the foregoing, the term "Confidential Information" shall not include information which: (i) was known by Executive prior to employment with the Company or Company Affiliate; (ii) becomes available to Executive from a source other than the Company or Company Affiliate, or third parties with whom the Company or Company Affiliates are not bound by a duty of confidentiality; or (iii) becomes generally available or known in the industry or by the public through lawful means (except where such public disclosure has been made by Executive without authorization).

------

![](formofchangeincontrolagr012.jpg)

12 h) "Disability" or "Disabled" means, as determined in the sole discretion of the Company, that Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted, or can be expected to last, for a continuous period of not less than one (1) year. i) "Good Reason" means Executive's termination of employment within ninety (90) days following the expiration of any cure period (discussed below) following the occurrence, without Executive's consent, of one or more of the following: (i) a material reduction in Executive's base compensation or incentive compensation opportunity; provided, that a reduction of less than five percent (5%) will not be considered a material reduction in such compensation; (ii) a material reduction in the authority or responsibilities of Executive's position; (iii) a change in the primary location at which Executive is required to perform duties of his/her employment to a location more than 50 miles from location at which his/her office is located on the Effective Date; or (iv) A material breach by the Company of a material provision of this Agreement. Executive will not be considered to have resigned for Good Reason unless executive provides the Company with written notice of the existence of the applicable good reason condition within sixty (60) days of the date the Executive believes the condition first arose, specifically identifying the acts or omissions constituting the grounds for Good Reason and a reasonable cure period of not less than thirty (30) days following the date of such notice during which such condition must not have been cured. j) "Section 409A" means Code Section 409A, and the final regulations and any guidance promulgated thereunder or any state law equivalent. k) "Solicit" shall mean any direct or indirect communication of any kind whatsoever, regardless of by whom initiated, inviting, advising, persuading, encouraging or requesting any person or entity, in any manner, to take or refrain from taking any action; provided, however, that the term "Solicit" shall not include general advertisements by an entity with which Executive is associated or other communications in any media not targeted specifically at any specific individual described in Section 5(b) or 5(c). 9. Successors. a) Company Successors. Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company's business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. The Company shall be permitted to assign this Agreement to a Company Affiliate in connection with a Change in Control without any consent of the Executive provided such assignment will not eliminate the application or potential trigger of a Change in Control as defined herein. For all purposes under this Agreement, the term "Company" will include any permitted Company assign hereunder or successor to the Company's business and/or assets which executes and delivers the assumption agreement described in this Section 9(a) or which becomes bound by the terms of this Agreement by operation of law.

------

![](formofchangeincontrolagr013.jpg)

13 b) Executive's Successors. The terms of this Agreement and all rights of Executive hereunder will inure to the benefit of, and be enforceable by, Executive's personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. Executive shall not be permitted to assign this Agreement. 10. Arbitration. a) Arbitration. Subject to the right of the Company and the Affiliated Companies to exercise the remedies described in Section 5 of this Agreement or the right of Executive to challenge, defend or contest same in any court having jurisdiction, the Parties agree that any and all controversies, claims, or disputes between Executive and the Company or any employee, officer, director, shareholder or benefit plan of the Company in their capacity as such or otherwise arising out of, relating to, or resulting from Executive's employment with the Company or termination thereof, including any breach of this Agreement, will be subject to binding arbitration under the then applicable Employment Dispute Resolution Rules of the American Arbitration Association. Claims subject to arbitration include but are not limited to claims under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Fair Labor Standards Act, the Older Workers Benefit Protection Act, the Sarbanes Oxley Act, the Worker Adjustment and Retraining Notification Act, the Family and Medical Leave Act, claims for breach of contract (express or implied), claims for violation of public policy or wrongful termination, and any other statutory or common law claim under federal or state law as permitted by law. b) Procedure. In any such arbitration, the arbitrators shall consist of a panel of three arbitrators, which shall act by majority vote and which shall consist of one arbitrator selected by each party subject to the arbitration and a third arbitrator selected by the two arbitrators so selected, who shall be either a certified public accountant or an attorney at law licensed to practice in the State of Florida and who shall act as chairman of the arbitration panel; provided that, if one party selects its arbitrator for the panel and the other party fails to so select its arbitrator within ten (10) business days after being requested by the first party to do so, then the sole arbitrator shall be the arbitrator selected by the first party. A decision in any such arbitration shall apply both to the particular question submitted and to all similar questions arising thereafter and shall be binding and conclusive upon both parties and shall be enforceable in any court having jurisdiction over the party to be charged. Each party shall bear the cost of its own attorney's fees. However, if any party prevails on a claim that, according to applicable law, affords the prevailing party attorney's fees, the arbitrator may award reasonable attorney's fees to the prevailing party. All other costs and expenses of arbitration shall be borne by the Company. All rights and remedies of each party under this Agreement are cumulative and in addition to all other rights and remedies that may be available to that party from time to time, whether under any other agreement, at law or in equity. Any arbitration under this Agreement shall be conducted in Miami Dade County, Florida, or virtually if otherwise agreed by the parties. c) Remedy. Except as otherwise provided by law or this Agreement, arbitration shall be the sole, exclusive, and final remedy for any dispute between Executive and the Company. Accordingly, except as otherwise provided by law or this Agreement, Executive and the Company hereby waive the right to seek remedies for any such disputes in court, including the right to a jury trial. Notwithstanding, the arbitrator will not have the authority to disregard or refuse to enforce any lawful Company policy, and the arbitrator will not order or require the Company to adopt a policy not otherwise required by law which the Company has not adopted.

------

![](formofchangeincontrolagr014.jpg)

14 11. Voluntary Nature of Agreement. Executive acknowledges and agrees that Executive is executing this Agreement voluntarily and without any duress or undue influence by the Company or anyone else. Executive further acknowledges and agrees that Executive has carefully read this Agreement and that Executive has asked any questions needed for Executive to understand the terms, consequences and binding effect of this Agreement and fully understands it, including that EXECUTIVE IS WAIVING EXECUTIVE'S RIGHT TO A JURY TRIAL. 12. Notice. a) General. Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of Executive, mailed notices will be addressed to him or her at the home address which he or she most recently communicated to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all notices will be directed to the attention of its chief legal officer. b) Notice of Termination. Any termination by the Company for Cause or by Executive for Good Reason will be communicated by a notice of termination to the other party hereto given in accordance with Section 12(a) of this Agreement. Such notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will be not more than thirty (30) days after the giving of such notice). The failure by Executive or the Company to include in the notice any fact or circumstance which contributes to a showing of Good Reason or Cause, as applicable, will not affect the termination date or waive any right of Executive or the Company, as applicable, hereunder or preclude Executive or the Company, as applicable, from asserting such fact or circumstance in enforcing his/her or its rights hereunder, as applicable. 13. Miscellaneous Provisions. a) No Duty to Mitigate. Executive will not be required to mitigate the amount of any payment contemplated by this Agreement, nor will any such payment be reduced by any earnings that Executive may receive from any other source. b) Waiver. No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time. c) Headings. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement. d) Entire Agreement. This Agreement constitutes the entire agreement of the parties hereto and supersedes in their entirety all prior or contemporaneous representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter hereof, except that any restrictive covenants of Executive contained in any other agreements with the Company shall survive. Executive acknowledges and agrees that this Agreement encompasses all the rights of Executive to any severance payments and/or benefits based on the termination of Executive's employment and Executive hereby agrees

------

![](formofchangeincontrolagr015.jpg)

15 that he or she has no such rights except as stated herein. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto and which specifically mention this Agreement. e) Prior Agreement. Executive acknowledges and agrees that the __________ Agreement dated ________ [insert date of agreement for each Executive] ("The Prior Agreement") shall terminate as of the Effective Date of this Agreement, and by execution of this Agreement, Executive intends to waive any right to entitlement to benefits under The Prior Agreement at such time. Executive also acknowledges and agrees that in no event would Executive be entitled to both payment or benefits under The Prior Agreement and to payments or benefits under this Agreement. [If not applicable, delete the above paragraph and replace with Intentionally left blank.] f) Choice of Law. The validity, interpretation, construction and performance of this Agreement will be governed by the laws of the State of Florida without giving effect to provisions governing the choice of law. g) Severability. The invalidity or unenforceability of any provision or provisions of this Agreement will not affect the validity or enforceability of any other provision hereof, which will remain in full force and effect. h) Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable income, employment and other taxes, and any other applicable deductions, as determined in the Company's reasonable judgment. i) Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. j) Compliance with Applicable Law. The benefits paid and provided under this Agreement are subject to and conditioned upon compliance with applicable requirements of federal, state and local law and regulation, whether currently in effect or subsequently enacted, including without limitation, 12 U.S.C. Section 1828(k) and the regulations promulgated thereunder in 12 C.F.R. Part 359. Consistent with the foregoing, the Company shall have the right to defer, cancel or recoup any payment or refuse to provide any benefit under this Agreement in the event the Company determines in good faith, acting in its sole discretion, that making such payment or providing such benefit violates any applicable law or regulation. Further, benefits paid and provided under this Agreement may be subject to any clawback policy generally applicable to the executives of the Company (whether in existence as of the Effective Date or later adopted) or as may be required by applicable law or as may be established by the Company in its sole discretion. To the extent determined necessary to comply with the Guidance on Sound Incentive Compensation Policies issued by the Office of the Comptroller of the Currency, the Board of Governors of the Federal Reserve System, the Federal Deposit Insurance Company and the Office of Thrift Supervision on June 21, 2010, as it may be implemented, modified and interpreted from time to time, the Executive and the Company mutually agree to amend the provisions of this Agreement and to cooperate in good faith with respect thereto. [Signature page follows]

------

![](formofchangeincontrolagr016.jpg)

16 IN WITNESS THEREOF, the Parties have executed and entered into this Agreement as of the Effective Date, as set forth below. EXECUTIVE AMERANT BANK, N.A. / AMERANT BANCORP, INC. By: ____________________ By: ____________________ Name: Name: Title: Title: Date ____________________ "Effective Date"

------

## Exhibit 31.1

**AMERANT BANCORP INC.**

**EXHIBIT 31.1** 

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

**<u>CERTIFICATION</u>**

I, Gerald P. Plush, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Amerant Bancorp Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as

defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial

&nbsp;&nbsp;&nbsp;&nbsp;reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial

&nbsp;&nbsp;&nbsp;&nbsp;reporting and the preparation of financial statements for external purposes in accordance with generally accepted

&nbsp;&nbsp;&nbsp;&nbsp;accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: October 31, 2025

---

| |
|:---|
| <u>/s/ Gerald P. Plush</u> |
| Gerald P. Plush<br>Chairman, President and<br>Chief Executive Officer  |

---

## Exhibit 31.2

**AMERANT BANCORP INC.**

**EXHIBIT 31.2** 

CERTIFICATION PURSUANT TO

RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

**<u>CERTIFICATION</u>**

I, Sharymar Calderon, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Amerant Bancorp Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as

defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial

&nbsp;&nbsp;&nbsp;&nbsp;reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial

&nbsp;&nbsp;&nbsp;&nbsp;reporting and the preparation of financial statements for external purposes in accordance with generally accepted

&nbsp;&nbsp;&nbsp;&nbsp;accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: October 31, 2025

---

| |
|:---|
| <u>/s/ Sharymar Calderon</u> |
| Sharymar Calderon<br>Senior Executive Vice President, <br>Chief Financial Officer |

---

## Exhibit 32.1

**AMERANT BANCORP INC.**

**EXHIBIT 32.1** 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Amerant Bancorp Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025, as filed with the Securities and Exchange Commission as of the date hereof (the "Report"), I, Gerald P. Plush, Chairman, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 31, 2025

---

| |
|:---|
| <u>/s/ Gerald P. Plush</u> |
| Gerald P. Plush |
| Chairman, President and<br>Chief Executive Officer |

---

## Exhibit 32.2

**AMERANT BANCORP INC.**

**EXHIBIT 32.2**

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Amerant Bancorp Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025, as filed with the Securities and Exchange Commission as of the date hereof (the "Report"), I, Sharymar Calderon, Senior Executive Vice President, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 31, 2025

---

| |
|:---|
| <u>/s/ Sharymar Calderon</u> |
| Sharymar Calderon<br>Senior Executive Vice President, <br>Chief Financial Officer |

---

<br>